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Abstract 
Dioxins, in particular TCDD, are potent mammalian toxins acting 
predominantly in the thymus and skin, in body weight regulation and in liver 
carcinogenesis. The Ah receptor (AhR) a Iigand activated transcription factor 
betonging to the bHLH-PAS protein family mediates the toxicity of dioxins. 
Despite the extensive research conducted during the past 20 years, the 
mechanism by which AhR mediates the toxicity of dioxins is not understood. 
Known AhR regulated genes mostly code for xenobiotica metabolizing enzymes 
but the AhR target gene(s) which mediate toxicity arenot known. 
ln this study 5L rat hepatoma cells were employed as a model system for 
dioxin toxicity in which TCDD severely delays cell cycle progression in the G 1 
phase by an AhR dependent mechanism. An AhR deficient variant subclone of 
5L cells, the BP8 cells, are resistant to TCDD. These AhR-deficient cells were 
used for a mutational analysis of AhR overexpression to test the required 
properties of AhR to delay cell cycle progression. 8oth, the receptor's capacity for 
sequence specific DNA recognition and the presence of the transcriptional 
activation domain are necessary to induce the cell cycle delay. This suggests that 
AhR mediates the TCDD effects on cell cycle by bona fide induction of yet tobe 
identified target genes. Such AhR target genes were searched following two 
approaches, e.g. based on the biochemical analysis of the cell cycle machinery 
and by a systematic search for AhR induced genes. 
Evidence from biochemical analysis of the cell cycle machinery suggested 
that TCDD might induce cell cycle inhibitor(s). One of the inhibitory proteins, 
p27K1P1 , is induced by TCDD in 5L cells. lnduction of p27K1P1 occurs through the 
direct induction of Kip1 mRNA by AhR. AhR-dependent activation of Kip1-
transcription is a novel mechanism of Kip1 induction which is distinct from the 
accumulation of Kip1 protein caused by posttranscriptional regulation in alt the 
cases reported so far. Kip1 is the cause for TCDD-induced delay of 5L cell 
proliferation, since inhibition of Kip1 accumulation by expression of antisense 
RNA almost completely abolishes the effects of TCDD on the cell cycle. The 
induction of Kip1 could explain some of the toxic effects of TCDD in vivo which 
are associated with reduced proliferation, like the TCDD-induced atrophy of the 
thymus. Evidence for a rote of Kip1 in thymus toxicity of TCDD has been 
generated in the group by the use of Kip1 deficient mice. 
ln a second approach, suppression subtractive hybridization was 
performed to identify TCDD-induced genes in 5L cells. Among the identified 34 
differentially expressed genes, 22 were already known to be induced by TCDD. 
ln addition, there are 3 known genes whose expression was previously not 
known to be induced by TCDD and 8 novel sequences. A Ionger cDNA fragment 
corresponding to one of the clones was isolated and identified as part of the N-
myristoyltransferase 2 (NMT-2) gene. TCDD is the first substance known to 
induce NMT-2 transcriptionally. NMT-2 is an enzyme catalysing myristoylation of 
many proteins, one of which is the signal transducing tyrosine kinase p6osrc. 
NMT-2 mRNA was also found tobe increased in livers of mice treated with TCDD 
in vivo. Thus NMT-2 may play a role in liver carcinogenicity of dioxins, since 
increased myristoylation of proteins and, in particular, the Src family protein 
kinases is implicated in carcinogenesis. 
ln conclusion, the chosen approaches allowed the identification of several 
novel dioxin-induced targetgenas of the Ah receptor. One of the induced genes, 
the p27Kip1 cell cycle inhibitor, was shown to be essentially required for dioxin 
toxicity in 5L cells. The complexity of changes in gene expression, as indicated 
by the independent induction of many and not obviously related genas, suggests 
that dioxins trigger multiple genetically defined response pathways rather than 
one 'master gene' responsible for all symptoms of dioxin toxicity. 
Ah-(Dioxin) rezeptorabhängig regulierte Gene, die 
Dioxintoxizität vermitteln können: Induktion des p27K1P1 
Zellzyklusinhibitors und der N-Myristoyltransferase 2 
durch Dioxine 
Zusammenfassung 
Dioxine und insbesondere TCDD sind potente Gifte für Säuger, die vor 
allem auf den Thymus, die Haut, das Körpergewicht und die Entstehung von 
Leberkrebs wirken. Der Ah-Rezeptor (AhA), ein Liganden-abhängiger 
Transkriptionstaktor aus der bHLH-PAS Proteinfamilie, vermittelt die Toxizität von 
Dioxinen. Trotz immenser Forschungsanstrengungen während der vergangenen 
20 Jahre ist der Mechanismus der Dioxintoxizität noch nicht geklärt. Bekannte 
AhA-abhängig regulierte Gene kodieren zumeist für Enzyme des 
Fremdstoffmetabolismus, aber AhA-regulierte Gene, die Dioxintoxizität 
vermitteln, sind nicht bekannt. 
ln dieser Studie wurden als Modellsystem der Dioxintoxizität SL 
Rattenhepatomzellen analysiert, in denen TCDD über einen AhA-abhängigen 
Mechanismus die Progression des Zellzyklus durch die G 1-Phase erheblich 
verzögert. Ein AhR-defizienter Subklon der SL-Zellen, die BP8-Zellen, ist 
resistent gegenüber TCDD. ln diesen AhA-defizienten Zellen wurde der AhA 
ektopisch exprimiert und eine Mutationsanalyse durchgeführt, um die für den 
Zellzyklusarrest erforderlichen Eigenschaften des AhA zu testen. Sowohl die 
Fähigkeit an spezifische DNA-Erkenungssequenzen zu binden als auch die 
transaktivierende Funktion des AhA sind notwendige Voraussetzungen für die 
Hemmung der Zellzyklusprogression. Diese Beobachtung deutet darauf hin, daß 
der AhA die TCDD-Effekte auf den Zellzyklus durch bona fide Induktion von im 
weiteren zu identifizierenden 'Toxizitätsgenen' vermittelt. 
Hinweise aus der biochemischen Analyse der Zellzyklusmaschinerie 
wiesen darauf hin, daß TCDD einen oder mehrere Zellzyklusinhibitor(en) 
induzieren könnte. Eines der lnhibitorproteine, p27K1p1, wird durch TCDD in SL-
Zellen induziert. Diese Induktion beruht auf der direkten Induktion der Kip1 
mANA durch den AhA. AhA-abhängige Aktivierung von Kip1-Transkription stellt 
einen neuen Mechanismus der Kip1-lnduktion dar, der sich von allen Formen 
der bisher beschriebenen posttranskriptionallen Regulation unterscheidet. Kip 1 
ist die Ursache für die Verzögerung des Zellzyklus durch TCDD, weil die 
Verhinderung der Kip1-Akkumulation durch Expression einer Kip1 Gegensinn-
RNA die Dioxineffekte auf den Zellzyklus nahezu vollständig unterdrückt. Die 
Induktion von Kip1 könnte auch einige der toxischen Dioxinwirkungen in vivo 
erklären, die, wie zum Beispiel die TCDD-induzierte Atrophie des Thymus, mit 
reduzierter Zellproliferation assoiziiert sind. Die Analyse Kip1 defizienter Mäuse 
in der Arbeitsgruppe zeigt tatsächlich Evidenz für die Rolle von Kip1 bei der 
Thymustoxizität von TCDD. 
ln einem zweiten Ansatz wurde die Methode der 'Suppression subtractive 
hybridisation' eingesetzt. um TCDD-induzierte Gene in SL-Zellen zu 
identifizieren. Unter den 34 isolierten differentiell exprimierten Genfragmenten 
fanden sich 22 Gene, deren Induktion durch Dioxine schon beschrieben wurde. 
Zusätzlich fanden sich 3 bekannte Gene, deren Induktion durch TCDD bisher 
nicht bekannt war, sowie 8 unbekannte Genfragmente. Die Isolation eines 
längeren cDNA-Fragmentes zu einem dieser unbekannten Fragmente führte zu 
dessen Identifizierung als Teil des N-myristoyltransferase-2 Gens (NMT-2). 
TCDD ist der erste beschriebene transkriptionalle Induktor der NMT-2-
Expression. Das Enzym NMT-2 katalysiert die Myristoylierung einer Vielzahl von 
Proteinen, von denen eines die signalübertragende p6osrc Protein-Tyrosinkinase 
ist. Erhöhte Spiegel der NMT-2 mRNA wurden auch in der Leber TCDD-
behandelter Mäuse gefunden. Damit könnte NMT-2 eine Rolle bei der 
Leberkanzerogenität von Dioxinen spielen, denn der Proteinmyristoylierung und 
insbesondere die Myristoylierung von Proteinen der Src-Familie wird eine 
Bedeutung bei der Kanzerogenase zugemessen. 
Zusammenfassend erlaubten die gewählten Ansätze die Identifizierung 
mehrerer neuer Dioxin-induzierter Zielgene des AhA. Für eines der induzierten 
Gene, Kip1, konnte eine essentielle Rolle für die Dioxintoxizität in SL-Zellen 
nachgewiesen werden. Die Komplexität der Veränderungen in der 
Genexpression, die sich in der Induktion vieler offensichtlich von einander 
unabhängiger Gene ausdrückt, deutet darauf hin, daß Dioxine mehrere 
genetisch definierte Programme triggern und kaum von einem 'Schlüsselgen' für 
alle Symptome der Dioxintoxizität auszugehen ist. 
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1. lntroduction 
The term 'Dioxins' is commonly used to describe a family of extremely toxic 
compounds, e.g. the polyhalogenated dibenzo-p-dioxins. All eight hydrogens in 
the dibenzo-p-dioxin molecule can be substituted by halogen atoms in various 
combinations. Only considering all possible chlorinated dioxins allows the 
formation of 75 chemically distinct congeners. Dioxins have never been 
produced by intention except for scientific purposes. Rather, dioxins are formed 
as by-products in many organic chemical reactions or combustion processes in 
the presence of halogens. Major sources of dioxins are the production of 
chlorinated phenols or phenoxy herbicides and pesticides, waste incineration, 
metal smelting, combustion of leaded fuels and chlorine bleaching of paper and 
pulp. Many of these processes release dioxins ubiquitously into the environment. 
As a consequence, some of the dioxin-generating processes have been 
dramatically improved or have been abandoned since the problern of dioxin 
contamination became apparent. One of the dioxins, the 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD) has gained special interest and serves the 
role of a model compound because of its high toxicity. Together with dioxins 
usually two related classes of halogenated aromatic hydrocarbons, the 
halogenated dibenzofuranes and biphenyls, are generated which can have 
similar effects on the biosphere. Hence a broader definition of the term dioxins 
usually includes the dibenzofurane-derived compounds (figure 1 ). 
Dioxins and TCDD in particular have gained a high degree of public 
attention because they are toxic to human and animals at very low doses. TCDD 
was in the focus of public interest when in 1976 at the Seveso (ltaly) chemical 
plant large quantities of TCDD and other dioxins were released into the 
environment and severely intoxicated the local population with chloracne being 
the acute and most prominent symptom. Other large-scale intoxication of humans 
occurred through contaminated rice oil in Yusheng (Taiwan), at chemical plants 
in Bophai (lndia) and Harnburg (Germany). A heavy public, legal, and scientific 
debate was fuelled by the intoxication of American Vietnam soldiers by dioxins 
which had been present as a contaminant in 'Agent Orange' which was used for 
defoliation and crop destruction. However, it is not the few cases of heavy 
intoxication, but rather the ubiquitous presence in the environment, the 
accumulation and persistence in the food chain Isading to dioxin exposure of 
humans which have kept dioxins in the public discussion since. Despite of this 
general interest and some success in understanding biological activities of 
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dioxins, the mechanisms how dioxins are toxic to mammals are not yet 
understood. 
Dibenzo-p-dioxins 
R R 
I# O*R 0 R R 
Dibenzofuranes 
R R 
R: H, F, Cl, Br, or I 
Biphenyls 
R H H R R-Q-tr 
R H H R 
2,3, 7,8-Tetrachlorodibenzo~p-d ioxin 
H H 
CIAOACI 
c1VoYc1 
H H 
Figure 1. Chemical structures of 'dioxins' and related biphenyls. The basic structures 
of dibenzo-p-dioxins, dibenzofuranes and the biphenyls are shown. Compounds with 'dioxin'-like 
biological activities contain halogen atoms, mostly chlorine, instead of hydrogen in numerous com-
binations at some of the positions indicated by R. The mostpotent congener and model compound 
2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (lower panel) contains chlorine atoms in the 4 lateral posi-
tions. 
1.1 Biological effects of dioxins in animals 
Labaratory animals including primates have been extensively used to 
study dioxin toxicity. The prominent effect of dioxins in Iabaratory animals is a 
wasting syndrome which is characterized by progressive loss in body weight 
which ultimately results in death (Huff et al., 1994 and Christian et al., 1986). The 
sensitivity to TCDD varies among different species. Guinea pigs have been 
shown to be highly susceptible to the Iethai effects of TCDD. The hamster is 
approximately 5000 times less sensitive, e.g. the LD50 for acute TCDD poisoning 
is 1 J..Lg/kg body weight in the guinea pig and 5000 J..Lg/kg in the hamster. Rats and 
mice showintermediate sensitivity (Poland et al., 1982). Many other symptoms of 
acute or subacute toxicity occur at much lower doses. The immune system for 
example isasensitive target of TCDD toxicity. The effects include thymic atrophy 
(Fine et al., 1990 and Silverstone et al., 1994a), degenerative changes in bone 
marrow (Silverstone et al., 1994b; Frazier et al., 1994 and Staples et al., 1998), 
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and alterations in the immune response affecting both humoral and cell-
mediated immunity (Fine et al., 1990 and Silkworth et al., 1986). The generation 
of sperm cells is affected resulting in a reduced sperm count. Toxic effects on the 
skin are found in nude mice (Knutson and Poland, 1982}. Dioxins are also toxic 
to the developing embryo resulting in increased rates of fetal mortality or 
malformations like cleft palate and skeletal abnormalities (Peterson et al., 1993 
and Gouture et al., 1990). 
TCDD isacarcinogen in several rodent species, including the hamster. ln 
rats TCDD induced neoplasms in Jung, oral and nasal cavities and liver (Kociba 
et al., 1978). ln mice it caused neoplasms in liver, subcutaneous tissue, Jung and 
lymphopoietic system (Toth et al., 1979) and in hamsters it produced squamous 
cell carcinomas of the facial skin (Rao et al., 1988). TCDD is carcinogenic at 
doses as low as 1 ng/kg body weight per day which is far below the Iethai dose 
(Huff et al., 1994). TCDD is, however, not mutaganie and this is consistent with 
the findings that it does not directly bind to DNA and form DNA adducts 
(Turteltaub et al., 1990). Thus, by the simple model of tumor initiation and 
promotion/ progression, TCCD would act as tumor promoter rather than an 
initiator. TCDD is considered a potent carcinogen because it is carcinogenic at 
quite low doses compared to other tumor promoters. 
1.2 Effects of dioxins in humans 
Dioxin exposure and toxicity in humans is relevant in three types of 
populations, the acutely poisoned people in accidents like those at Seveso, 
people exposed occupationally during their work life, and the generat population 
which is exposed to low Ievels of dioxins through environment and food chain. 
The predominant effect observed in humans exposed to relatively large 
amounts of TCDD is chloracne. Chloracne is a severe skindisaase characterized 
by follicular hyperkeratosis occurring with or without cysts and pustules. 
Carcinogenicity of dioxins in rodents raised the concern that dioxins may also be 
human carcinogens and this proposition is supported by the follow up study of 
the dioxin-poisoned population of Seveso. With a latency of up to now 20 years 
increased rates of soft tissue sarcomas, lymphoid and myeloid neoplasms as 
weil as stomach and rectal cancer are found clearly supporting the view that 
dioxins are human carcinogens (Bertazzi et al., 1993, 1997 and Pesatori et al., 
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1993). The strength of such studies lies in good knowledge about the initial 
intoxication but the draw back from a statistician's point of view is the relatively 
low numbers of individuals. 
Epidemiological data from occupationally exposed workers have 
established an association between exposure to TCDD and several human 
cancers, especially digestive and respiratory cancers (Fiesch-Janys et al., 1995, 
Kogevinas et al., 1997; Manz et al., 1991; Ott and Zober, 1996; Smith and Bates, 
1992 and Smith et al., 1992). A number of diseases other than cancer have also 
been reported which include infectious and parasitic diseases, skin and liver 
diseases, respiratory tract infections and mental disorders (Zober et al., 1994). 
The difficulty in these studies is that occupational exposure probably was not 
only to dioxins but also other non-dioxin hazardous compounds. Although best 
efforts have been taken to compensate for such potential influences for example 
by work history exploration and direct measurements of dioxin body burdens, 
such studies are more difficult to interpret than the single exposures in the few 
accidents. 
The major concern in the public discussion is the low Ievei of dioxin 
exposure through the environment. lt is estimated that exposure Ieveis to 2,3,7,8-
TCDD in industrialised nations are approximately 20 to 40 pg per day. Effects 
induced by 2,3,7,8-TCDD arealso elicited by other dioxins (Rodriguez-Pichardo 
et al., 1991) and usually average exposure is to a complex mixture of several 
dioxins. Different dioxins differ dramatically with respect to their potency, e.g. 
required doses in vivo or concentrations in cultured cells, compared to 2,3,7,8-
TCDD. The biological system responds to the cumulative exposure to these 
chemieals rather than to any single compound. To account for such cumulative 
effects, each toxic congener has been given an equivalence factor which allows 
to transform the actual dose or concentration of any congener to the amount of 
2,3,7,8-TCDD which would have the same biological activity, the so-called 
'toxicity equivalent' (TEQ). The rational for such a comparison is based on the 
knowledge discussed below on a common primary intracellular target for TCDD-
Iike dioxins (Eadon et al., 1986). Taking into consideration exposure to all 
relevant dioxins including polychlorinated biphenyls, dibenzofuranes, and other 
dibenzo-p-dioxins results for adults an average uptake of 200 to 400 pg TEQ per 
day. The most important dioxin uptake occurs with the food. Due to their lipophilic 
and chemically inert properties, dioxins are found particularly in products which 
are made from late stages in the food chain like animal products or milk fats. The 
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biological half life of TCDD in humans is about 7 years and thus the daily uptake 
accumulates to substantial Ieveis. 
The accumulated body burdens in humans are within one order of 
magnitude close to those which show signs of toxicity in rodents. There is, 
however, no indication, that the average burdens of dioxins cause any diseases 
in humans. This may be because humans are not very sensitive or because of 
the inability to detect adverse effects of dioxins with the existing scientific tools. 
Reasons for these difficulties could be that doses after all are low and only few 
particularly sensitive people are affected. Another reason could be based on the 
limited power of epidemiological studies because there is no non dioxin-exposed 
control population which a dioxin-exposed population can be compared to. 
Comparison of Jow versus high Ievei exposed subpopulations based on their 
dioxin Ieveis in the blood Iipids may be an approximation of limited power. 
Understanding the mechanisms by which dioxins are toxic in rodents 
could help to extrapolate to humans and could particularly help to predict at 
which doses or body burdens dioxin toxicity can be expected. The realisation that 
there is an intracellular receptor binding dioxins and cloning of that receptor have 
been important, but by far not sufficient, steps towards understanding the 
mechanism(s) of dioxin toxicity. 
1.3 Evidence for a dioxin binding, intracellular receptor 
ln rodents or in cultured cells polycyclic aromatic hydrocarbons (PAHs) like 
benzo(a)pyrene or methylcholantherene induce the aryl hydrocarbon 
hydroxylase activity (AHH), which is associated with a number of individual 
cytochrome P450-dependent monooxygenases, e.g. the CYP450 1 A and 1 B 
families. The inducibility of AHH activity varied among mouse strains, with 
C57BU6 mice being highly responsive to PAHs, where as DBA/2 mice were only 
poorly responsive. The F1 offsprings after crossing these two strains showed 
high responsiveness to PAHs. Backerosses to the parental strain showed that the 
high AHH inducibility is inherited as an autosomal dominant trait and resulted in 
the postulation of a gene locus which was named as Ahr- locus (Ahr for Aryl 
hydrocarbon responsiveness). 
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Experimental evidence that the Ahr-locus encodes a protein for binding 
aromatic hydrocarbons came from studies using TCDD which at very low doses 
induced AHH in the 'responsive' but not in the 'non-responsive' mouse strains. 
Ligand-binding studies with 3H-TCDD, analogaus to those performed with steroid 
hormones, demonstrated the presence of high affinity, and saturable binding 
sites in cytosolic extracts from 'responsive' mice but not from the 'non-responsive' 
mice. The presence of high affinity binding sites segregated with the 'responsive' 
phenotype in the crosses between 'responsive' and 'nonresponsive' strains. 
Binding of TCDD could be competed by other AHH-inducing aromatic 
hydrocarbons. This indicated the presence of a receptor binding TCDD and aryl 
hydrocarbons which was named the Ah receptor (AhA) (Swanson and Bradfield, 
1993). 
Due to its low abundance, the receptor has resisted purification for almest 
20 years. The development of a photoaffinity Iigand carrying a radioactive iodine 
atom had finally allowed purification and N-terminal amino acid sequencing of 
the receptor (Perdew and Poland, 1988). The degensrate cDNA sequence 
deduced from the peptide sequence allowed cloning of the AhR's cDNA from 
recombinant cDNA and genomic libraries (Burbach et al., 1992 and Ema et al., 
1992). 
1.4 AhR is a Iigand activated transcription factor 
Much of the knowledge on AhR function was gathered before the AhR 
gene was cloned by biochemical and cell biological methods mostly using the 
inducibility of AHH activity in cultured Hepa 1 murine hepatoma cells as the 
experimental system. ln these cells the unliganded receptor is found exclusively 
in the cytoplasm bound to heat shock protein 90 (HSP90) (Denis et al., 1988; 
Okey et al., 1994 and Perdew, 1988). Upon Iigand binding (e.g. TCDD), the 
Hsp90 gets dissociated and the ligand-bound receptor translocates into the 
nucleus (Okey et al., 1994). AHH activity in these cells is mostly constituted by the 
cytochrome P450 1 A 1 enzyme. Cytochrome P450 1 A 1 is induced by AhR ligands 
on the Ievei of increased gene expression and hence the gene encoding this 
enzyme, e.g. the CYP450 1A 1 gene, has been studied as a model case how the 
nuclear AhR can regulate gene expression. 
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The cloning and deletion analysis of the 5' regulatory region of the 
CYP450 1A 1 gene has revealed the existence of several short sequence 
elements, each of which can mediate enhanced gene expression upon activation 
ot the AhA. These elements are functional in the context of the CYP450 1 A 1 
promoter or when placed in front of other initially not AhA responsive promoters 
(Hankinson, 1995; Nebert et al., 1993 and Whitlock, 1990). Thus these short DNA 
sequences fulfil the criteria of a true transcriptional enhancer element and have 
been called dioxin responsive elements (DREs). Apart from dioxins also many 
other non physiologic compounds like non-halogenated aromatic hydrocarbons 
or aromatic amines (Cikryt et al., 1990 and 1992) induce CYP450 1 A 1 through 
these elements and therefore they are also called XAEs for xenobiotica 
responsive elements .. 
The nuclear translocation of activated AhA and the presence of 
specific DAEs in the 5' regulatory region of an AhR activated gene strongly 
suggested that AhR acts as a ligand-activated transcription factor much like the 
steroid hormone receptors. This mode of action would require specific binding 
through one domain of AhR to short recognition sequences in the regulated 
target gene promoter, e.g. the DRE/XAE, and activation of transcription through a 
second so-called transactivation domain. The first requirement, the sequence-
specific binding to the XAE, has been shown tobe matched by the presence of a 
XRE-binding activity in extracts from TCDD treated Hepa1 cells in a gel mobility 
shift analysis (Carlstedt-Duke et al., 1981; Denison et al., 1989 and Fujisawa-
Sehara et al., 1988). The Observations that this DNA-binding activity was not 
present in cells which had not been treated with TCDD or in TCDD-treated 
mutant Hepa 1 cells which lacked a functional AhR proved that the DNA-binding 
activity was specifically associated with AhR (Hapgood et al., 1989). The most 
simple explanation of this observation was that AhR itself is a DNA-binding 
molecule. The experimental evidence for this proposition was generated much 
later after cloning the AhR cDNA and generation of AhR directed antibodies 
(Poland et al., 1991 ). 
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Cytoplasm 
Nucleus 
Figure 2. Outline of the function of the Ah receptor (AhR) as a ligand-activated 
transcription factor. AhA is found in cytoplasm bound to heat shock protein 90 (Hsp90) in the 
absence of a Iigand. Ligand binding results in release of Hsp90 and nuclear translocation of AhA. 
The receptor dimerises with Arnt. The heterodimeric complex binds to specific sites, so-called 
xenobiotica responsive elements (XAEs), in the promoters of genes coding for xenobiotic metabo-
lising enzymes and activates their transcription. AhA regulated genes mediating dioxin toxicity are 
not known. 
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The Hepa 1 cell line and the derived mutant cell lines which lacked 
AHH inducibility were also used to generate the initial evidence that several 
genetic loci contribute to AHH inducibility by the AhR system (Legraverend et al., 
1982). The AhR-deficient clones described above only constituted one 
complementation group which appeared by the Iack of detectable 3H-TCDD 
binding to AhR. Another complementation group appeared by the presence of 
Iigand binding AhR which however did not properly translocate to the nucleus. 
Complementation cloning in these deficient cells allowed identification of the 
gene responsible for this defect and the protein encoded by that gene was called 
the as Ah receptor nuclear translocator (Arnt) (Hoffman et al., 1991 ). Later 
studies have suggested that Arnt is not directly involved in translocating AhR into 
the nucleus, because AhR can be found in the nucleus after Iigand treatment in 
Arnt deficient Hepa cells (Pollenz et al., 1994). Using antibodies generated 
against Arnt, it was shown that Arnt was a part of the complex binding to the XRE 
together with AhA (Reyes et al., 1992) (figure 2). The consensus sequence of the 
XRE was identified as 5' TC/TGCGTG 3'. AhR binds to the 5' (TC/TGC) and Arnt 
to the 3' (GTG ) half sites of the XRE (Swanson et al., 1995). 
Besides CYP450 1A 1, genes for other xenobiotic metabolizing enzymes 
are regulated through XREs, including CYP450 1A2, CYP450 181 and non-P450 
enzymes like glutathione-S-transferase Ya, UDP-glucuronosyltransferase, 
NAD(P)H:quinone oxidoreductase and aldehyde dehydrogenase. 
1.5 AhR and Arnt are members of the basic-helix-loop-helix-PAS 
family of transcription factors 
Cloning of the AhA and Arnt cDNAs revealed that they are distinct from 
steroid hormone receptors. Amino acid sequence alignments showed a striking 
resemblance in overall structure of AhA and Arnt (Burbach et al., 1992; Ema et 
al., 1992; Hoffman et al., 1991 and ltoh and Kamataki 1993}. They contain basic-
helix-loop-helix (bHLH) motifs near their amino termini. Such motifs are found in 
other transcription factors like Myc, Max and MyoD that bind specific DNA 
sequences as homodimers and heterodimres, where they function in both protein 
dimerization and DNA binding (Davis et al., 1990 and Murre et al., 1989). A 
feature of many bHLH proteins is the presence of a secondary dimerization 
surface adjacent to the HLH domain. An example of such a secondary 
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dimerization domain is the leueine zipper, and bHLH proteins containing this 
motif are called bHLH-ZIP proteins (Kadesch, 1993). 
The AhA and Arnt contain a segment of homology adjacent to the bHLH 
motif, which is also found in two regulatory proteins of Drosophila, Per and Sim 
(Huang et al., 1993 and Nambu et al., 1991). The homologaus domain present in 
all four proteins has been termed the PAS domain, for Per-AhA/Arnt-Sim 
homology domain. The PAS domain contains two copies of an approximately 50-
amino acid degensrate direct repeat, referred to as the PAS A and PAS 8 
repeats (Citri et al., 1987; Crewset al., 1988 and Nambu et al., 1990). 8oth AhA 
and Arnt contain glutamina-rich regions near the carboxy termini. Glutamine rich 
regions are also found in other transcription factors such as SP1, and function as 
transcriptional activation domains (Jain et al., 1994 and Whitelaw et al., 1994). 
The AhA is unique among bHLH proteins as its activity is dependent on 
the binding of a Iigand. Hypoxia inducible factor 1 a (HIF-1 a) is a new member of 
the PAS family and regulates transcription of genes in response to hypoxia as a 
heterodimeric complex with Arnt (Wang and Semenza, 1995). Per is an unusual 
member of the PAS family without a bHLH domain (Huang et al., 1993). 
1.6 Functional domains of AhR and Arnt 
Functional domains of AhA and Arnt were investigated by deletion 
analysis by several groups. The basic region of both AhA and Arnt are required 
for DNA binding (Bacsi and Hankinson 1996 and Swanson and Yang 1996). The 
PAS domain is necessary and sufficient for dimerization (Lindebro et al., 1995 
and Weiß et al., 1996) of both proteins. The bHLH domain is shown to stabilize 
the heterodimers. Ligand binding of AhA is localized to a region encompassing 
the PAS 8 repeat in AhA (Fukunaga et al., 1995 and Whitelaw et al., 1993). The 
PAS domain of AhA also harbours the contact region for association with HSP90. 
This binding is necessary for the ability of AhA to assume and/or maintain a 
Iigand binding confirmation since the receptor loses its affinity for its Iigand if 
HSP90-receptor complex is disrupted (Pongratz et al., 1992 and Whitelaw et al., 
1995). C-terminal glutamina-rich regions of both AhA and Arnt have potent 
transcriptional activation domains (TADs) (Hui Li et al., 1994; Jain et al., 1994 
and Weiß et al., 1996) which function on heterologous DNA binding domains. 
Wh ich T AD prevails in gene activation in a given context seem to depend on the 
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assay system (Fukunaga et al., 1995, Whitelaw et al., 1994, and results 
presented in this thesis). 
1. 7 AhR mediates the toxicity of TCDD 
AhR mediates the toxicity and carcinogenicity of TCDD and its structural 
analogues based on several Observations. Firstly, structure-activity relationships 
demonstrate that within a particular series of halogenated aromatic hydrocarbons 
(for example, polychlorinated dioxins and polychlorinated biphenyls), the toxicity 
of a compound is correlated with the affinity with which it binds to AhR. Secondly, 
mice strains differ in their susceptibility to the toxic effects of TCDD. The AhR from 
the nonresponsive strains of mice such as DBA/2 binds TCDD with an affinity that 
is about tenfold lower than the receptor from the responsive strains such as 
C57BU6 mice. This difference in affinity parallals the difference between the 
strains in their sensitivity to the biochemical and toxic effects of TCDD (Swanson 
and Bradfield, 1993). Lastly, studies of AhR knockout mice indicated that mice 
lacking the receptor are resistant to TCDD-induced toxic effects (Fernandez-
Salguero et al., 1996). 
Despite the extensive research conducted during the past several years, 
the mechanism by which AhR mediates the effects of dioxins is not known. Much 
of what we know about AhR function comes from the studies of CYP450s and 
other xenobiotic metabolizing enzymes. Function of these genes is not likely to 
explain dioxin toxicity. However, AhR regulated genes which mediate dioxin 
toxicity are unknown. No link has been demonstrated between the induction of 
xenobiotic metabolizing enzymes and any toxic end points of dioxins. 
A number of groups have attempted to identify changes in gene 
expression following TCDD exposure by 'educated guess' and 'differential 
screening' approaches. The changes in gene expression which could Iead to 
alteration in differentiation and proliferation of cells upon TCDD treatment were 
analysed. Members of the AP-1 family of proto oncogenes like C-jun, c-fos and 
jun-D were shown to be induced by TCDD in mouse and rat hepatoma cells 
(Hoffer et al., 1996; Nebert et al., 1993; Puga et al., 1992 and Carsten Weiß, 
personal communication). However, the mode of induction of these genes is not 
clear and data in the Iiterature are not conclusive. 
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Using differential hybridization, two TCDD-responsive genas, plasmino-
gen activator inhibitor 2 and interleukin 1 ß were isolated from human keratino-
cytes (Sutter et al., 1991). Though it was shown that both the genas were 
induced at the transcription Ievei, it could not be ruled out that the induction was 
a consequence of differentiation of the used keratinocytes. Neither of these 
genas is induced in other cell systems for example in 5L cells (Own unpublished 
observations and W. F. Greenfee, personal communication) or in livers of TCDD-
treated rats (Fox et al., 1993 and Vanden Heuval et al., 1994). The differential 
display technique was employed to isolate a novel TCDD-induced gene from rat 
liver with sequence homology to a cytokine/growth factor/prolactin receptor 
superfamily (Selmin et al., 1996). Very recently, TCDD also was shown to induce 
ecto-ATPase in mause hepatoma cells (Gao et al., 1998). 
lnduction of these genas provide evidence that TCDD alters different sets 
of genas in different cells/organs. But there are no studies published linking the 
induction of these genas and TCDD toxicity. Thus, there is considerable interest 
in identifying more AhA regulated genas and determining which of these genes 
are responsible for the manifestations of TCDD toxicity. 
1.8 Model system for TCDD toxicity 
Most of the toxic effects of TCDD are associated with changes in differen-
tiation and proliferation of cells. I chose a modal system which allows to study the 
effects of TCDD on proliferation. 
One of the few toxic actions of TCDD in continuously growing cell culture is 
a severe delay in G1-S progression of 5L rat hepatoma cells (Göttlicher and 
Wiebel 1991). This effect of TCDD on cell proliferation is not found in BP8 cells, 
the variant clones of 5L cells which Iack AhA, suggesting that AhA is mediating 
TCDD etfects on cell cycle progression (Göttlicher et al., 1990). Stable 
expression of AhA in the receptor deficient BP8 cells, reconstitutes the TCDD-
induced cell cycle delay (Weiß et al., 1996). Thus AhA plays a causal role in 
mediating the TCDD-induced cell cycle delay in 5L cells. However, it is not 
known which genas are regulated and how they are regulated. lt is also not 
known whether changes in gene expression are the primary cause at all for the 
AhA-mediated cell cycle delay. 
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AhA is known to mediate diverse effects of TCDD apart from transcriptional 
activation of XAE regulated genes. The AhA was shown to intertere with growth 
factor signaHing (Astroff et al., 1990; Hudson et al., 1985 and Lin et al., 1991 ), to 
bind to cell cycle regulatory molecules like the retinoblastoma protein and cyclin-
CDK complexes (Ge and Elferink, 1998 and Greenlee, personal communication) 
and also to increase tyrosine kinase activity of p6oc-src (Enan and Matsamura, 
1995). From steroid hormone receptor studies there is evidence for different 
modes of nuclear receptor action independent of binding to DNA and direct 
transcriptional activation of genes. The steroid receptors can transrepress genes 
and also induce signal transduction cascades (Göttlicher et al., 1998; Jonat et al., 
1990; Migliaccio et al., 1996; Peterziel, 1998 and Schuele and Evans, 1991 ). 
Thus it appears possible that AhA can also have fuctions independent of direct 
activation of genes. So, it is important to determine whether all functions of AhA 
as an activator of transcription are also required for mediating TCDD-induced cell 
cycle delay. 
1.9 Regulation of the cell cycle 
Living cells repeatedly grow and divide in a cyclic fashion and the period 
from one division to the next is called the cell cycle. The duration of the cell cycle 
in animal cells is usually 18-24 hours and is divided into 4 phases namely G 1, S, 
G2 and M- phases (for Gap, Synthesis and Mitosis). After mitosis, cells are 
released into a condition as G1 phase. This is the usually Iongest phase in the 
cell cycle and its duration varies in different cells. Commitment to chromosome 
replication occurs in G1 phase. The initiation of DNA replication marks the 
transition from G1 phase toS phase. During S phase, the genome is replicated 
and the total content of DNA increases from the diploid value of 2n to the tully 
replicated value of 4n. The period from the end of S phase until mitosis is called 
G2 phase. During this period, the cell has two complete diploid sets of 
chromosomes. Mitosis of a cell generates two identical daughter cells, each 
bearing a diploid set of chromosomes. This period corresponding to the actual 
division is called the M phase (Heichman and Aoberts, 1994). After division, the 
cells start with G1 phase again. Since the effect of TCDD is in the G1 to S phase 
progression, only the events of this part of the cell cycle are presented in more 
detail here. 
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1.9.1 G1 to S phase progression 
The transition of cells through G1 to S phase of the cell cycle involves 
major check points which allow modulation of proliferation by signals from inside 
or outside the cell. The commitment of cells to enter the S phase occurs at the 
restriction (R) point in mid/late G1 phase, after which growth factors are no Ionger 
required for cells to complete division (Pardee, 1989). 
Phosphorylation of the retinoblastoma tumor suppressor gene product 
(pRb) coincides with the R point of transition and is also likely to play an essential 
role in commitment to replication. ln its hypophosphorylated state pRb binds to 
and negatively regulates transcription factors such as E2F, whose functions are 
important for G1 to S phase progression (Bartek et al., 1996 and Weinberg, 
1995). Phosphorylation of pRb during middle to late G1 phase reverses the 
growth suppressive effects of pRb by releasing E2F, there by enabling it to 
activate genes required for ONA replication. Cyclin 0 and E- associated kinase 
activity is required for phosphorylation of pRb in G 1 phase and progression of 
cells from G1 toS phase. 
Three 0-type cyclins (01, 02 and 03) are expressed early in G1 phase 
and complex with either COK4 or COK6. Cyclin E is expressed later than the 0-
type cyclins in G1 phase and enters into a complex with COK2. ln cantrast to the 
Ieveis of cyclins, the expression of COKs is not altered during the cell cycle. 
Cyclin-bound COKs are phosphorylated on a single threonine residue by a COK-
activating kinase (CAK) and become catalytically active kinase complexes. Thus 
the expression of cyclins and the phosphorylation of cyclin-bound COKs by CAK 
control the G1 cyclin-COK kinase activity (Morgan, 1995). 
1.9.2 Negative regulation of G1 cyclin-CDK acivity 
There is an additional mode of cell cycle regulation by COK-inhibitory 
proteins (CKis) which negatively regulate G 1-S phase progression (figure 3). So 
far, seven CKis have been found and can be divided into two major classes 
based on sequence similarity and mode of action. Members of INK4 family of 
inhibitors specifically bind to COK4 and COK6 and inhibit their association with 
cyclin 0. There are four members of this family p151nk48, p161nk4A, p181nk4c and 
p 191nk40 (Sherr and Roberts, 1995). The Cip/Kip family of inhibitors comprises 
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three distinct gene products: p21 Cipi, p27Kipi and p57Kip2 • They bind to G1 cyclin-
CDK complexes and inhibit their catalytic activity. These three proteins share an 
amino-terminal conserved region that is shown to be important for interaction 
with cyclin-CDK complexes (Lees, 1995; Massague, and Polyak, 1995 and Sherr 
and Roberts, 1995). 
CycD 
CDK4/6 
i 
I CycD llcoK4/61 
~ ~ 
i 
@ 
CycE II CDK2 I 
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Figure 3. Regulation of G1 to S phase progression. The retinoblastoma tumor 
suppressor gene product (pRb) plays a key role in G1-8 progression. ln its hypophosphorylated 
state it binds to and negatively regulates transcription factors such as E2F, whose functions are 
important for G1- to 8-phase progression. 0-type cyclins (CycD) and cyclin E (CycE) acting tagether 
with cyclin-dependent kinases (CDKs), phosphorylate pRb during mid to late G1 phase. pRb 
releases E2F in response to phosphorylation. The liberated E2F enhances expression of genes 
required for 8-phase entry. Cyclin-Cdk activity is negatively regulated by two families of CDK-
inhibitory proteins (shaded). lnk4 type inhibitors bind to CDK4/6 and inhibit their association with 
cyclin D. The Cip/Kip family of inhibitors consisting of p21, p27 and p57 bind to cyclin-Cdk 
complexes and inhibit their catalytic activity (8herr and Roberts, 1995). 
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The large number of inhibitors may reflect the requirement to respond to a 
variety of different signalling pathways. Transforming growth factor ß (TGFß)-
induced cell cycle arrest for example is associated with increased Ieveis of 
p27K1P1 and p 151nk48 (Hannon and Beach, 1994; Polyak et al., 1994a and 1994b 
and Reynisdottir et al., 1995). p27K1P1 is also identified as a key regulator of 
growth arrest in response to removal of growth factors (Coats et al., 1996). p21 clp1 
is a target of transcriptional activation by the p53 tumor suppressor gene product 
and is induced in response to DNA darnage (Dulic et al., 1994 and EI~Deiry et al., 
1993). Expression of p21 Cip1 is also increased in senescing cells (Noda et 
al., 1994). The Cip/Kip proteins are also upregulated in many differentiating 
tissues suggesting that these proteins play a role in withdrawal from the 
proliferative cycle with the onset of differentiation (Sherr and Roberts, 1995). 
Each CKI may play independent and non redundant roles in whole the 
organism as knock-out mice of each CKI revealed different phenotypes (Zavitz 
and Zipursky, 1997). 
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1.10 Aims 
Dioxins are potent mammalian texins affecting poliferation and 
differentiation of cells. Despite the knowledge that AhR mediates these 
effects, little is known about the signaHing pathways which Iead to 
dioxin toxicity. For studying dioxin toxicity, I used 5L rat hepatoma cells 
as a model system in which TCDD severely delays cell cycle 
progression through the G-1 phaseinan AhR-dependent fashion. The 
aim of this work was to determine how AhR mediates TCDD-induced 
cell cycle delay. The following questions were addressed. 
1. ls AhR dependently induced transcription of yet to be defined target 
genes required for TCDD induced cell cycle delay? 
2. lf AhR mediated transcription is required, what are target genes of 
AhR responsible for cell cycle effects and possibly the other toxic 
activities of dioxins? 
Two approaches were followed to find AhR regulated genes. 
One was the analysis of known cell cycle regulatory and, in 
particular, inhibitory proteins after TCDD treatment of 5L cells. The 
secend approach was to find TCDD-induced genes by differential 
screening. Two of the identified genes were studied in detail for 
their role in TCDD toxicity. 
3. Does the TCDD induced cell cycle delay follow the same AhR 
dependent signalling pathway as the known target gene in TCDD-
induced metabolism of xenobiotica? ln particular, the role of the 
AhR partner protein Arnt was tested. 
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2. Results 
2. 1 Functions of AhR which are required for cell cycle delay in 
SL cells 
One of the aims of the work presented here, was to determine whether 
AhA regulated gene transcription is required for TCDD-induced cell cycle delay. 
DNA binding and transactivation properties of AhA are required for transcrip-
tional activation of genes (Hankinson, 1995). The BP8 cells are insensitive to 
TCDD due to the Iack of AhA. Ectopic expression of AhA reconstitutes TCDD 
effects such as cell cycle delay in these cells (Weiß et al., 1996). The expression 
of various receptor mutants in BP8 cells allows to determine whether DNA 
binding and transactivation properties of AhA are required to reconstitute cell 
cycle delay. 
2. 1 . 1 Mutational analysis of AhR 
Mutants of AhA which were defective in DNA binding or transactivation 
were created. This was to determine the functions of AhA required for reconstitu-
tion of cell cycle delay in the receptor deficient BP8 cells. A schematic outline of 
AhA and AhA mutants is given in figure 4. AhA A39A encodes an AhA with a 
single amino acid exchange at position 39 from arginine to alanine. This 
mutation was shown to be sufficient to abolish DNA binding to a XAE sequence 
both in vivo and in vitro (Dong et al., 1996). ln GaiAhA 83-805, the entire DNA 
binding domain of AhA is exchanged with that of the yeast Gal4 transcription 
factor and thus this mutant Iacks the native AhA DNA binding activity but can ac-
tivate gene expression from a Gal4-responsive promoter (Weißet al., 1996). AhA 
1-408 and AhA 1-605 encode receptors that partially (AhA 1-605) or completely 
Iack the C-terminal transactivation domain. 
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Figure 4. Schematic outline and expected defects of Ah receptor mutants used 
in this study in comparison to wild type Ah receptor (AhR). Numbers refer to the 
positions of amino acids. Marked areas identify the core bHLH-DNA-binding domain (1-83), the 
Iigand binding domain and the conserved PAS-A (A) and PAS-S (B) motifs withil) the dimerization 
domain (83-418) and a glutamina-rich region (Q) within the transactivation domain (418-805). 
DNA binding and transactivation domains of AhR are essential for trans-
activation of XRE regulated genes (Hankinson, 1995). Thus AhR mutants defec-
tive in DNA binding or transactivation should not transactivate a XRE-dependent 
reporter gene. To test whether the AhR mutants behave as expected, they were 
transiently cotransfected with a XRE-dependent luciferase reporter construct into 
the receptor deficient BP8 cells (figure 5). ln BP8 cells the reporter gene was not 
inducible in the absence of AhR. Transfeetion of an expression vector for the full 
length receptor led to high basal luciferase activity without addition of TCDD and 
was further inducible two fold by TCDD treatment consistent with published data 
(Weiß et al., 1996). The DNA binding defective AhR mutant (AhR A39A) and the 
two C-terminal deletion constructs lacking the transactivation domain (AhA 
1-408) or a part of it (AhA 1-605) did not activate the XRE-dependent reporter 
gene activity significantly. 
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Figure 5. Transactivation of a XRE-dependent reporter gene by AhR or AhR 
mutants in AhR deficient BP8 cells. AhR deficient cells were transiently transfected by 
electroporation with 10 Jl9 of the XRE-Luc reporter gene together with 2 Jl9 of the expression 
vectors for AhR or AhR mutants or the empty expression vector as a control. Cells from the two 
electroporations transfected with the same DNA were pooled and then split equally onto two 
culture dishes. One was treated with 1 nM TCDD (filled bars) and the second with 0.1% DMSO 
(used as a solvent, open bars) immediately after transfection. Reporter gene activities were 
determined 24 h later. The reporter gene activity obtained with coexpression of the wild type AhR 
(solvent treated) was arbitrarily set to 1. Bars represent means +1- range from two independent 
experiments. 
Functional expression of the AhA mutants wastobe confirmed as they did 
not activate the XAE-dependent reporter activity. This was shown by transient 
cotransfection of various AhA mutants with the XAE-dependent reporter gene 
into 5L cells which contain endogenaus AhA. lf the two DNA-binding defective 
AhA mutants (AhA A39A and GaiAhA 83-805) are functionally expressed, they 
should heterodimerize with the AhA's partner protein Amt and by that sequester 
Amt into complexes which can not bind to an XAE. This should Iimit the amounts 
of Arnt which are available to heterodimerize with endogenaus AhA to form AhA-
Amt heterodimers binding to and activating the XAE-dependent reporter gene. lf 
the two C-terminal deletion constructs Jacking the complete transactivation do-
main (AhA 1-408) or a part of it (AhA 1-605) are functionally expressed, they 
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should heterodimerize with endogenaus Arnt by forming mutant AhR-Arnt het-
erodimers with reduced transcriptional activity. These transcriptionally inactive 
heterodimers should compete with endogenaus AhR-Arnt heterodimers for the 
XRE-binding sites on the reporter gene construct and as a result interfere with 
the expression of the reporter gene. 
The results of such a cotransfection experiment are shown in figure 6. The 
XRE-dependent reporter gene was 15 fold inducible by TCDD in 5L cells without 
transfection of AhR mutants. Coexpression of various receptor mutants down 
regulated the reporter gene activity. This indicated that the AhR mutants could be 
functionally expressed. 
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Figure 6. Expression of AhR mutants interferes with XRE-dependent reporter 
gene activity. 5L cells were transfected by electroporation with 6 119 of the XRE-Luc reporter 
construct and 24 119 of the expression vectors for AhR mutants or the empty expression vector as 
control. Cells from two electroporations transfected with the same DNA were pooled and then split 
equally onto two culture dishes. One dish was treated with 1 nM TCDD (filled bars) and the second 
with 0.1% DMSO (used as solvent, open bars) 12 h aftertransfection. Reporter 9ene activities were 
determined 40 h later. The reporter 9ene activity obtained with coexpression of the control vector 
(solvent treated) was arbitrarily set to 1. The bars represent means +1- ran9e from 2 independent 
experiments. 
22 Results 
2.1.2 Establishment of conditions in which transiently expressed 
mutants of AhR can be tested for their effect on cell 
proliferation 
The mutants of AhR described in the previous paragraph were to be 
expressed in BP8 cells to determine whether DNA binding and transactivation 
properties of AhR are required to induce cell cycle delay. Attempts to generate 
stable transfectants using BP8 cells had failed before (Göttlicher - personal 
communication). Therefore a method was established to test the effect of AhR 
mutants on cell cycle by transient transfections. ln transient transfections, only a 
minor population of cells efficiently takes up the transfected genes. Therefore the 
efficiently transfected cells had to be detected by some kind of 'flag' amongst the 
inefficiently transfected cells from the same culture dish. This would allow to 
analyse all cells simultaneously for their distribution over the cell cycle by flow 
cytometry and to use the 'flag' afterwards to gate the acquired data for efficiently 
transfected cells or inefficiently transfected cells respectively. 
A method was developed employing coexpression of green fluorescent 
protein (GFP) (Chalfie., 1994 and Heim et al., 1995), which allowed identification 
of efficiently transfected cells by means of their green fluorescence in a flow 
cytometer (figure 7 A). 
To show that the system works, full length AhR was transiently coex-
pressed tagether with GFP in the AhR deficient BP8 cells. TCDD treatment 
reduced the proliferation of cells (represented by the decrease in the percentage 
of cells in the Sand G2 phases of the cell cycle) in the efficiently transfected cells 
(green flourescing) expressing wild type AhR compared to the inefficiently 
transfected (non-green) cells of the same culture dish (figure 7, compare panels 
in row 2). When empty expression vector was transfected there was no effect of 
TCDD either in the efficiently transfected (green) compared to inefficiently 
transfected (non-green) population of cells (figure 7, compare panels in row 1 
and the data for non transfected control vs. TCDD treated cells not shown). Thus 
the transient expression of full length receptor reconstitutes TCDD-induced cell 
cycle delay in BP8 cells. 
Results 23 
2.1.3 Reconstitution of cell cycle delay by AhR mutants in the AhR 
deficient BPS cells 
The AhR mutants described in section 2.1.1 were tested for their ability to 
reconstitute cell cycle delay in the receptor deficient BP8 cells by the GFP 
cotransfection analysis. Neither the DNA binding defective (AhR R39A, GaiAhR 
83-805) nor the transactivation deficient AhR mutants (AhR 1-408, AhR 1-605) 
could reconstitute the cell cycle delay in BP8 cells. 
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Figure 7. A DNA binding defective mutant Ah receptor (AhR R39A) does not 
reconstitute cell cycle delay in receptor deficient BPB cells. BP8 cells were 
transiently cotransfected with 2.5 1!9 of expression vector for 9reen fluorescent protein (GFP) and 
24 1!9 of expression vectors for wild type AhR or mutant AhR (AhR R39A) or the empty expression 
vector as control. (A) The GFP-expressin9 sub population of transfected cells was identified by 
high 9reen fluorescence as indicated in comparison to non-transfected cells by flow cytometry. 
(B) Cells were treated with 1 nM of TCDD, 24 h after transfection and harvested for flow cytometric 
analysis 24 h later. Gell cycle profiles were determined by H33258 stainin9 and analysed 
individually for the green fluorescin9 sub populations and the non-green fluorescing sub 
populations. One representative out of 3 similar experiments is shown. 
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As an example, the cell cycle profilas obtained with the transient coexpression of 
the DNA binding defective AhAmutant (AhA R39A) and GFP are shown in figure 
7. There was no effect of TCDD in the efficiently transfected (green) compared to 
inefficiently transfected (non-green) population of cells (figure 7 compare panels 
in row 3). The results obtained with other mutants are summarized in table I. 
TABLE I 
Reconstitution of cell cycle delay in the receptor deficient BP8 cells by 
expression of AhA or AhA mutants. 
Name of the mutant Defect Ce II cycle delay 
Full length AhA (aa 1-805) - + 
AhA R39A DNA binding -
GaiAhR 83-805 Native DNA binding -
AhA 1-408 Transactivation -
AhA 1-605 Transactivation -
The analysis of AhA mutants indicates that both DNA binding and 
transactivation domains of the AhA are essential for reconstitution of TCDD-
induced cell cycle delay in BP8 cells. This suggested that transcriptional activa-
tion of genes by AhA is required for mediating cell cycle effects of TCDD, since it 
is unlikely that potential other modes of AhAaction were as sensitive to all the 
mutations tested here. 
There is further support for this hypothesis generated by Carsten Weiß 
(Personal communication). TCDD inhibits G1-phase progression prior to hyper-
phosphorylation of the retinoblastoma protein (Rb) in 5L cells synchronously 
released from a low serum-induced cell cycle arrest. Addition of TCDD 2 h prior 
to the expected hyperphosphorylation of Rb almost completely prevented Rb hy-
perphosphorylation. Treatment with the transcriptional inhibitor actinomycin D 
alone during these 2 h did not prevent Rb hyperphosphorylation. lf TCDD was 
added tagether with actinomycin D, phosphorylated Rb accumulated as effi-
ciently as in untreated cells. This indicated that the effects of dioxin on cell cycle 
require ongoing and presumably induced gene expression. 
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2.1.4 Dissociation of the XRE dependent induction of genes and 
cell cycle delay in 5L cells 
Having established that the transcriptional activation of genes by AhR is 
required for mediating cell cycle eftects of dioxins, I now asked whether activa-
tion of XRE-regulated genes could be essential for these eftects. 
For this purpese I compared different ligands or doses of TCDD for their 
ability to induced XRE-regulated transcription and cell cycle delay. 
TCDD induced CYP450 1A 1, a classical XRE-regulated gene, and de-
layed cell cycle progression at 1 nM concentration (figure 8A, compare lanes 1 
and 4). However, TCDD at lower concentrations (1 and 5 pM) induced CYP450 
1 A 1 but did not have any eftect on the cell cycle progression (figure 8A, compare 
lanes 1, 2 and 3). Thus induction of CYP450 1A 1 and cell cycle delay mediated 
by AhR follow different dose response relationships. 
Among AhR binding dioxins there is a good correlation between the affin-
ity of a given Iigand, and its potency to induce transcription of the CYP450 1 A 1 
gene in vivo (8erghard et al., 1992). However, there are few compounds distinct 
from dioxins which bind to the receptor but are poor activators, so-called partial 
agonist/antagonists (Wilhelmsson et al., 1994). One of these compounds, a-
naphthoflavone (ANF), was tested for its ability to induce XRE-regulated 
transcription and cell cycle delay (figure 88). ANF induced the cell cycle delay in 
5L cells without increasing CYP450 1A 1 or GST-Ya transcription after 24-96 
hours of treatment (figure 88, compare lanes 1 to 5). The effect of ANF is AhR 
dependent, as it did not have any effect on the proliferation of receptor deficient 
8P8 cells ( data not shown). Thus the induction of CYP450 1 A 1 or GST-Ya 
representing XRE regulated genes in two promoter contexts was not essential for 
cell cycle delay. These data also suggest that the induction of XRE-dependent 
genes and the cell cycle effects of TCDD may involve qualitatively distinct modes 
of AhR action. The AhR activates transcription of XRE-regulated genes as a 
heterodimeric complex with Arnt. Thus it is possible that the AhR-Arnt complex 
which binds to the classical XRE may not be essential for TCDD-induced cell 
cycle delay. 
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Figure 8. Dissociation of AhR-mediated cell cycle delay and induction of XRE-
regulated genes in SL cells. SL cells were treated with (A) various concentrations of TCDD 
for 24 h or (8) with 20 J1M a-naphthoflavone or 1 nM TCDD for the indicated time interval. Gell 
proliferation (% of cells in G2/S phase) was estimated from the cell cycle profiles obtained with 
H33258 staining of cells by flow cytometry. Total RNA was prepared from parallel culture dishes 
and induction of (A) CYP450 1A1 or (8) CYP450 1A1 and GST-Ya RNAs was tested by Northern 
blot analysis using 10 1!9 total RNA. Equal loading of RNA was confirmed by rehybridisation of the 
blots with a GAPDH probe. 
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2.1.5 Arnt but not mutant Arnt antagonises TCDD-induced cell cycle 
delay in 5L cells 
Todetermine whether Arnt is required for the cell cycle delay mediated by 
AhR, mutant Arnt was used which is defective in DNA binding. When over-
expressed, this mutant is expected to heterodimerize with endogenaus AhR and 
to sequester AhR into non-DNA binding inactive heterodimers with the mutant 
Arnt. lf activation of XRE regulated genes were required for TCDD-induced cell 
cycle delay, overexpression of the DNA binding defective mutant Arnt 
(ArntßbHLH) should interfere with the cell cycle delay. Similarly, overexpression 
of Arnt is expected to synergise with the TCDD-induced cell cycle delay if the 
cell cycle delay depends on upregulation of genes by the AhR-Arnt heterodimer. 
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Figure 9. Effect of Arnt and mutant Arnt overexpression on XRE-dependent 
reporter gene activity. 5L cells were transfected with 6 1-LQ of the XRE-Luc reporter gene and 
1 o 1-LQ of expression vectors for Arnt or mutant Arnt or the empty expression vector as control. Cells 
from two electroporations transfected with the same DNA were pooled and then split equally onto 
two culture dishes. One dish was treated with 1 nM TCDD (filled bars) and the second with 
0.1% DMSO (used as solvent, open bars) 12 h after transfection. Reporter gene activities were 
determined 40 h later and values were normalised for the activity of a 2 llQ of a cotransfected 
expression vector for Renilla luciferase. The bars represent means +1- S.D. from 3 independent 
experiments. 
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The behaviour of Arnt and the DNA binding defective mutant Arnt 
(Arnt.LlbHLH) was first tested in a reporter gene assay by transient transfection. 
Arnt and ArntßbHLH were cotransfected with a XRE-dependent luciferase 
reporter gene construct into 5L cells which contain endogenous AhR and Arnt. 
The coexpression of Arnt had a positive effect probably because endogenous 
Ieveis are limiting and ArntßbHLH had the expected dominant negative effect on 
the reporter gene activity (figure 9). 
Next, full length Arnt or DNA binding defective mutant Arnt (ArnMbHLH) 
were transiently coexpressed with GFP in 5L cells to determine whether Arnt was 
required for the TCDD-induced cell cycle delay. Gell cycle analysis of the effi-
ciently transfected (green) population of cells by flow cytometry revealed that 
expression of the full length Arnt prevented TCDD-induced cell cycle delay 
(figure 10, compare 5 and 6), whereas the ArntßbHLH had no effect (figure 1 0 
compare {8 and 9). These effects of Arnt and mutant Arnt are the opposite to what 
would be expected from a phenomenon which depends on upregulation of 
genes by the AhR-Arnt heterodimer. Arnt would have synergised with the AhR 
and the DNA binding defective Arnt mutant (ArntßbHLH) should have acted 
dominant negatively. These data suggest that the AhR/Arnt heterodimer is not 
required for TCDD-induced cell cycle delay. Possibly AhR acts without a partner 
protein or together with partner protein(s) distinct from Arnt. 
ln summary, the most likely interpretation of the experiments in this section 
is that transcriptional activation of genes is required for TCDD-induced cell cycle 
delay. AhR mediated cell cycle delay seems, however, not to depend on gene 
activation by AhR/Arnt heterodimer. AhR regulated genes which are likely to act 
on cell cycle were not known. Hence most of the remaining work was dedicated 
to finding such AhR regulated genes for cell cycle control. 
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Figure 10. Arnt but not DNA-binding deficient Arnt antagonises TCDD-induced 
cell cycle delay in SL cells. 5L cells were transiently cotransfected with 2.5 ll9 of expression 
vector for green fluorescent protein (GFP) and 10 ll9 of expression vectors for wild type Arnt or 
DNA binding deficient Arnt (Arnt ~bHLH) or the empty expression vector as control. Cells were 
treated with 1 nM TCDD or 0.1% DMSO solvent 12 h after transfection and harvested for flow 
cytometric analysis 40 h later. The GFP-expressing Subpopulation of transfected cells was 
identified by high green fluorescence in comparison to non-transfected cells. Cell cycle profilas 
were determined by H33258 staining and analysed individually for the transfected green 
fluorescing Subpopulations (green) and the non-transfected (non-green) subpopulations. 
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2. 2 Search for AhR regulated genes 
Two approaches were followed simultaneously to find AhR regulated 
genes involved in TCDD-induced cell cycle delay. One of the approaches was to 
analyse the known inhibitor proteins regulating cell cycle progression. The 
second approach was to systematically search for AhR target genes by 
subtractive hybridization. 
2.2.1 Cell cycle inhibitory proteins 
Gell cycle progression is regulated through the co-ordinated expression, 
and degradation of cyclins and posttranslational modification of their catalytic 
partners, cyclin-dependent kinases (CDKs). Cyclins, expressed at particular 
stages of the cell cycle, associate with specific CDKs to form active kinase 
complexes which phosphorylate multiple cellular proteins like Rb and promote 
cell cycle progression. Cyclin-CDK complexes are negatively regulated by a 
family of CDK-inhibitory proteins (CKis) which bind to CDKs or cyclin-CDK 
complexes and inhibit their catalytic activity, ultimately impeding cell cycle 
progression (Sherr and Roberts, 1995). 
2.2.1.1 TCDD induces the p27Kip1 cell cycle inhibitor 
5L cells are arrested in G1 phase of the cell cycle upon TCDD treatment. 
The various cyclin/CDK inhibitors which could Iead to a G1 arrest, were analysed 
in the Iabaratory and p27Kip1 Ieveis were found to be elevated after 4, 8 or 24 
hours of TCDD treatment (figure 11 A). The increase in protein Ieveis coincided 
with the increase in Kip1 mRNA after 4 or 24 hours of TCDD treatment 
(figure 11 8). 
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Figure 11. TCDD induces the p27K1P1 cell cycle inhibitor. 5L cells were non-treated or 
treated with 1 nM TCDD for the indicated time interval. p27Kip1 (A) protein Ieveis were determined by 
Western blot analysis of whole cell extracts. Comparable loading of lanes was confirmed by 
Coomassie staining of a part of the gel. (B) mRNA Ieveis were determined by Northern blot analysis 
using 1 0 119 of total RNA. Equalloading of RNA was confirmed by rehybridisation of the blot with a 
GAPDH probe. 
To determine whether the increase in Kip1 mRNA Ievels was due to an 
increase in stabilization of mRNA by TCDD, the decay of Kip1 mRNA was 
followed in solvent or TCDD treated cells after disruption of transcription by the 
transcriptional inhibitor actinomycin D (figure 12). The half life of Kip1 mRNA in 
solvent or TCDD treated cells was found by quantitative evaluation to be about 
100 and 110 minutes respectively (figure 128). Thus stabilization of mRNA is not 
the cause for the increased Ievels of Kip1 steady state mRNA Ievels in TCDD-
treated 5L cells. 
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Figure 12. Kip1 mRNA half life in control and TCDD-treated 5L cells. 
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(A) Decay of Kip1 mRNA after inhibition of transcription by actinomycin D. SL cells were treated with 
1 nM TCDD or 0.1% DMSO solvent control. 4 h Later cells were additionalfy treated with 
actinomycin D (5 J.LQ/ml) for the indicated time interval. Kip1 mRNA Ievels were determined by 
Northern blot analysis using 1 0 J.!Q of total RNA. The blot was stripped and rehybridised with a 
GAPDH probe to correct for variations in RNA loading. (8) Graphie representation and quantitative 
evaluation of the data shown in (A) normalised to GAPDH mRNA amounts. The normalised Kip1 
mRNA Ieveis in the controi/TCDD-treated cells without actinomycin D treatment were arbitrarily set 
to 100. The lines in figure represent the decay of Kip1 mRNA in the solvent (dashed line) and 
TCDD-treated (solid lines) cells. The thin lines indicate determination of the half life times. The half 
lives of Kip1 mRNA in the control and TCDD-treated SL cells are estimated to be 100 and 
110 minutes. 
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2.2.1.2 Kip1 mRNA induction by TCDD does not require new protein 
synthesis 
lt was determined whether Kip 1 mRNA is induced by TCDD directly or as 
the consequence of induction of additional intermediary proteins. TCDD-induced 
Kip1 mRNA Ieveis were analysed after inhibition of protein synthesis by cyclo-
heximide pre-treatment (figure 13). Cycloheximide pre-treatment increased the 
Ievei of Kip1 mRNA expression (compare lanes 1 and 3) for unknown reason. 
However, TCDD still induced the Kip1 mRNA on top of the increased Ieveis 
obtained with cycloheximide treatment (compare lanes 3 and 4). Thus Kip1 
mRNA induction by TCDD is direct and does not require expression of 
intermediary proteins. Thereby Kip1 is identified as a novel target gene of AhR. 
TCDD 
Cycloheximide 
Kip1-
mRNA 
GAPDH...., 
+ 
1 2 
+ 
3 
+ 
+ 
4 
Figure 13. Kip1 mRNA induction by TCDD does not require new protein synthe-
sis. lnduction of Kip1 mRNA was tested after 4 h of exposure to 1 nM TCDD or 0.1% DMSO 
solvent with or without 30 min of pre-treatment with the translational inhibitor cycloheximide 
(50 JlQ/ml) by Northern blot analysis using 10 JlQ of total RNA. Equalloading of RNA was confirmed 
by rehybridisation of the blot with a GAPDH probe. 
2.2.1.3 Comparison of dose dependent induction of CYP450 1 A 1 
and Kip1 mRNAs by TCDD 
To test whether the increase in Kip1 mRNA Ieveis follow the increase in 
mRNA Ieveis of classical XRE-regulated genes like CYP450 1A 1, the dose 
response curves of Kip1 and CYP450 1A 1 mRNA induction were compared 
(figure 14). 
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Figure 14. Dose dependent induction of CYP450 1A1 and Kip1 mRNAs by TCDD. 
(A) Northern blot analysiswas done using 2 J.!Q poly(A)+ RNA for CYP450 1A1 and Kip1 mRNAs 
after 24 h treatment with different doses of TCDD or 0.1% DMSO solvent control. Loading of RNA 
was controlled by rehybridisation of the blot with a GAPDH probe. Dose response curves for Kip1 
and CYP450 1A1 mRNA induction are normalised to GAPDH shown in (8). The TCDD doses for 
half-maximal induction (EC50) of Kip1 and CYP450 1A1 mRNA are estimated tobe 36 and 14 pM 
respectively. 
The halfmaximal TCDD doses for Kip1 and CYP450 1A1 mRNA induction were 
calculated and found to be 36 and 14 pm respectively. lnterestingly the 
halfmaximal response dose for TCDD-induced cell cycle delay is reported to be 
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30-100 pM (Göttlicher et al., 1990). Thus there is a correlation of the halfmaximal 
dose for p27Kip1 mRNA induction and the cell cycle delay. This suggested that 
p27Kip1 may be a relevant target gene for mediating cell cycle effects of TCDD in 
5L cells. 
2.2.1.4 lncreased p27Kip1 Ievels - Cause or consequence of TCDD-
induced cell cycle delay? 
Having shown that TCDD directly induces Kip1 without the need for induc-
tion of additional intermediary proteinsstill does not prove that Kip1 indeed is the 
cause of the cell cycle arrest. lt also appears possible that TCDD arrests SL cells 
in the G1-phase of the cell cycle and this particular segment of the G1 phase 
could per se be associated with high expression of Kip1. To rule out this possi-
bility, 5L cells were arrested in the G1-phase of the cell cycle by serum starvation 
for 24 hours. These cells were treated for an additional 4, 8 and 24 hours in 
serum free medium with TCDD. Extracts from serum starved cells revealed that 
Kip1 protein and mRNA Ieveis remained at low Ievels, even though cell cycle 
progression was delayed by serum starvation (figure 15, compare lanes 1 and 
3). Thus, an arrest in G 1-phase of the cell cycle did not necessarily Iead to 
increased Ieveis of Kip1 protein or mRNA. However, when the serum starved 
cells were treated with TCDD, both Kip1 mRNA and protein Ievels were 
increased (figure 15, compare lanes 4 to 5, 6 to 7 and 8 to 9). This indicated that 
increased p27Kip1 Ievels upon TCDD treatment were not a consequence of a 
delay in cell cycle. 
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Figure 15. fnduction of p27K1P1 by TCDD in Gi-arrested 5l cells. 5L Cells were 
arrested in G 1 phase of the cell cycle by serum starvation for 24 h. Cells were then treated with 1 nM 
TCDD or 0.1% DMSO solvent control for the time intervals indicated. Non-serum starved cells were 
treated for 24 h with 1 nM TCDD or 0.1% DMSO. (A) p27KiP1 protein Ieveis were determined by 
Western blot analysis of whole cell extracts. Comparable loading of lanes was confirmed by 
Coomassie staining of a part of the gel. (B) mRNA Ievels were determined by Northem blot analysis 
using 10 fl9 of total RNA. Loading of RNA was controlled by rehybridisation of the blot with a 
GAPDH probe. Ce!! proliferation (% of cells in G2/S phase) was estimated from the cell cycle profiles 
obtained with H33258 staining of cells from parallel culture dishes treated with 1 nM TCDD or 0. 1 % 
DMSO for 24 h or 24 h serum starved cells. 
2.2.1.5 Expression of antisense Kip1 RNA impairs TCDD·induced 
cell cycle delay 
To now prove directly that p27K1P1 is required for TCDD-induced delay of 
cell cycle progression, antisense Kip1 RNA was transiently expressed to inhibit 
the accumulation of. Kip1 protein. Coexpression of GFP allowed identification of 
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the efficiently transfected cells by flow cytometry as described in section 2.1.2. 
Gell cycle profiles were determined by H33258 staining and analysed individu-
ally for the efficiently transfected green fluorescing subpopulations and the ineffi-
ciently transfected (non-green) subpopulations. lf GFP was expressed tagether 
with an empty expression vector, TCDD treatment reduced the relative number of 
cells in S/G2 phase in both the efficiently transfected and the majority of the inef-
ficiently transfected cells of the same culture dish (figure 16, compare panels in 
rows 1 and 2). lf Kip1 antisense RNA was expressed tagether with GFP, the 
TCDD-effect on cell cycle distribution was disrupted in the efficiently transfected 
Subpopulation of cells (figure 16, compare panels in row 3). ln the inefficiently 
transfected subpopulation of the same cell culture dish, TCDD delayed cell cycle 
progression as expected (figure 16, compare panels in row 4 ). 
ln a second approach, bromodeoxyuridine (BrdU) incorporation was 
monitared after the cells were transfected with antisense Kip1 cDNA or empty 
expression vector. BrdU is an analogue of thymidine which is incorporated into 
actively proliferating cells. The efficiently transfected cells were isolated by 
fluorescence activated cell sorting (FACS) for the analysis of Kip1 protein 
expression and incörporation of BrdU in to S-Phase cells (figure 17). 
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Figure 16. Expression of antisense Kip1 RNA impairs TCDD-induced cell cycle 
delay in 5L cells. SL cells were transiently cotransfected with expression vectors for a Kip1 
antisense RNA and the green fluorescent protein (GFP) or the empty expression vector and GFP. 
Cells were treated with 1 nM of TCDD or 0.1% of the DMSO solvent control 32 hours after transfec-
tion and harvested for flow cytometric analysis 18 hours later. The GFP-expressing Subpopulation 
of transfected cells was identified by high green fluorescence in comparison to non transfected 
cells (please refer also to figure 4). Cell cycle profiles were determined by H33258 staining and 
analysed individually for the efficiently transfected green fluorescing subpopulations and the non-
transfected (non green) subpopulations. One representative out of 4 similar experiments is shown. 
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Figure 17. Expression of Kip1 antisense RNA inhibits the accumulation of TCDD-
induced Kip1 protein and reverses the effects of TCDD on BrdU incorporation. 
Proliferation rates were determined by the incorporation of BrdU in 5L cells which had been tran-
siently cotransfected with expression vectors for a Kip1 antisense RNA (Anti-Kip1) and the green 
fluorescent protein (GFP) or the empty expression vector (control) and GFP. Green fluorescing 
cells were collected by FACS sorting and were either (A) analysed by Western blotting for the 
expression of p27Kip1 protein, or (B) spun onto glass slides for immunocytochemical detection (Kit 
by Boehringer, Mannheim) of the percentage of cells having incorporated BrdU. 32 h after 
transfection cells were treated with 1 nM of TCDD or 0.1% of the DMSO solvent control for 
additional 18 h of which during the last 5 h BrdU was present in the culture medium. Cells were 
harvested using trypsin and green fluorescing cells were sorted to a purity greater than 80%. For 
Western blot analysis 2x1 04 cells were lysed in sample buffer. Comparable loading of lanes within a 
factor of 2 was confirmed by reprobing the blot against ERK1 and 2 and Coomassie staining of a 
part of the gel. Bars in part B represent means +1- S.O. from 3 independent experiments. 
ln cells transfected with GFP and the empty expression vector, TCDD induced 
Kip1 in the efficiently transfected (green) cells (figure 17A, compare lanes 1 and 
2). TCDD also inhibited proliferation as indicated by the reduction of BrdU 
incorporation (figure 158, compare the left pair of bars). After expression of Kip1 
antisense RNA, no TCDD-induced Kip1 could be detected (figure 17A, compare 
lanes 3 and 4) and TCDD effects on Brdu incorporation were only marginal 
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(figure 178, compare the right pair of bars). The minor inhibition of proliferation 
could be explained by 10% of non-transfected cells sticking to and copurifying 
with the sorted fluorescing cells as revealed by microscopic examination. These 
data strongly indicate that Kip1 is required for AhR-dependent delay of SL cell 
proliferation. 
ln summary, TCDD induces Kip1 by inducing its mRNA. Kip1 mRNA 
induction is direct as the translational inhibitor cycloheximide had no effect. Kip1 
plays a causal role in TCDD-induced cell cycle delay as inhibition of its accu-
mulation reversed the effects of TCDD on the cell cycle. 
2.2.2 Suppression subtractive hybridization to find target genes of 
AhR 
ln addition to the analysis of cell cycle regulatory proteins a systematic 
search for AhR induced genes in SL cells was initiated for two reasons. (i) initially 
it was not clear which approach could be successful. (ii) not all activities of diox-
ins/AhA may follow the same pathway and need the same initially AhR regulated 
genes. 
Subtractive hybridization is a powerful technique that allows comparison 
of two populations of mRNA and obtain clones of genes that are expressed in 
one population but not in the other. A new PCR-based cDNA subtraction method, 
termed suppression subtractive hybridization (SSH) has been described recently 
to obtain differentially expressed genes (Diatchenko et al., 1996; Gurskaya et al., 
1996). SSH was used to search for AhR target genes in SL cells. 
2.2.2.1 The principle of suppression subtractive hybridization (SSH) 
A schematic representation of the SSH method is shown in figure 18. 8oth 
the mRNA populations to be compared are first converted into cDNA. The cDNA 
that contains specific differentially expressed transcripts is raterred as 'tester' and 
the reference cDNA as 'driver'. The driver and tester ds cDNAs are first digested 
with Rsa I, a four-base cutting restriction enzyme that yields blunt ends. After 
digestion cDNAs have an average length of approximately 600 bp, which aids 
hybridization of complementary strands. The tester cDNA fragments are then 
divided into two fractions and each is Iigated with a different cDNA adaptor. The 
ends of the adaptor do not have a phosphate group, so only one strand of each 
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adaptor attaches to the 5' ends of cDNA and the adaptors cannot be Iigated into 
dimers. 
Tester cDNAwith adaptor1 
., . 
Driver cDNA (in excess) Tester c:DNA with adaptor 2 
~
ss-tester 
~ tester-tester 
homohybrid 
Second hybridization: mix ·samples, add 
fresh denatured driver, and anneal 
tester-driver 
heterohybrids 
ss-driver 
ds-driver 
a, b, c, d + e~ 
""---G-iil tester-tester heterohybrids 
~ Fill in the ends 
I Add primers • + lll'll 
• Amplify by PCR 
a, d no amplification 
panhandle-like ~ b -+b' no amplitication 
structure 
suppression PCR 
effect 
c linear amplification 
e exponentialamplification 
Figure 18. Scheme of Suppression Subtractive Hybridisation (SSH). Solid lines 
represent the Rsal digested tester or driver cDNA. Solid boxes represent the outer part of the 
adaptor 1 corresponding to PCR primer 1. Shaded boxes represent the outer part of adaptor 2 
corresponding to PCR primer 2. Clear boxes represent the inner part of the adaptors and 
corresponding nested PCR primers adapted from Diatchenko et al., 1996. 
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Two hybridizations are then performed. ln the first, an excess of driver is 
added to each of the samples of the tester. The samples are then heat denatured 
and allowed to anneal. During the hybridization, single stranded tester mole-
cules which have a complementary strand in the driver mostly form tester-driver 
heterohybrids (c) and are removed from the single-stranded (ss)-fraction (a). 
Tester cDNAs can also be removed from the ss-pool by reannealing of 
complementary ss tester cDNAs forming ds tester homohybrids (b). This process 
is faster for highly abundant cDNAs in the tester cDNA as compared to low 
abundant cDNAs. Therefore the hybridization also Ieads to a normalization of the 
ss cDNA tester fraction (a) e.g. concentrations of high and low abundance 
cDNAs become roughly equal (Gurskaya et al., 1996). 
in the second hybridization, the samples from the first hybridization are 
mixed tagether without denaturing in the presence of freshly denatured driver 
cDNA. Only the normalized and subtracted ss tester cDNAs are able to reassoci-
ate and form new type (e) molecules. The newly formed hybrids (e) have an 
important feature that distinguishes them from hybrids (b) and (c) formed during 
the first and second hybridizations. This feature is that they are double-stranded 
(ds) tester molecules with different ends, which correspond to adaptor 
sequences 1 and 2. These molecules with the different adaptors 1 and 2 or either 
end are the only ones which will be efficiently, e.g. exponentially, amplified in the 
subsequent PCR reaction. An extension reaction is performed to fill in the sticky 
ends of the molecules for primer annealing before the initiation of the PCR 
procedure. 
ln all PCR cycles, exponential amplification can only occur with type (e) 
molecules which have different sequences at their ends. Type (b) molecules 
contain long inverted repeats on the ends and form stable 'panhandle-like' 
structures after each denaturation-annealing PCR step. The resulting 
'panhandle-like' structure cannot serve as a template for exponential PCR, 
because intramolecular annealing of long adaptor sequences is both highly 
favoured and more stable than intermolecular annealing of the much shorter 
PCR primers (Siebert et al., 1995). This effect is called 'suppression' PCR. Type 
(a) and (d) molecules do not contain primer binding sites and so can not be 
amplified. Type (c) molecules can be amplified only at a linear rate as they 
contain annealing sequence for only one of the primers. A secondary PCR 
amplification is then performed using nested primers to reduce background and 
enrich for differentially expressed sequences. 
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2.2.2.2 Generation of the subtractive library from 5L cells (-/+ TCDD} 
Poly(A)+ RNA was first prepared from non treated and 4 hours TCDD 
treated 5L cells. Northern hybridizations were done to confirm the presence of 
known TCDD-induced transcripts such as cytochrome P450 1A1 (CYP450 1A 1) 
and glutathione-S-transferase Ya (GST-Ya) in the mRNA prepared from TCDD-
treated cells. Both CYP450 1A1 and GST-Ya were induced after 4 hours of 
TCDD treatment as shown in figure 19. cDNA was synthesized from poly(A)+ 
RNA of non-treated (driver) and TCDD-treated (tester) cells. Subtractive 
hybridization was then performed using the PCR-select™ cDNA subtraction 
method to enrich for differentially expressed sequences in the tester cDNA 
population. The different steps in the screening system subsequent to the SSH 
are depicted in form of a flow chart in figure 20. Prior to screening of the 
subtractive library it is important to monitor the efficiency of subtraction. 
GST-Ya 
CYP450 1A1 
GAPDH 
Figure 19. Quality control of mRNA used for subtractive hybridization. 
lnduction of two known genes was confirmed after TCDD treatment in the mRNA used for subtrac-
tive hybridization. Northern blot analysis was performed using 2 1!9 poly(A)+ RNA for CYP450 1 A 1 
and GST-Ya mRNAs after 4 h treatment with 0.1% DMSO solvent or 1 nM TCDD. Loading of RNA 
was controlled by rehybridization with a GAPDH probe. 
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Figure 20. Flow diagram of the screen to find TCDD induced genes. 
2. 2. 2. 3 Efficiency of subtraction 
The subtraction efficiency is determined by monitoring depletion of tran-
scripts common to both driver and tester populations and enrichment of 
sequences specific to 'tester' population after subtraction. Southern blot analysis 
of subtracted and unsubtracted tester cDNA samples was done using one abun-
dant non-differentially expressed gene, glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) and two known TCDD-induced genes CYP450 1A 1 and 
GST-Ya. GAPDH was almest completely removed after subtraction indicating the 
efficient removal of non-differentially expressed genes (figure 21 ). The cDNAs of 
CYP450 1A 1 and GST-Ya two known tester specific genes Were enriched in the 
subtracted cDNA population (figure 21). This is an indication that the subtraction 
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had proceeded efficiently. The subtracted secondary PCR products were cloned 
into a plasmid vector. The resulting clones were analysed by the following 
method to identify the differentially expressed clones. 
A. B. 
N s s N S N S 
GAPDH CYP450 1A1 GST-Ya 
Figure 21. Monitaring of efficiency of subtraction. PCR amplified non-subtracted tester 
(N) and subtracted tester (S) cDNAs were separated in triplicates (approximately 500 ng per lane) 
on a 1.5% TAE agarose gel and transferred to a Hybond-N+ membrane under alkaline conditions. 
A photograph of the gel stained with ethidium bromide before transfer is shown in (A). (B) The 
membranes were probed with radioactive cDNAs of GAPDH, CYP4501A1 and GST-Ya 
2.2.2.4 ldentification of differentially expressed genes in the 
subtractive library 
To identify the differentially expressed clones in the subtractive library, 
individual clones were picked and the inserts were amplified by colony PCRs. 
DNA is denatured with alkali treatment and duplicate set of dot blots were 
prepared in 96 weiHormat. These dot blots were then hybridized with 
radioactively Iabeiied ds cDNA derived from either non-treated or 4 hours TCDD-
treated cells. An example is shown in figure 22. To control hybridization 
conditions, each set of dot blots had two dots (25 and 50 ng) each of non-
differentially expressed GAPDH and differentially expressed CYP450 1A 1. Equal 
intensities of signals obtained with GAPDH indicated similar hybridization 
conditions. 
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Figure 22. Differential screening of the subtractive library. Subtraction products were 
amplified individually by colony PCRs and duplicate dot blots were prepared. Each set of blots had 
two dots of cDNA (25 and 50 ng) each of non-differentially expressed GAPDH and differentially 
expressed CYP450 1A1 to control hybridisation. To identify cDNAs that represent TCDD-induced 
genes the DNA dot blots were hybridised with Rsa I digested radio-labelled cDNA from non-treated 
(Biot 13/1) or 4 h TCDD-treated (Biot 13/2) cells. Arrows indicate the clones corresponding to 
mRNAs that are differentially expressed in 5L cells after 4 h TCDD treatment. Equal intensities of 
signals were obtained with GAPDH indicating similar hybridisation conditions. CYP450 1 A 1 gave a 
signal only in the blot 13/2, probed with cDNA from 4 h TCDD-treated cells and served as a positive 
control for differentially expressed genes. 
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CYP450 1A 1 gave a signal only in dot blot 13/2, probed with cDNA from 4 hours 
TCDD treated cells and acted as a positive control for differentially expressed 
genes. The clones which preferentially hybridized with radiolabelled cDNA from 
4 hours TCDD treated cells represent potential cDNA clones induced by TCDD 
(figure 22, for example compare the dots at position H1). The clones that gave 
equal hybridization signals with both probes represent clones that were not 
differentially expressed (for example compare the dots at position F1). The 
hybridization signals obtained with different clones varied considerably which 
indicate the relative abundance of those genes in the cDNA used as 
radiolabelled probe. The clones which did not give any hybridization signal may 
represent low abundant mRNAs which in consequence are poorly represented in 
the radiolabelled cDNA probe. Though possibly differentially expressed, dot blot 
hybridizations are not sensitive enough to identify this class of low abundant 
cDNAs. 
By this approach, 1500 clones were analysed and 34 of them hybridized 
preferentially with radiolabelled cDNA from 4 hours TCDD-treated cells. 
2.2.2.5 Sequencing and confirmation of TCDD-inducibility of clones 
by Northern blot analysis. 
To know the identity of the clones that hybridized preferentially with radio-
labelled cDNA from TCDD-treated cells, plasmid DNA was isolated from the 
initial bacterial cultures and inserts were sequenced. The sequence analysis 
revealed that some of the genes that gave a differential signal on the dot blots 
were already known to be induced by TCDD. The isolation of such genes from a 
subtractive library indicated that the experimental approach to isolate TCDD-
induced genes had been successful. 
Besides the known TCDD-induced genes (group I in table II), there are 
3 known genes (group II) and 8 unknown genes (group 111). lt is possible that 
some of the clones classified as unknown genes are from hitherto not sequenced 
or not published regions of known genes. 
From the known directly TCDD-inducible genes I found cytochrome P450 
1A 1, cytochrome P450 181, aldehyde dehydrogenase, glutathione-S-trans-
ferase Ya, NAD(P)H:quinone reductase and UOP-glucuronosyl transferase 
(Hankinson, 1995). The genes given in group II are known but not reported to be 
induced by TCDD such astheB-eeil translocation gene 1 {BTG1) (Rouault et al., 
1992) lost on transformation 1 (LOT1) (Abdollahi et al., 1997) and transglutami-
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nase (Gentile et al., 1991 ). Novel sequences without any data base matches are 
given in group 111. Differential expression of clones in groups II and 111 was 
confirmed by Northern blot analysis (figure 23). The inserts of these clones were 
amplified by colony PCR, digested with Rsa I to remove adaptor sequences, and 
gel purified before they were radioactively labelled. Inserts were hybridized 
against poly(A)+ RNA derived from non treated, 4 or 24 hours TCDD treated 5L 
cells. The Northern blots of 11 TCDD-induced clones (groups II and 111) are 
shown in figure 23. 
TABLE II 
Summary of sequencing data of TCDD-induced clones 
ldentity of the clone Number of times 
picked 
GROUPI 
1. Cytochrome P450 1 A 1 4 
2. Cytochrome P450 181 1 
3. Aldehyde dehydrogenase 13 
4. Glutathione-S-transferase Ya 1 
5. NAD(P)H : quinone reductase 1 
6. UDP-glucuronosyl transferase 2 
GROUPII 
7. B-eeil translocation gene 1 1 
8. Lost on transformation 1 1 
9. Transglutaminase 1 
GROUP 111 
10. clone 106 1 
11. clone 1514 2 
12. clone 1525 1 
13. clone 1531 1 
14. clone 361 1 
15. clone 750 1 
16. clone 735 1 
17. clone 1396 1 
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Figure 23. Northern blot analysis of' TCDD-induced clones identified by subtrac-
tive hybridisation. 5 fl9 of poly(A)+ RNA from non treated (control), 4 and 24 h TCDD-treated 5L 
cells was analysed in Northern blot hybridisation using radio-labellad cDNA from individual clones. 
Equal loading of RNA was confirmed by rehybridisation of the blots with a GAPDH probe. The 
numbers refers to the clones depicted in Table II. Lot1 is lost on transformation (Abdollahi et al., 
1997). BTG1 is B cell translocation gene 1 (Rouault et al., 1992). 
The inducibility of the clones differed from one to another. There are 
clones which are induced >10 fold (clones 1531, 750 and 735) and others which 
are induced <4 fold (BTG1, LOT1, transglutaminase, clones 106, 1396 and 
1525). This indicates that the experimental approach followed is also suitable to 
get clones of genes which are not heavily (<4 fold) regulated. The majority of the 
clones are clearly induced already after 4 hours of TCDD treatment and stay 
induced after 24 hours of treatment. There are clones, however which are clearly 
induced only after 24 hours of TCDD treatment (transglutaminase and 1396). 
Some clones gave two distinct bands on the Northern blot, only one of which is 
induced by TCDD. These clones might represent differentially spliced genes or 
two closely related genes, out of which only one is induced by TCDD (clones 735 
and 750). Alternatively the double bands on Northern blots might also be a result 
of an artefact in generation of the subtractive library if inserts from two genes 
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would have been Iigated into one clone out of which only one is regulated by 
TCDD. 
2. 3 Analysis of new TCDD-induced clones obtained through 
subtractive hybridization. 
Subtractive hybridization was done to find TCDD-induced genes which 
led to the identification of eleven sequences whose expression was increased in 
5L cells after TCDD treatment. Three of the sequences have homology to the 
known genes which are B-eeil Translocation Gene 1 (BTG1), Transglutaminase 
and 'Lost On Transformation' 1 (LOT1). No data base matches were found for 
the remaining 8 sequences. 
BTG 1 is reported to negatively regulate cell cycle proliferation (Rouault et 
al., 1992). Transglutaminases are calcium-dependent enzymes that catalyse the 
cross-linking of proteins by promoting the formation of isopeptide bonds between 
protein-bound glutamine and Iysine residues (Gentile et al., 1991 ). LOT1 is a 
novel gene recently cloned based on its loss of expression in malignantly 
transformed cell lines (Abdollahi et al., 1997). 
The role of BTG1 was tested in TCDD-induced delay of 5L cell prolifera-
tion. A full length clone of BTG1 was obtained by RT-PCR using primers which 
were based on the published sequence information. BTG 1 was overexpressed in 
sense or antisense orientations together with GFP by transient transfections to 
test~ts effect on 5L cell proliferation. Analysis was done as described in section 
2.1.2. BTG1 overexpression had no effect on the proliferation of cells in the 
absence of TCDD. Antisense expression of BTG1 also did not affect TCDD-
induced delay of 5L cell proliferation (data not shown). Hence BTG1 does not 
seem to play a role in TCDD-induced delay of 5L cell proliferation. 
The significance of Lot1 and transglutaminase induction by TCDD is diffi-
cult to test in the absence of any functional assay. Every TCDD-induced gene 
may not be functionally linked to cell cycle effects of TCDD in 5L cells. 
ln addition to the three known genes, 8 novel TCDD-induced cDNA frag-
ments were identified by subtractive hybridization. The starting point in the 
analysis of novel differentially expressed genes is to isolate longer/full length 
fragments of their cDNAs. Analysis will indicate if the sequence is part of the 
untranslated region of a known gene or truely a novel gene, meaning that no 
significant homology exists with the known genes reported in the data bases. 
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2.3.1 Cloning of Ionger fragments of a novel TCDD-induced gene 
Since it is not possible to analyse all 8 novel TCDD-induced sequences 
due to time Iimitation, only clone 106 was picked for further analysis. 
Longer fragments of clone 1 06 were obtained by rapid amplification of 
cDNA ends (RAGE). An adaptor Iigated double stranded cDNA ·(Marathon-Ready 
cDNA ™ from Clontech Laboratories, lnc., USA) was used as a template for 
RAGE. Two gene-specific primers in different orientations and one adaptor 
specific primer are required for performing 5' and 3'-RACE PGRs. Schematic 
representation of this procedure is shown in figure 24. This procedure was 
successfully used to isolate full length genes (Frohman et al., 1988 and Selmin 
et al., 1996). 
Primer 106.1 
~ 
Known fragment of clone 1 06 
PGR product 1: 
PCR product 2: 
___... 
Primer 106.2 
Primer 106.1 
~ 
r----r-----=~:-:--:--:---::-:---~------,----,NHt3' 5,.. L__ cDNA Iigated with adaptors ~ _5, ~ ==:J 
~. Adaptor pnmer 
Adaptor primer 
~ 
5,..r---.------c~D"N~A"Ii~ga~te~drw~it~h~ad~a~pLto~ffi---~-~ ~1-5'
--.. 
Primer 106.2 
Figure 24. Amplification of Ionger fragments of a TCDD-induced novel sequence. 
Gene specific primers (1 06.1, reverse; 1 06.2, forward) were designed based on the known 
sequence of clone 106 (filled box). Double stranded cDNA Iigated with adaptors (Ciontech 
Laboratories, lnc., USA) was used as a template using the adaptor primer in combination with one of 
the two gene specific primers in separate PCR reactions, respectively. The 3' end of the adaptor is 
blocked with an amino group which prevents extension of the 3' end and formation of a binding site 
for the adaptor primer. The binding site for the adaptor primer is generated only by the extension of 
the gene specific primers. 
52 Results 
Primers were designed based on the known sequence of clone 106 and 
RACE analysis for both 5' and 3'-ends was carried out. Two PCR products of 
3.0 kb and 2.5 kb were obtained by 5' and 3' RACE. The PCR products were 
cloned into a vector and partial sequence was obtained from each end of the 
PCR products. 8oth the PCR products contained the sequence of clone 106, 
indicating that they represent the Iongerfragments of clone 106. 
2.3.2 N-Myristoyltransferase 2 (NMT-2) is the novel TCDD-induced 
gene 
Sequence analysis indicated that the 5' RACE product of clone 106 has 
95% homology to the 5' part of the recently cloned mouse N-Myristoyltransferase 
2 (NMT-2) cDNA (Giang and Cravatt, 1998). No data base homology was found 
to the 3' RACE product. This indicates that clone 1 06 is part of untranslated 
region of the NMT-2 gene which was not a part of the initially isolated and 
published clone. 
N-Myristoyltransferase (NMT) is an enzyme catalyzing protein N-
myristoylation which is the co-translational linkage of myristic acid, to the N-
terminal glycine residues of some eukaryotic cellular proteins (Johnson et al., 
1994). Examples of NMT substrates include protein kinases such as the catalytic 
subunit of cAMP-dependent protein kinase (PKA) and p6osrc. N-myristoylation 
was reported to play a causal rote in transformation of cells by p6ov-src (Kamps et 
al., 1986). NMT protein and its activity has been shown to increase in colon 
tumors (Raju et al., 1997). 
2.3.3 NMT-2 mRNA induction by TCDD does not require new 
protein synthesis 
To test whether NMT-2 is a direct target gene of the AhA, TCDD-inducu-
bility of NMT-2 mRNA was tested in the presence of the protein synthesis inhibi-
tor cycloheximide (figure 25). TCDD induced NMT-2 mRNA both in the absence 
and presence of cycloheximide. Thus, ongoing or new protein synthesis is not 
required for induction of NMT-2 mRNA by TCDD indicating that NMT-2 is directly 
regulated and a new target gene of the AhA. 
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Figure 25. N-myristoyltrasferase 2 (NMT-2) mRNA induction by TCDD does not 
require new protein synthesis. lnduction of NMT-2 (clone 106) mRNA was tested after 4 h 
exposure to 1 nM TCDD or 0.1% DMSO solvent with or without 30 min of pre-treatment with the 
translational inhibitor cycloheximide (20 !lQiml) by Northern blot analysis using 5 !lQ of poly(A+) 
RNA. As a loading control, the Northern blot was re-probed with GAPDH cDNA. 
2.3.4 lnducibility of NMT-2 mRNA in livers of mice treated with 
TCDD 
One possibility to form a hypothesis on the role of NMT-2 in mediating any 
of the effects of TCDD in vivo is to test its inducibility in a target organ of dioxin 
toxicity. TCDD is a potent promoter of hepatocarcinogenesis. So, the inducibility 
of NMT-2 mRNA in livers of TCDD-treated mice was tested. Semi-quantitative 
RT -PCR was done with total RNA from livers of TCDD-treated mice (liver samples 
were kindly provided by Prof. Michael Schwarz, Tuebingen), using gene specific 
primers to NMT-2 and GAPDH in a single tube. The RT-PCR products were ana-
lysed by Southern blot hybridization for NMT-2 and GAPDH (figure 26). The 
signals obtained with NMT-2 were normalized to the signals obtained with 
GAPDH. Analysis of the results indicated that NMT-2 mRNA was upregulated in 
livers of TCDD-treated mice (by 2.5 fold after 5 days and 4 fold after 7 days of 
treatment). 
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Figure 26. N-myristoyltransferase 2 (NMT-2) mRNA is induced in livers of TCDD 
treated mice. Total RNA was prepared from iivers of mice 5 or 7 days after they had received a 
single injection of solvent(-) or TCDD (+; 1.4 ).tg/kg body weight). RT-PCR was done as described 
in methods and materials using primers specific to NMT -2 (1 06.1 and 1 06.2) and GAPDH (GP3 and 
GP5) in a single tube. Sampies were collected after 25 or 30 cycles of PCR. PCR conditions were 
94°C for 30 sec, 58°C for 45 sec and 72°C for 90 sec. PCR products were separated on a 1% TAE-
agarose gel, denatured and transferred to a membrane under alkaline conditions. Hybridisations 
were done with radio-labelled NMT-2 or GAPDH cDNAs. 
ln summary, subtractive hybridization led to the identification of 34 TCDD-
induced clones in 5L cells. Out of them, 22 were known TCDD-induced genes 
coding for drug metabolizing enzymes. The remaining 12 clones, represent 
8 novel sequences and 3 known genes whose expression was previously not 
known to be induced by TCDD. Cloning of a Ionger fragment of a novel 
sequence has identified it as part of the N-Myristoyltransferase 2 gene which in 
addition to 5L cells is induced in livers of TCDD-treated mice. 
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3. Discussion 
The AhR mediates toxic and carcinogenic effects of dioxins (Huff et al., 
1994). Known AhR regulated genes mostly code for xenobiotica metabolizing 
enzymes but AhR regulated genes responsible for dioxin toxicity were largely 
unknown. The aim of this work was to identify target genes of AhR relevant for 
dioxin toxicity. 
3.1 Choice of the model system 
Choosing the right system for studying dioxin toxicity and searching for the 
AhR target genes is utmost important. At the beginning of this work, I had to 
choose between an in vivo or a cell culture model system. The advantages and 
disadvantages of these two systems are discussed below. 
ln vivo studies with TCDD-treated animals provide an opportunity to 
directly analyse the affected organs. However, mechanistic studies which involve 
gene transfer and gene inactivation are difficult and tedious to perform in vivo. 
Generating knock-out or transgenic mouse strains are feasible in principle, but 
these techniques can not be used for screening purposes, e.g. analysis of many 
site-directed mutations in a protein of interest. 
The cell culture system which was available to me was 5L rat hepatoma 
cells. The 5L cells are genetically weil defined with respect to the expression of 
AhR and the effects of TCDD. TCDD severely delays proliferation of 5L cells. This 
constitutes one of the very few toxic actions of TCDD in continuously growing 
cells in vitro. ln the 5L cell system, AhR-deficient and TCDD-resistant variant 
subclones, the BP8 and the BP8AhR+ cells are available (Göttlicher et al., 1990). 
The Iack of AhR is the only defect which renders BP8 cells resistant to TCDD, 
since stable expression of AhR in these cells restores TCDD sensitivity 
completely (Weiß et al., 1996}. 5L cell cultures are composed of a single cell 
type. They offer a possibility for analysing primary events in TCDD toxicity since 
the effects on proliteration are manifested within a few hours. The cell culture 
system allows the usage of transcriptonal/translational inhibitors which help in 
determining the direct effects of dioxins on gene expression. Large sets ot 
experimental points can be collected in cell culture for example in studying dose-
response relationships. Furthermore, gene transter experiments can be 
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performed easily in cell culture and low amounts of dioxins are required 
compared to what is needed for in vivo experiments. 
Keeping the several advantages in mind I had decided for 5L cell culture 
system for studying dioxin toxicity. However, a general concern in using cell 
culture systems is to what extent they do reflect a cell type and a response 
pathway being relevant in the whole organism. So the findings in in vitro systems 
have to be validated in vivo. This has been done successfully in this study and is 
discussed in section 3.4. 
3.2 A positively induced genetic programme for TCDD-induced cell 
cycle delay 
Having chosen 5L cell system for studying TCDD toxicity, I wanted to 
determine how AhR mediates the delay in proliferation of these cells. There is 
evidence in Iiterature for diverse functions of AhR after TCDD treatment. The AhR 
regulates the expression of a number of genes involved in drug metabolism 
(reviewed in Schmidt and Bradfield, 1996). The receptor is reported recently to 
interact with cell cycle regulatory proteins like Rb and cyclin-CDK complexes 
(Greenlee-personal communication; Ge and Elferink 1998). A reduction in 
epidermal growth factor (EGF) binding in liver plasma membranes of TCDD-
treated ratswas shown to be due to a decline in the number of EGF receptors 
(Hudson et al., 1985; Lin et al., 1991 and Madhukar et al., 1984). lncreased 
phosphorylation and activity of protein-tyrosine kinases such as p6oc-src in thymus 
of TCDD-treated mouse was reported (Enan and Matsamura, 1995). lt is not 
known how AhA mediates such diverse effects. There is, however, evidence from 
studies of steroid hormone receptors that one and the same receptor can serve 
qualitatively quite distinct functions which are described below. 
Transcription factors are classically described as sequence-specific DNA-
binding proteins which activate transcription of genes. ln addition to this classical 
mode of action at least two more functions of steroid receptors have been 
discovered in recent years (Göttlicher et al., 1998). Firstly, steroid receptors have 
been shown to modulate the activity of other transcription factors apparently 
without binding to DNA themselves. Rather, this type of so called 'transcriptional 
cross-talk' is likely to be based on protein-protein interactions. A typical example 
of this cross-talk is the mutual interference of the glucocorticoid receptor and the 
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AP-1 family of transcription factors (Jonat et al., 1990 and Schuele and Evans, 
1991 ). Most frequently negative interference of both factors with each other's 
activity has been observed but also positive 'Cross-talk' is possible under certain 
conditions (Diamond et al., 1990; Shemshedini et al., 1991 and Teurich and 
Angel, 1995). Secondly, transcription factors (e.g. androgen and estrogen 
receptors) are reported to induce signal transduction (MAPK/SAPK signalling) 
cascades. These so called 'non-genomic actions' are independent of the 
receptor acting on chromatin in the cell nucleus (Migliaccio et al., 1996 and 
Peterziel, 1998) 
Different functions of the steroid receptors could be dissociated with the 
use of mutants which can perform one tunction but not the otheL Specific 
mutations in the DNA binding domain of glucocorticoid receptor for example, 
affect its ability to bind DNA and transactivate genes but do not affect its ability to 
repress AP-1 transcription factors (Heck et al., 1994). Similarly, mutants of 
androgen receptor defective in the nuclear localisation can not directly 
transactivate genes but still can induce signal transduction cascades (Peterziel, 
1998). Knowing the different actions of steroid receptors, I wanted to determine 
whether AhA positively induce a genetic programme for cell cycle delay and to 
obtain circumstantial evidence how AhR could induces such a delay. This was 
done by mutational analysis of the AhR in receptor deficient BP8 cells. 
Expression of wild type but not of any of the mutant forms of AhR defective 
in DNA binding or transactivation reconstituted TCDD-induced cell cycle delay in 
BP8 cells. Thus, both DNA binding and transactivation functions of the receptor 
appear to be essential for mediating cell cycle effects of TCDD. This suggested 
that transcriptional activation of genes by AhR is required for mediating TCDD-
induced cell cycle delay. 
One could argue that the mutants of AhR used for reconstitution of cell 
cycle delay are also defective in other functions of the receptor. lt is, however, 
unlikely that all four mutants of the AhA tested (one of them having a single 
amino acid exchange in the DNA binding domain) are deficient with respect to a 
specific but hitherto unknown function of the receptor distinct from activation of 
target genes upon binding to DNA. 
There is further support for the requirement of transcription in TCDD-
induced cell cycle delay. TCDD inhibited G1-phase progression prior to 
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hyperphosphorylation of the retinoblastoma protein (Rb) in 5L cells 
synchronously released from a low serum-induced cell cycle arrest. This effect of 
TCDD was antagonised by the transcriptional inhibitor actinomycin D, although 
actinomycin D alone during the same short time period did not inhibit Rb 
hyperphosphorylation (Carsten Weiß- personal communication). This suggests 
that ongoing and presumably induced gene transcription (likely but not 
necessarily by AhA) is required for cell cycle effects of TCDD in 5L cells. This 
requirement for transcription together with the results of the mutational analysis, 
argues for AhR-dependent transcription in TCDD-induced cell cycle delay. 
Having this as the basis, I searched for AhA regulated genes responsible for cell 
cycle delay in 5L cells. 
3.3 Search for target genes of AhR 
The search for AhAtargetgenes was done by two different ways. The first 
was an 'educated guess' approach ana.lysing the known cell cycle inhibitory 
proteins. The secend was an unbiased search for TCDD-induced genes. 
3.3.1 Transcriptional induction of p27K1P1 by AhR inhibits SL cell 
pro Iiteration 
The p27Kip1 cell cycle inhibitor was found to be upregulated upon TCDD 
treatment in 5L cells. This induction is specific because the Ieveis of other 
inhibitors did not change substantially or were not detected (Martin Göttlicher -
personal communication). AhA mediates p27Kip1 induction, since TeDO-
dependent p27Kip1-upregulation was not found in the receptor deficient BP8 cells. 
Furthermore, the induction was restered by stable expression of AhA in BP8 cells 
(data not shown). 
lnduction of p27Kip1 occurs through the direct induction of Kip1 mRNA by 
AhA as the translational inhibitor cycloheximide did not prevent Kip1 mRNA 
induction. This is a novel mode of Kip1 regulation distinct from previously 
described posttranscriptional mechanisms. ln every case reported so far p27Kip1 
induction occurred through increased stability of the protein (Pagano et al., 1995) 
and/or increased rate of translation (Hengst and Reed, 1996 and Millard et al., 
1997). Posttranscriptional regulation of Kip1 in 5L cells upon TCDD treatment is 
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unlikely as the half lives of mRNA and protein did not differ in TCDD treated and 
control cells. 
lnduction of p27Kip1 is the cause for TCDD-induced cell cycle delay. 
Genetic evidence for this was generated by the expression of antisense Kip1 
RNA which impaired the accumulation of TCDD-induced p27Kip1 and reversed the 
cell cycle effects of TCDD in 5L cells. 
3.3.1.1 How is Kip1 regulated? 
The AhR regulates transcription of the xenobiotic metabolizing enzymes as 
a heterodimeric complex with Amt by binding to XRE sequence(s) (Schmidt and 
Bradfield, 1996). However, the regulation of Kip1 seems to be different from that 
of xenobiotic metabolizing enzymes. The human and murine promoters of Kip1 
have been cloned and do not contain a consensus XRE (Kwon et al., 1996 and 
Minami et al., 1997}. lnduction of a reporter gene containing the luciferase cDNA 
under control of the murine Kip1 promoter by TCDD suggests that the cloned 
promoter has the necessary elements required for centerring inducibility (Carsten 
Weiß - personal communication). 
The dose-response curves for induction of mRNAs for Kip1 and the 
classical XRE-regulated gene CYP450 1A 1 were different. The half-maximal 
induction of Kip1 and CYP450 1A 1 mRNAs was observed at TCDD 
concentrations of 36 and 14 pM respectively. These observations could mean 
that AhR regulates Kip1 differently from xenobiotic metabolizing enzymes. Such 
putative other modes of AhR-function could be independent of Amt and evidence 
for that is discussed below. 
Amt and DNA binding defective mutant Amt were overexpressed in 
5L cells to determine the requirement of Amt in TCDD-induced cell cycle delay. 
lf activation of genes by the AhR-Amt complex was required, overexpression of 
Amt was expected to synergise with AhR activation by TCDD and mutant Amt 
should act dominant negatively. However, the observed effects of Amt and 
mutant Amt were opposite to what was expected. Ovarexpression of full length 
Amt led to the reversal of TCDD-induced cell cycle delay, whereas the DNA 
binding defective mutant Amt had no effect. This suggests that the mechanism of 
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TCDD-induced cell cycle delay is unrelated to transcriptional regulation by the 
AhR-Arnt complex. 
There are two possible ways to explain how Arnt can antagonise AhR 
mediated cell cycle delay. Arnt is shown to form homodimers and bind to E-box 
sequence in vitro in the absence of AhR (Swanson et al., 1995). Arnt is also 
shown to heterodimerize with other factors (e.g. hypoxia inducible factor 1 a) and 
regulate transcription of genes independent of AhR or dioxin (Wang and 
Semenza, 1995). 
Thus, the ligand-AhA may sequester Arnt into complexes with AhR and 
Iimit the amounts of Amt available for other functions which are required for ceii 
cycle progression. lt is unlikely that this is the mechanism for TCDD-induced cell 
cycle delay because the mutants of AhR which have intact dimerization capacity 
with Arnt did not have any effect on cell cycle in the AhR deficient BP8 cells (refer 
section 3.2). 
The second possibility is that AhR mediates cell cycle effects of TCDD 
without a partner protein as a homodimer or tagether with partner protein(s) 
distinct from Arnt. With Arnt overexpression, the AhR mediated cell cycle effects 
are reversed possibly owing to the sequestration of limiting amounts of AhR or a 
putative partner protein of AhR by Arnt. 
To solve this question requires to understand in detail how AhR regulates 
the Kip1 promoter, e.g. delineation of the responsive elements in the promoter 
and characterisation of the protein complexes binding to these elements. 
3.3.2 Analysis of TCDD-induced genetic programme by suppression 
subtractive hybridization (SSH) 
3.3.2.1 Choice of the method 
A number of techniques are currently available such as differential display 
(Liang and Pardee, 1992), representational difference analysis (Hubank and 
Schatz, 1994 and Lisitsyn et al, 1993), serial analysis of gene expression 
(Velculescu et al., 1995) among others to monitor changes in gene expression. 
Despite the fact that many differentially expressed genes have been cloned by 
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these methods, all have one draw back or the other. For example these methods 
are not suitable for the identification of cDNAs of rare transcripts which are 
differentially expressed. The reason is that the original disproportion in the 
concentration of high- and low-abundant fractions is maintained in most of the 
procedures and often only the cDNAs of most abundant transcripts are isolated. 
However, the products of weakly expressed genes are also of interest, as they 
could play a role in the initiation and control of cellular processes. Recently, a 
new PCR-based cDNA subtraction method termed as suppression subtractive 
hybridization (SSH) has been described to obtain differentially expressed genes 
(Diatchenko et al., 1996). This is an ideal system for subtractive cloning as it 
equalizes representation of differentially expressed genes irrespective of their 
initial relative abundance. The high efficiency of this system was demonstrated 
by isolation of rare transcripts (Gurskaya et al., 1996; von Stein et al., 1997). 
3.3.2.2 Analysis of the results of SSH 
SSH was performed to identify TCDD-induced genes in 5L cells. Amongst 
the identified 34 differentially expressed genes, 22 were already known to be 
induced by TCDD. This indicated that the experimental approach to isolate 
TCDD-induced genes had been successful. Furthermore, the identification of 
genes which are induced <4 fold indicate that the experimental approach 
followed here is also suitable to identify genes whose expression is not altered 
drastically. 
Besides the known TCDD-induced genes, there are 3 known genes (B-eeil 
translocation gene 1, transglutaminase and lost on transformation 1) which were 
not reported to be induced by TCDD and 8 novel sequences without any data 
base matches. 
3.3.2.3 Completelyness of the identified genetic programme 
lt is appropriate to ask whether all the differentially expressed genes 
present in the subtractive library have been identified. Remarkably, the expected 
gene for the TCDD effect on the cell cycle, Kip1, was not at all picked. Though not 
picked from the library, it had been present after completion of the subtraction 
reaction. Thus, the failure to isolate Kip1 by the SSH method was a problern of 
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too few colanies being analysed, rather than the SSH reaction to generate the 
differential library. The notion that 1500 analysed clones were too few for a 
saturating analysiswas also supported by the finding that many genes were only 
picked once (refer Table II). Only two genes were picked multiple times ( CYP450 
1A 1 (4 times) and aldehyde dehydrogenase (13 times) ). The reason why these 
genes were isolated particularly efficiently is not known. One has to conclude that 
the number of isolated clones did not suffice to cover the complete set of AhR-
dependently induced genes. Amongst the expected genestobe found there was, 
however, only one geneout of 7 is missing. lt is fair to assume that also amongst 
the novel genes the percentage of missed genes is similarly low. 
3.3.2.4 N-Myristoyltransferase 2 is a novel TCDD-induced gene 
One of the novel sequences induced by TCDD was chosen for further 
analysis. Langer fragments of that sequence were isolated by a PCR based 
RAGE (rapid amplification of cDNA ends) approach. Sequence analysis has 
identified it as the gene coding for N-Myristoyltransferase 2 (NMT-2). NMTs are 
enzymes catalysing protein myristoylation which is the co-translational Iinkaga of 
myristic acid to the N-terminal glycine residues at position 2 of some of eukaryotic 
cellular proteins. Human and mause cDNAs for two distinct NMTs termed as 
NMT-1 and NMT-2 have been cloned. The specific role of each NMT in protein 
myristoylation is not yet studied (Giang and Cravatt, 1998). Furthermore, nothing 
is known about the transcriptional regulation of NMTs. Thus, TCDD is the first 
substance known to induce at least one NMT transcriptionally. 
3.4 Relevance of Kip1 and NMT -2 induction by TCDD in vivo 
As discussed in section 3.1, the findings in cell culture systems have to 
validated in vivo. The inducibility of Kip1 and NMT-2 by TCDD was tested and 
found tobe induced in vivo or in a primary system very close to in vivo. For Kip1, 
the relevance of induction in mediating TCDD toxicity was also tested. 
Discussion 
3.4.1 Kip1 is causally linked to TCDD-induced inhibition of 
thymocytes in organ culture of fetal thymus glands 
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lnduction of thymic aplasia by dioxins in vivo is reproducible in organ 
culture of thymus glands (FTOC) (Lai et al., 1997). FTOC was used to test if 
dioxins operated through induction of Kip1 in a primary system, as had been 
shown for immortalised 5L cells. TCDD induced Kip1 protein and decreased 
thymocyte proliferation in FTOC (Martin Göttlicher - personal communication). 
The causal role of Kip1 in TCDD effects on the fetal thymus was tested by 
establishing FTOCs from wild-type or Kip1-mutant litter-mate embryos. The 
targeted mutation in the Kip1 gene (~51 allele) impairs interaction with the 
cyclin/CDK complexes and hence does not permit inhibition of these kinase 
complexes (Kiyokawa et al., 1996). TCDD had only a minor effect in the FTOCs 
from Kip1 mutant mice as compared to FTOCs from wild type litter-mates (Martin 
Göttlicher, personal communication). This indicates that the major part of the 
TCDD response in FTOC is dependent on p27Kip1• Thus the induction of Kip1 by 
TCDD plays a causal role in inhibition of cell proliferation not only in 5L cells but 
also in FTOC, which is more close to an in vivo situation. This proves that the use 
of a cell culture system is valid to identify genes (and signalling pathways) 
relevant for TCDD-toxicity. 
Loss of Kip1 by targeted mutagenesis in mice Ieads to increased body 
weight and multiple organ hyperplasia including a hyperplastic thymus which is a 
phenotype Iargely opposite to the symptoms of dioxin poisoning (Fero et al., 
1996; Kiyokawa et al., 1996 and Nakayama et al., 1996). The induction of Kip1 
could thus explain some of the biological effects of dioxins such as thymic 
atrophy and sperm count reduction and reduced body weight gain in rodents, 
which are associated with reduced proliferation. Proof for this hypothesis has to 
be generated by the analysis of TCDD treated Kip1 knock-out mice. 
3.4.2 NMT-2 is induced in livers of TCDD-treated mice 
The first step in investigating the rote of NMT-2 in mediating any of the 
effects of TCDD in vivo is to test its inducibility in a target organ of dioxin toxicity. 
Liver is a major organ of TCDD action as it is a carcinogen in the rodent liver 
(Huff et al., 1994}. The inducibility of NMT-2 mRNA was tested and found to be 
increased in livers of mice after 5 or 7 days of TCDD treatment. Thus NMT-2 
fulfills one essential requirement to be a candidate gene in mediating TCDD 
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toxicity e.g. it is induced in a target organ of dioxin toxicity. Whether NMT-2 really 
plays a role in TCDD induced toxicity is at the present stage of knowledge up to 
speculation. Published data on NMTs may help to form a hypothesis. 
The substrates of NMT include protein kinases like p6osrc, cAMP-
dapendent protein kinase (PK-A) and phosphatases such as calcineurin B. 
Deletion or substitution of the N-terminal glycine at position 2 of N-myristoylated 
proteins by site-directed mutagenesis prevents their myristoylation, allowing 
comparison of the properties of the mutant, nonmyristoylated and wild type N-
myristoylated proteins. For example glycine 2 to alanine mutagenesis of p6ov-src 
prevents its targeting to the plasma membrane and blocks its ability to transform 
cells (Kamps et al., 1986). ln a different approach to prevent myristoylation by 
treatment of colonic cell lines with N-fatty acyl compounds a similar result was 
obtained. Inhibition of p6oc-src myristoylation depressed colony formation and cell 
proliferation (Shoji et al., 1990). 
ln colon tumors NMT protein and its activity has been shown to be 
increased compared to normal tissue (Magnuson et al., 1995 and Raju et al., 
1997). Tyrosine kinase activities of p6oc-src and p62c-ves protein kinases have also 
been shown to be elevated in primary colorectal adenocarcinoma (Bolen et al., 
1987; Cartwright et al., 1993 and Park et al 1993). Although the analysis of the 
tumor can never prove the reason for its generation, it is tempting to speculate 
that an inappropriate increase in protein myristoylation plays an important role in 
pathogenesis. Since TCDD induces NMT-2 in vivo, it is tempting to speculate that 
this ectopic induction of NMT-2 plays a role in the induction of carcinomas by 
TCDD. 
Protein myristoylation plays an important role also in other cellular and 
pathological processes, e.g. the assembly and viability of human 
immunodeficiency virus-1 (HIV-1) (Gottlinger et al., 1989). TCDD was shown to 
increase virus production in MT-4 human lymphoid cells infected with HIV-1 virus 
(Pokrovsky et al., 1991 and Tsyrlov and Pokrovsky, 1993). lt is tempting to 
speculate that the increase of myristoylation activity after TCDD-treatment was 
the reason for the observed effects. 
The following approaches will help to elucidate the role of NMT-2 
induction in carcinogenicity of TCDD. The first step is to measure 
myristoyltransferase activity in livers of TCDD-treated mice. Since there are at 
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least two NMTs, it is important to test whether the increase in NMT-2 mRNA 
correlates with a corresponding increase in enzymatic activity. This will help to 
estimate whether NMT-2 plays a major role in myristoylation of proteins in liver. 
The next step is to test whether there is a correlation of NMT-2 expression and 
enhanced proliferation of cells (for example by immuno-histochemical 
examination) in livers of TCDD-treated animals. lf the outcome of these 
experiments is still compatible with a role for NMT-2 in tumor promotion by 
dioxins, one could plan TCDD toxicity studies in NMT-2 knock-out mice once they 
are available. An alternativeapproachwas to cotreat the animals with TCDD and 
specific inhibitors of NMT-2 enzymatic activity (if available) and determine 
whether the animals are resistant to TCDD-induced tumors. 
3.5 Endogenaus functions of AhR 
The gene targeting technology to inactivate murine genes in vivo has been 
a powerful technique to elucidate the function of any gene product of choice. AhR 
knock-out mice have been generated by two different groups (Fernandez-
Salguero et al., 1995 and Schmidt and Bradfield, 1996). The livers of these mice 
were reduced in size by 50 percent and showed bile duct fibrosis. ln addition, the 
AhR knock-out mice generated by one group also had a phenotype in the 
immune system (Fernandez-Salguero et al., 1995). These mice showed 
decreased accumulation of lymphocytes in the spleen and lymph nodes. Thus 
the AhR is required for normal development of the liver and possibly the immune 
system. lt is not known, however, how AhR becomes activated by an endogenaus 
mechanism during development, e.g. whether there is an endogenaus Iigand for 
the receptor or whether AhR is activated by a Iigand-independent mechanism. lt 
is also not known which genes have to be regulated by AhR to ensure proper 
development of the liver and of the peripheral lymphatic organs. 
Now the question is whether Kip1 or NMT-2, the new target genes of AhR, 
can explain the phenotype of the AhR knock-out mice. Lack of AhR in mice might 
Iead to reduced expression of either or both of these genes during normal 
development. Camparisan of the expression of Kip1 and NMT-2 in wild type and 
AhR knock-out mice could give a first hint about the involvement of these genes. 
Lack of Kip1 in mice leaas to increase in body weight and also results in 
proportional increase in liver size. These mice also have increased accumulation 
of lymphocytes in spleen and lymph nodes (Fero et al., 1996; Kiyokawa et al., 
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1996 and Nakayama et al., 1996). Thus, the phenotype of Kip1 knock-out mice 
does not correlate with that of AhA knock-out mice and it is unlikely that 
reduced/loss of expression of Kip1 explains the phenotype of AhA knock-out 
mice. 
Whether AhA dependent expression of NMT-2 plays a role during 
development of liver and the immune system is not known. Certainly the 
development of thymocytes depends on the presence and most likely the 
myristoylation of Src-family tyrosine kinase Lek (Lowell and Soriano, 1996). 
Theoretically NMT-2 thus could be an AhA target gene which is required for 
normal thymic development, but too little is known at present to decide this 
question. 
ln summary, 12 (11 from SSH + Kip1) new target genes of AhA have been 
identified. Two of them, Kip1 and N-myristoyltransferase 2 (NMT-2} have been 
studied in detail. For both of them AhA constitutes the first pathway of conditional 
regulation on the transcriptional Ievei. Kip1 is shown to play a causal role in 
inhibition of proliferation by TCDD in 5L cells and in fetal thymus glands. The 
induction of Kip1 could explain some of the biological effects of TCDD, such as 
thymic atrophy, which are associated with reduced cell proliferation. Since 
increase in myristoylation of proteins is implicated in carcinogenesis, it is 
tempting to speculate that the AhA-dependent induction of NMT-2 mediates 
Carcinogenecity of dioxins. 
The complexity of the genetic program regulated by AhA already in a 
single cell line suggests that there is no simple AhA regulated master gene for 
the physiological function of AhA and for the dioxin toxicity. The analysis of 
clearly defined cellular models and genetic profiling as performed in the present 
study provide the tools to understand the mechanisms of dioxin toxicity. 
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4. Materialsand methods 
4.1 Materials 
All generat chemieals were of the highest purity grade, the majority of 
which were supplied from Merck, Darmstadt, Gar/ Roth GmbH & Co Karlsruhe 
and Sigma Chemie GmbH, Deisenhofen. Radioactive chemieals were from 
Amersham Buchler (Braunschweig). Aqueous solutions were made with water 
purified (bi-dest) by a Milli-Q water purification system. A number of protocols 
and recipes for commonly used buffers were taken from the laboratory manual of 
Maniatis et al. (1 989) and Current protocols in Molecular Biology (Ausubel et al., 
1989) unless otherwise stated. 
4.2 General methods 
Cell lines 
5L and BP8 cells: Rat hepatoma cells were supplied by Martin Göttlicher, 
Forschungszentrum, Karlsruhe and were maintained in Dulbecco's Modified 
Eagle's Medium (DMEM) supplemented with 10% Fetal Bovine Serum (FBS, 
Gibco, Eggenstein). 
Cell culture 
All cells were maintained at 37°C in an incubator (Forma Scientific, 
Labotect GmbH, Göttingen) in 5% C02 and 95% air humidity. All cells were 
grown in culture dishes (Greiner Labortechnik, Frikenhausen) of varying sizes. 
The cells were allowed to grow until a confluency of 80-90% had been reached, 
whereupon the cells were trypsinized and either reseeded at a lower density or 
plated out for an experiment. 
Trypsintreatment of cells was performed by removal of the culture medium. 
from the cells, followed by one wash with 10 ml of Ca2+/Mg2+ free PBS (137 mM 
NaCI, 2.7 mM KCI, 6.5 mM Na2HP04 x 2 H20, 1.5 mM KH2P04). 
After removal of the PBS, cells were incubated with 1 .0 ml of prewarmed 
0.25% trypsin at 37°C until cells had become detached from the culture dish. 
The cells were resuspended in fresh medium and replated at the desired density. 
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Gell stocks were maintained in liquid nitrogen. Logarithmically growing 
cells were trypsinized and 1 0 ml of medium was added. Cells were collected by 
centrifugation at 250xg. The medium was removed and cells were resuspended 
in previously cooled 90% FBS and 1 0% DMSO (Fiuka Chemie AG, Buchs, 
Switzerland} and transferred to cryo vials in 1 ml aliquots. The cells were kept on 
ice for an hour and transferred to -80°C for several hours before they were finally 
moved to liquid nitrogen. To re-propagate cells, the vials were removed from 
liquid nitrogen and thawed at 37°C. The cells were mixed with 1 0 ml of fresh 
medium and centrifuged at 250xg (to remove DMSO) and plated out on culture 
dishes with fresh culture medium. 
Mini-prep plasmid preparation from bacteria 
Individual colonies were picked from a LB agar plate and used to 
inoculate 3 ml of LB medium (10 g/L tryptone, 5 g/L yeast extract, 5 g/L NaCI}, 
containing 1 00 J.Lg/ml ampicillin. The inoculated bacteria were then incubated 
with shaking (220 rpm) overnight at 37°C until a stationary phase had been 
reached. 1.5 ml were removed and the bacteria were pelleted by centrifugation 
at 4000xg for 5 min. 
(a) Using Phenol-Chloroform 
Bacterial pellet was resuspended in residual 1 00 J.LI LB medium and 50 J.LI 
phenol were added. After vortexing, 5 min centrifugation at 1 OOOOxg the 
supernatant was mixed with equal amount of chloroform, again vortexed, 
centrifuged at 1 OOOOxg. Aqueous phase was taken to precipitate DNA with 2.5x 
volumes of ethanol at a final NaCI concentration of 0.1 M at RT for 30 minutes. 
DNA was collected by centrifugation at 1 OOOOxg, pellet was air dried and 
resuspended in 50 J.LI TE-butter. 
(b) Wizard Mini-prep kit (Promega) 
Resuspension, Iysis and neutralisation of the bacterial pellet was carried 
out according to the manufacturer's instructions using the provided buffers. The 
plasmid DNA in the retained supernatant was isolated using the supplier's DNA-
binding resin. The resulting plasmid DNA was then eluted in 50 Jll of bi-dest H20. 
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This method was primarily used for the production of sequencing grade plasmid 
DNA. 
Large scale plasmid preparation from bacteria 
Usually, a volume of 200-250 ml of LB (16 g/L tryptone, 5 g/L yeast extract, 
and 5 g/L NaCI) medium supplemented with the relevant antibiotic was 
inoculated with a single bacterial colony and incubated with shaking (220 rpm) at 
37°C overnight until the bacteria had reached a stationary growth phase. The 
bacteria were pelleted by centrifugation in a fixed angle rotor at 4000xg for 
10 min and the peilet resuspended in 10 ml of solution I (1 0 mM EDTA, 50 mM 
Tris-HCI pH 8.0 and 400 mg/ml of RNase A). Following 5-10 minutes of 
incubation at RT, the cells were lysed by the addition of 10 ml of solution II {200 
mM NaOH and 1% SOS). Once the solution had taken an opaque appearance, 
the mixture was neutralized with 10 ml solution 111 (3 M potassium acetate pH 
5.5). After additional 10-20 minutes on ice, the cell wall fragments and the 
bacterial chromosomal DNA were sedimented by centrifugation at 13000xg for 
20 minutes at 4°C in a fixed angle rotor. The retained supernatant was then 
added directly to a pre-equilibrated Qiagen-tip 500 column (Qiagen lnc., Hilden) 
and the plasmid DNA was recovered according to the manufacturer's instructions 
using the supplied buffers. The purified DNA was precipitated using 0.7 volumes 
of isopropanol, washed twice in 70% ethanol before resuspending the DNA to a 
final concentration of 1-3 mg/ml in bi-dest H20 and stored at -20°C. 
Preparation of competent bacteria (E.Coli) 
Chemical competent E.Coli (ca/cium ch/oride method) 
A single colony of E.co/i DH5a was taken to inoculate 5 ml of LB medium 
(1 0 g/L tryptone, 5 g/L yeast extract, 5 g/L Na Cl) and allowed to grow o/n at 37°C 
with shaking (220 rpm). 4 ml were removed and added directly to 400 ml of LB 
medium. The bacteria were grown to an OD590 of 0.375 before incubating the 
bacteria on ice for 10 min. The bacteria were sedimented by centrifugation at 
3600xg for 7 min at 4°C. The pellet was carefully resuspended in 20 ml of ice 
cold 0.1 M CaCI2 and allowed to stand on ice forafurther 10-15 min. The cells 
were centrifuged again under the same conditions and resuspended in another 
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20 ml of ice cold CaCI2. This process was repeated once more and the final 
pellet resuspended in 2 ml of ice cold CaCI2. After a short period on ice, the 
bacteria were dispensed in 50 J.tl aliquots in pre-chilled reaction tubes and snap-
frozen in liquid nitrogen before storing at -80°C. 
Transformation of bacteria 
(a) Chemically 
Depending on the application, 5 ng of supercoiled plasmid DNA or 1 J.tl of 
a ligation mix (usually a 1/10 of the !igation) was added to 50 f.ll of competent 
cells and left on ice for 30 minutes. Following this, the cells were heat-shocked at 
42°C for 90 seconds before chilling the tube on ice for two minutes. After addition 
of 1 ml of SOC medium (2.0% tryptone, 0.5% yeast extract, 10 mM NaCI, 2.5 mM 
KCI, 10 mM MgS04, and 20 mM glucose) the bacteria were transferred to a 
shaker and incubated for 45 minutes at 37°C. The cells were then pelleted by a 
short centrifugation (3 min at 1 OOOxg) and 1 ml of the supernatant was removed 
before resuspending the cells in the remaining 200 J.tl. A volume of 50-200 J.tl 
was plated out on LB-agar plates supplemented with the appropriate antibiotic 
and the plates incubated 18-24 hours at 37°C. 
(b) Electroporation 
Usually, 1-2 J!l of a ligation mixture was added to 40 J.tl of electrocompetent 
cells (lnvitrogen BV, The Netherlands) previously aliquoted in pre-chilled 
reaction tubes. The cells were then immediately transferred to a pre-cooled 
electroporation cuvette (0.1 cm gap, BioRad) and pulsed at 1.8 kV (Gene pulser, 
BioRad). After the pulse, 1 ml of SOC medium was added to the cuvette and 
retrieved with the cells and placed in an eppendorf tube before incubation at 
37°C for 60 minutes. Cells were pelleted before plating out on appropriate LB-
agar plates. 
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Phenol/Chloroform extraction of nucleic acids 
To remove protein contaminants from nucleic acids, an equal volume of 
Tris-buffered phenol/chloroform/isoamylalcohol (25:24:1) was added and 
vortexed. The two phases were separated by centrifugation at 1 OOOOxg for 15 
minutes after which the upper aqueous nucleic acid containing phase was 
transferred to a new tube and subjected to another round of extraction with 
chloroform/isoamylalcohol (24: 1). 
lsolation/Purification of DNA from agarase gels 
A number of methods were employed to isolate DNA (e.g. PCR fragments, 
restriction digested vectors and inserts) from agarase gels once electrophoresis 
was completed. 
(a) Electrophoretic isolation of DNA 
Once the DNA had migrated the desired distance, as determined by 
visualising the gel under UV light, a slit was cut into the gel with a scalpel just 
below the chosen DNA band. A strip of DE81 DEAE-celfulose membrane 
(Schleicher & Schuell, Dassel) was inserted into the slit and electrophoresis 
continued until the DNA fragment had run onto the membrane. At this point the 
membrane was removed, rinsed briefly with distilled H20 and the DNA eluted by 
incubation in 400 J.tl 1.5 M NaCI, 1 0 mM Tris-HCI pH 7.5 and 1 mM EDT A for 30 
min at 65°C with shaking. After two extractions with phenol/chloroform, the DNA 
was precipitated with ethanol, air dried and dissolved in an appropriate volume 
of water. 
(b) EasyPure Kit (Biozyme) DNA iso/ation from agarose ge/s 
As above with the exception that the gel strip containing the DNA is added 
to 3x it's weight to volume of salt buffer (alf reagents provided in the kit). The gel 
piece is melted in the buffer by incubation at 55°C before the binding resin is 
added. After incubation for 5 min at room temperature, the binding resin is 
pelleted at 1 OOOOxg for 5 s, washed with washing buffer, pelleted once more and 
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finally atter air dryin9 taken up into 20 !-LI of water. To remove the resin the 
dissolved ONA is recovered by centrifu9ation at 1 OOOOx9 for 5 min. 
Ethanolllsoamylalcohol precipitation of nucleic acids 
The precipitation of both RNA or ONA was performed by adjustin9 the final 
salt concentration of the reaction mixture to 300 mM with 3M Na-acetate (pH 5.2) 
and addin9 2.5 volumes of 1 00% ethanol followed by a 30 minute incubation at 
-20 °C. The precipitate was pelleted by centrifu9ation at 13000X9, at RT for 
30 minutes atter which the aqueous phase was discarded. The pellet was 
washed once with 70°/o ethanol to remove salt and allowed to air dry for 
10 minutes. 
Determination of nucleic acid concentration 
The concentration of nucleic acids in aqueous solution can be determined 
by spectroscopic measurement of their extinction coefficient at 260nm and 
280nm. An optical density (00) of 1 at 260 nm is equivalent to 50 1-!9/ml of 
double stranded DNA, 40 1-!9/ml of RNA or 20 1-!9/ml sin9le stranded 
oli9onucleotide. The 00280 is used as an indication of purity and should be 
approximately 50% of the 00260 value. Pure RNA and ONA should have an 
00260/00280 ratio of 1.8-2.0 and 1.6-1.8 respectively in bi-dest water. 
Restrietion digest of DNA 
5 units of the enzyme per 1-!9 of ONA have been used for restriction 
di9ests. The di9estion was performed usin9 the appropriate enzyme buffer and 
incubation temperature as recommended by the supplier. Reactions were 
incubated for ~1 hour at a final ONA concentration of 1 !-!911 0 !-LI atter which the 
reaction was terminated by heat inactivation of the enzyme (65°C for 10 minutes) 
followed by phenol/chloroform extraction. The di9estion was controlled by 
a9arose 9el electrophoresis. 
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DNA ligation 
All ligation reactions were pertormed in a total volume of 10 J..LI and 
incubated overnight at 16°C. 
(a) Ligation of PCR fragments 
After purification of the PCR fragment, the DNA was directly cloned via the 
T/A overhangs into the T/A cloning vector (original T/A cloning kit®, lnvitrogen BV, 
The Netherlands) according to the suppliers protocol and using the kit's 
components. 
(b) Sub-cloning 
The cloned fragment of DNA was released from the vector using 
appropriate restriction endonucleases, purified by agarase gel electrophoresis 
and subsequently cloned into the new vector using compatible sites or through 
blunt end ligation. 
Isolation of total RNA from cells or tissue 
Total RNA was prepared from cells which were 40-60% confluent in 9 cm 
culture dishes (Greiner, Frickenhausen). The medium was completely removed 
and cells were lysed by adding 550 J..LI of RNA solubilization buffer (4 M 
Guanidinium thiocyanate, 25 mM sodium citrate pH 7.0, 100 mM 
ß-Mercaptoethanol and 0.5% sodium-lauroylsarcosine) drop by drop to cover the 
entire plate. The cell lysate was collected, transferred to an eppendort tube and 
vortexed briefly. 60 J..LI of 3 M sodium-acetate pH 4.2 was added and mixed by 
vortexing. 550 J..LI of phenol (pH 4.0) was added and mixed by vortexing for 
30 seconds. 150 J..LI of chloroform was added and again mixed by vortexing. The 
mixture was incubated on ice for 1 0 minutes and centrifuged for 15 minutes at 
1 OOOOxg at 4°C. The aqueous phasewas transferred to a fresh tube and the RNA 
was precipitated by adding equal volume of isopropanol and kept for 30 minutes 
at -20°C. The samples were centrifuged at 1 OOOOxg for 10 minutes and the 
supernatant was discarded. The RNA pellet was dissolved in 200 J..LI of RNA 
solubilization buffer by vortexing. The RNA was reprecipitated by addition of 
200 J..LI isopropanol and kept at -20°C for 30 minutes. The samples were 
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centrifuged at 1 OOOOxg at 4°C. The supernatant was discarded and the pellet 
was resuspended in 75% ethanol, vortexed and incubated for 15 minutes at 
room temperature (Rn to dissolve residual amounts of guanidinium 
contaminating the pellet. The samples were centrifuged for 10 minutes at 
1 OOOOxg at RT. The RNA pellet was dried at RT for 5 minutes and then dissolved 
in 30-50 f..LI of freshly autoclaved water by incubating at 65°C for 5 minutes. The 
RNA was quantified and stored at -80°C. 
RNeasy Mini protocol for RNA clean-up 
Tissue total RNA was purified using the RNeasy clean-up protocol and 
reagents supplied (Qiagen, Hilden). 20f..Lg of total RNA was taken and processed 
according to supplier's recommendations. The cleaned RNA was then eluted in a 
total volume of 40 f..LI. RNeasy clean-up was only performed on those RNA 
samples intended for the use of RT-PCR. 
Isolation of Poly(A)+ RNA 
Poly(A)+ RNA was prepared from cells which were 40-60% confluent in a 
15 cm culture dish (Greiner, Frickenhausen). The medium was removed and the 
cells were washed twice with ice cold PBS. The cells were then immediately 
lysed in 10 ml of STE-SOS-buffer (20 mM Tris-HCL pH 7.4, 100 mM NaCI, 
10 mM EOTA and 0.9% SOS) containing 300 mg/ml proteinase K (Sigma, 
München). The high molecular weight ONA was sheared for 10 seconds with an 
Ultra-Turax™ homogenizer followed by incubation at 37°C for 30 minutes. After 
adjusting the final concentration of NaCI to 500mM, 50-200 mg of oligo-dT 
cellulose (type VII, Pharmacia Biotech) swollen in STE {20 mM Tris-HCL pH 7.4, 
100 mM NaCI, 10 mM EOTA and 0.5% SOS) was added and the resulting 
mixture rotated at least for 4 hours to allow binding of the poly(A)+ RNA to the 
oligo-dT cellulose. The oligo-dT cellulose was collected by pouring the contents 
into a 20 ml Bio-Rad Econo-Pac column, allowing the liquid to drain out while 
retaining the oligo-dT cellulose. lt was then washed with 3 x 20 ml of HSB 
solution (300 mM NaCI, 10 mM Tris-HCI pH 7.4, 5 mM EOTA and 0.1% SOS). 
The poly A + RNA was eluted from the oligo-dT cellulose by addition of 5 ml of 
freshly autoclaved water and the contents were collected in an autoclaved corex 
tube and precipitated by adding 1/10 volume (500 f..LI) of 3M Na-Acetate pH 5.2 
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and 2.5 volumes (12.5 ml) ethanol for 2 hours at -80°C, followed by centrifugation 
at 1 OOOOxg for 45 minutes at 4°C. The RNA pellet was washed once with 75% 
ethanol, and air dried for 10 minutes. The pellet was then dissolved in freshly 
autoclaved water. The RNA concentration was determined and stored at -80°C. 
Transient transfection of Sl and BPS cells 
Cells were plated out at a density of 2.5x1 06 per 15 cm culture dish 2 days 
prior to transfection. Cells were trypsinized, resuspended in DMEM 
supplemented with 1 0% FBS. ln order to neutralize trypsin they were collected 
by centrifugation at 50xg, washed twice in DMEM (w/o FBS) prewarmed to room 
temperature. The cells were then resuspended in DMEM without FBS. 200 111 of 
cell suspension containing approximately 5x1 06cells was mixed with DNA to be 
transfected. Electroporation was performed in 4 mm gap cuvettes with a pulse of 
280 V and a capacitance of 500 11F in a Bio-Rad gene pulser. After 
electroporation, cells were allowed to recover for 10 min at room temperature 
and suspended in 10 ml of DMEM containing 10% FBS. For -1+ TCDD treatments 
(with same set of DNAs transfected) cells from two electroporations were pooled 
and splitted into two 9 cm culture dishes. Cells were treated with 1 nM TCDD by 
addition of 111M stock solution of TCDD in DMSO or with 0.01% DMSO at 
indicated time points. 
First and second strand cDNA synthesis 
( a) First strand synthesis using SuperScript ™ II for RT-PCR 
For most applications, 2 J.L9 of high quality poly (A)+ RNA together with 
500 ng of oligo ( dT) 12-18 primer in a total volume 11 J.LI was heated to 70°C for 
1 0 minutes in a thermal cycler (Perkin Eimer 9600/2400) before placing the 
reactions rapidly on ice. The reaction mixture was subsequently made up to 20 J.LI 
by adding 4 J.LI of 5x first strand reaction buffer (provided with the reverse 
transcriptase), 2 J.LI of 0.1 M DTT and 1 J.LI dNTP mix {10 mM each dATP, dCTP, 
dGTP and dTTP). Reverse transcription was started by addition of 2 J.Ll of 
SuperScript™ reverse transcriptase (Gibco BRL, Eggenstein) to each reaction 
before incubation for 1-1.5 hours in an air incubator previously equilibrated at 
42°C. The reverse transcriptase was inactivated by rapidly heating the contents 
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to 94°C for 3 minutes and then placing the tubes on ice. The first strand reactions 
were stored at -20°C once their volume had been adjusted to 200 J.LI by the 
addition of 180 J.LI bi-dest H20. 
ln order to monitor the efficiency of the first strand reaction, 1 J.LI was removed 
directly after the addition of the reverse transcriptase and added to 1 J.LI of a 
labelling mixture containing 0.3 J.LI [32P]dCTP and likewise incubated at 42°C. 
This so called tracer reaction was stopped by the addition of EDTA to a f.c. of 
20 mM. Specific incorporation of dCTP into high molecular weight nucleic acid 
was determined by the TCA precipitation procedure. Typically, -28 % of all 
poly(A) + RNA transcripts were converted into first strand cDNA. Note: first strand 
cDNA synthesis performed for the generation of a subtracted library was done 
exact!y as described above with one exception. The oligo (dT} primer used for 
cDNA synthesis contained an Rsa I restriction site and a 'dT' tail of 
30 nucleotides in length. This primer was provided in the PCR-Select™ cDNA 
subtraction kit (Ciontech Laboratories, lnc. USA). 
ln case of performing secend strand synthesis, the heat inactivation and dilution 
steps were omitted and the reaction vials were placed on ice after incubation at 
42°C instead. 
(b) One-tube second strand synthesis 
Following first strand synthesis, second strand synthesis was performed by 
adding 92 J.LI of sterile, bi-dest water, 32 J.LI of Sx second strand buffer [94 mM 
Tris-HCI, pH 6.9, 453 mM KCI, 23 mM MgCI2, 750 J.LM ß-NAD and 50 mM 
(NH4)2S04], 3 J.LI of Escherichia coli DNA ligase (7.5 U/J.LI), 4 J.LI E.coli DNA 
polymerase I (1 0 U/J.LI) and 0.7 J.LI of E.coli RNase H (2 U/J.LI). The contents were 
mixed and 5 J.LI removed for the radioactive incorporation assay (as above). 8oth 
reactions were incubated at 16°C for 2.5 h. The double stranded cDNA in the 
unlabelled reaction was blunted by the addition of 2 J.LI of T4 polymerase 
( 1 0 U/J.LI, using 10 U per J.Lg of mRNA taken in the reaction), followed by further 
incubation at 16°C for 20 minutes before both reactions were stopped by addition 
of EDTA to a final concentration of 10 mM. As before, Iabeiied second strand 
cDNA synthesis was monitared by TCA precipitation and separated on an 
alkaline agarase gel as described by Maniatis et al. (1989). The unlabelled 
fraction was phenol/chloroform extracted and precipitated in the presence of 
1 0 J.Lg of glycogen before resuspending the ds-cDNA in bi-dest H20 to a 
concentration of 0.1-0.5 mg/ml. 
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Polymerase Chain Reaction (PCR) 
All PCR reactions were performed in a total volume of 25-1 00 J.LI, in the 
presence of 250 J.LM dNTPs, 1-2 pmol of primer(s), 0.25U to 1 U of Taq and 
1 x supplier's buffer and 1.5 - 2.0 mM MgCI2 f.c .. The reactions were carried out 
in a number of commercially available PCR thermo Cyclers (e.g. Perkin Eimer 
9600/2400 and DNA Engine MJ Research), using specific cycling parameters 
depending on the application. Analysis of the PCR reaction was performed using 
gel electrophoresis. 
Reverse Transcription Polymerase Chain Re~u~tion (RT-PCR) 
All reactions were performed as described for standard PCR with the 
exception that 5 J.LI of a previously diluted first-strand cDNA reaction was taken as 
template DNA and the primers used were specific for the gene of interest only (as 
determined through BLAST). Again, specific cycling parameters were dependent 
on the primers chosen and size of the expected product. Evaluation of the RT-
PCR reaction was performed by gel electrophoresis. The product was 
sequenced after cloning when required. 
Radioactive labelling of DNA I cDNA probes 
Approximately 25 ng of ds cDNA in a volume of 45 J.LI was denatured by 
heating to 1 00°C for 5 minutes. The entire solution was then added to a 
redi Prime reaction vial (redi Prime kit, Amersham. Life Science) to which was 
added 5 J.LI of [a32P]-dCTP (Amersham Buchler GmbH, Braunschweig, 
370 MBq/ml, 10 mCi/ml). After incubation for 15 minutes at 37°C unincorporated 
nucleotides were removed from the Iabeiied DNA using Sephadex G-50 
columns (Pharmacia) according to the manufactures guidelines. The Iabeiied 
DNA was eluted in a volume of 400 J.LI TE-buffer and the required amount was 
denatured at 1 00°C for 5 minutes immediately before use. 
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Sequencing of double-stranded template DNA 
(a) [a-33Pj-ddNTP method 
The Thermo Sequenase radiolabellad terminator cycle sequencing kit 
(Amersham) was used for the sequencing of cloned templates. The kit combines 
two revolutionary innovations for sequencing DNA. First, the Iabei is incorporated 
into the DNA reaction products by the use of four [a33P]-ddNTP terminators and 
secondly, the use of an engineered Thermo Sequenase DNA polymerase which 
allows efficient incorporation in cycling sequencing protocols. Sequencing of 
desired templates was carried out according to the manufacturer's guidelines. 
Approximately; 0.5 1!9 of plasmid DNA was taken together with 1-2.5 pmol of an 
appropriate primer (usually M13 Forward or Reverse universal primers) with 8 U 
of the Thermo Sequenase polymerase in a total volume of 20 J.LI. From this 
mixture 4.5 J.LI was aliquoted into each termination vial (G, A, T and C) and 
cycled in a Perkin Eimer 9600 PCR machine using the following cycle 
parameters: 95°C, 30 s, 55°C, 30 s and 72°C, 1 minute for a total of 35 cycles. 
Upon completion, 4 J.LI stop solution was added and 3 J.LI of the mixwas loaded 
per lane and resolved over a 6% polyacrylamide 6 M urea TBE gel. Once the run 
had reached the desired length, the gel was removed, dried on Whatman 3MM 
paper at 80°C for 2 hours on a vacuum gel dryer before autoradiography. Films 
were developed after 18-36 hours exposure. 
(b) ™Vistra DNA sequencer 725 
For the use of automated fluorescent sequencing of template DNA, a 
commercially available kit was used (Thermo Sequenase pre-mixed cycle 
sequencing kit, Amersham) tagether with the appropriate Texas Red Iabeiied 
primers. All reagents were taken from and used following the supplier's protocol. 
The thermocycling conditions for the sequencing reactions were set at: 94°C 
1 minute, then 22 cycles of 94°C, 30 s; 50°C, 15 s; and 72°C for 30 s. Following 
completion, 3 J.LI of loading dye was added to each reaction vial and mixed 
before placing the reactions in a vacuum centrifuge until the desired volume had 
been reached (usually 3-4 J.LI). After the gel had been pre-run for 30 minutes 3 J.LI 
of each reaction sample was loaded onto the gel and allowed to run overnight. 
Sequences were analysed using the provided software. 
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Generation of a subtracted library by SSH 
Suppression Subtractive Hybridization was performed between non 
treated 5L cells (driver) and 4 h TCDD treated 5L cells (tester), using the PCR-
Select™ cDNA Subtraction Kit (Ciontech Laboratories, lnc. USA) according to 
the manufacturers' recommendations. All PCR and hybridization steps were 
performed on a Perkin-Eimer 9600 thermal cycler. Double-stranded cDNA was 
synthesized from 2 J.Lg of poly(At RNA of the non treated or 4 h TCDD treated 
cells as described earlier. 8oth ds cDNAs were then Rsa I digested, precipitated 
and redissolved in freshly autoclaved water according to Clontach cDNA 
subtraction user manual. Tester cDNA was Iigated with adaptors provided in the 
kit. The ligation efficiency was verified by comparing PCR products obtained with 
gene specific primers for GAPDH or one GAPDH specific primer and another 
adaptor specific primer. The difference between the intensities of the above PCR 
reactions was less than two fold. All manipulations were performed in 
accordance with the protocol in the user manual. 
For the first hybridization the mixture of driver and tester cDNAs was denatured at 
98°C for 90 seconds and then incubated at 68°C for 11 h. For the secend 
hybridization, fresh driver cDNA was denatured at 98°C for 90 seconds then the 
samples from the first hybridization were mixed tagether without denaturing in 
the presence of freshly denatured driver cDNA and incubated at 68°C for 
20 hours. At the end of the incubation period 200 J.LI of dilution buffer (20 mM 
Hepes-HCI (pH 8.3), 50 mM NaCI and 0.2 mM EDTA (pH 8.0)) was added. 
Differentially expressed cDNAs were selectively amplified in two rounds of PCR 
as described in the user manual provided in the subtraction kit. 
Evaluation of subtraction efficiency 
Equal amounts of amplified cDNA from the tester and the subtracted 
library cDNA were resolved on a 2.0% TAE agarosa gel, blotted and transferred 
onto nylon membrane as described later under southern blotting. This was 
performed in order to monitor the degree of subtraction efficiency as determined 
by the removal of genes common to both populations (e.g. GAPDH) and the 
subsequent enrichment of genes specific to the tester population (e.g. 
CYP450 1A1 and GST-Ya). Hybridizations were carried out as mentioned in 
southern blotting and hybridization analysis. After washing the membranes were 
sealed in a plastic bag and exposed to Amersham hyper film MP at -80°C. 
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Cloning into TA vector 
After evaluation of the subtraction efficiency the subtracted PCR products 
were cloned into pCR2.1 vector (TA cloning kit, lnvitrogen BV, The Netherlands). 
The subtracted PCR products were incubated for 30 min at 72°C with additional 
dATP and Taq DNA polymerase (Eurobiotaq) to ensure that most of the cDNA 
fragments contained 'A-overhangs' as the initial PCR amplification of subtracted 
products was done with Kien Taq polymerase mix (Ciontech Laboratories, lnc. 
USA) which contained proof-reading polymerases. The subtracted PCR products 
were precipitated and approximately 100 ng of the cDNA was Iigated into 50 ng 
of linearized vector having 3' T -overhangs provided in the kit. One third of the 
ligation products were introduced into electro-competent bacteria by 
electroporation in 2 mm gap cuvette using an E.coli pulser (Bio-Rad) at 1.8 kV. 
The library was plated onto 15 cm agar plates containing 100 J.tg/ml ampicillin, 
100 JlM IPTG and 50 Jlg/ml X-Gal. Plates were incubated at 37°C until coloniss 
were visible and then incubated further at 4°C until blue/white staining could be 
clearly distinguished. 
4.3 Analytical methods 
Northern blot hybridisation 
1 0 to 20 Jlg of total RNA or 2-5 11g poly (A)+ RNA was diluted with freshly 
autoclaved bi-dest H20 to give a final volume of 11.25 Jll. To this was added 
38.75 Jll of formaldehyde denaturing buffer (25 ~-tl formamide, 5 ~-tl 1 OxMOPS 
(200mM MOPS, 50mM EDTA, pH 7.0) running buffer and 8.75 ~-tl of 
37% formaldehyde) and the samples were mixed weil by vortexing. The 
samples were incubated at 55°C for 15 minutes before addition of 1 0 ~-tl of RNA 
loading buffer (1mM EDTA, 50% glycerol, 0,1% bromphenolblue). The RNA 
samples were then size fractionated on a 1% formaldehyde/MOPS agarose gel. 
1% previously autoclaved agarase in 1 xMOPS buffer was melted in a microwave 
oven and allowed to cool to 60°C before addition of formaldehyde to a f.c. of 
3.5% and 1 Jll of ethidium bromide (1 0 mg/ml). Electrophoresis was done at 
1 00 V at RT for 2 h in 1 xMOPS running buffer. The integrity of the RNA was 
visualised under 260 nm UV light source. The RNA was then transferred to 
Hybond-N+-membrane (Amersham Buchler GmbH, Braunschweig) using 
20xSSC (3 M NaCI, 0.3 M Na3citratex2H20) as the transfer buffer. After the o/n 
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transfer the membrane was rinsed with 5xSSC and the RNA was covalently 
cross-linked to the active OH groups in the membrane with UV (UV stratalinker 
2400, Stratagene, La Jolla, CA, USA). 
The hybridization procedure was carried out as follows: the membrane was 
prehybridized in a glass tube for 15 min at 65° C in 4xSSC, 0.02% Ficoll 400, 
0.02% polyvinylpyrollidone, 0.02% BSA, 3% Pippi (0.5 M sodiumphosphate pH 
7 ,3, 1.5% sodiumpyrophosphate) and 0.1% SOS in a hybridization oven 
(Amersham Buchler GmbH, Braunschweig). Salmen sperm ONA was added 
then to block the unspecific hybridization to a final concentration of 20 !l91ml and 
prehybridization was continued for another 45 minutes. Hybridization was 
carried out in 4xSSC, 10mM EOTA and 0.1% SOS containing 1x106 cpm/ml of 
random primer Iabeiied DNA probe (to which 20 119/ml of salmon sperm ONA 
was added and denatured at 95°C for 10 minutes) for about 12 h at 65°C. The 
membranewas washed three times at 65°C in 2xSSC (1 h), 1xSSC (30 min) and 
0.5xSSC (15 min) respectively each containing 0.1% SOS and 3% Pippi. 
The membrane was sealed in a plastic bag, exposed to a phosphoimager plate 
for quantification (Phospholmager Fujix BAS 2000) and then later exposed to 
Amersham hyper film MP at -80°C with an intensifying screen. 
lmmobilization of cDNAs on a Hybond-N+-membrane via 
slot blot 
A Hybond-N+-membrane was rinsed in water and fixed tagether with a 
piece of 3MM-paper soaked in 1 OxSSC in a slot blot chamber 
(Schleicher&Schuell, Oassel). 50-100 ng of ONA in 30 ~-tl were mixed with 20 ~-tl 
of loading buffer (0.3M NaOH, 15% Ficoll 400, 0.1% bromphenolblue). ONA 
mixturewas soaked onto the membrane, washed two times with 300 ~-tl 0.3 M 
NaOH and rinsed in 5xSSC. Membrane was air dried and ONA was cross-linked 
with UV (UV stratalinker 2400, Stratagene, La Jolla, CA, USA). Prehybridisation 
and hybridisationwas done like given in the southern blotting procedure below. 
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Southern blotting and hybridization analysis of PCR products 
The PCR products were loaded onto an agarose gel and run in 1 xTAE 
buffer until the ONA had migrated sufficiently as determined by visualisation 
under UV-Iight. The gel was then incubated in a solution of 0,4 M NaOH for 
20 min and shaken slowly on a platform shaker. The ONA was transferred to 
Hybond-N+ membrane as described in Current Protocols in Molecular Biology 
using 0.4 M NaOH as the transfer butfer. After the overnight transfer, the 
membrane was rinsed in SxSSC and stored dry if not used immediately. The 
membrane was prehybridized in a glass tube for 1 h at 65°C in church buffer 
(1.0 M NaP04, pH 7.2, 7% SOS) (Church and Gilbert, 1984)). The hybridization 
was also carried out in church buffer containing 1 x1 06 cpm/ml of random primer 
Iabeiied ONA probe (to which 20 ~-tQ/ml of salmon sperm ONA was added and 
denatured at 95°C for 10 minutes) for about 12 h at 65°C. The membranes were 
washed three times for 30 min each at 65°C in 2xSSC, 0.2xSSC and 0.1 xSSC 
containing 0.1% SOS each. The membranes were sealed in a plastic bag and 
exposed to Amersham hyper film MP at -80°C. 
lmmunoblot analysis of proteins (Western blot) 
(a) Separation of profeins by polyacrylamide ge/ e/ectrophoresis (PAGE; 
Laemmli, 1970) 
The polyacrylamide gel consisted of a 12% separating gel and a 
5% stacking gel. Reagents for the separating gel were 2 ml of acrylamide/bis-
acrylamide (30:0.8, Carl Roth GmbH & Co, Karlsruhe), 1.3 ml of 1.5 M Tris-HCI 
pH 8.8, 25 J.LI of 20% SOS, and 1.7 ml of H20. To the mixture 50 J.LI of 
10% ammonium persulphate (APS) was added and the reaction initiated with 
5 J.LI of TEMEO. The gel mixwas poured between two glass plates with spacers 
in between (Mighty smallll, Hoefer) and allowed to polymerize for 30 min. Then, 
a stacking gelwas poured on top. This was made up of 330 J.LI of acrylamida/bis-
acrylamide, 250 J.LI of 1M Tris-HCI pH 6.8, 1 0 J.LI of 20% SOS, 1.4 ml of H20, 
200 J.LI of 10% APS and 2 J.tl of TEMEO. The gel was run in 1x Laemmli-running 
butfer (25 mM Tris-HCI pH 8.3, 0.2 M glycine and 0.1% SOS) until the desired 
distance had been reached. 
Materials and methods 83 
(b) Preparation of ce/1 extracts 
Cells were grown logarithmically on a 9 cm culture dish. Before harvesting 
cells were washed once in PBS, lysed in 2xlaemmli sample buffer (125 mM Tris, 
pH 6.8, 4% SOS, 20% glycerol, 2% ß~mercaptoethanol, 0,01% bromphenolblue) 
and sonified with a Branson sonifier. 
Before loading the samples, the extracts were denatured by heating for 
5 minutes at 95°C, chilled on ice and loaded onto the gel. The electrophoresis 
was carried out at 100 V for 2 hrs. 
(c) Determination of profein contents by Coomassie blue staining 
The part of the gel that was not used for transfer was cut and incubated 
with mild shaking for 1 ~2 hours in Coomassie staining solution (0.25% Serva 
Blue G250, 46% methanol, and 8% acetic acid). Afterwards the gel was 
destained in two steps. First in 50% methanol and 10% acetic acid and then in 
5% methanol with 7% acetic acid until blue clear bands were visible. The gel 
was then removed and vacuum dried. 
(d) Electrophoretic transfer of resolved profeins onto membrane and 
subsequent antibody detection 
The section of the gel containing proteins of interest was isolated and a 
piece of Immobilen membrane (Millipore, type PVDF, pre~soaked in methanol, 
water, transfer buffer ( 200 mM glycine, 25 mM Tris~base, 20% methanol)) placed 
on top of the gel. The proteins were transferred in transfer buffer using a BioRad 
Trans~Biot Gell transfer chamber. Transfer was usually carried out at 65 mA for 
one hour using semidry blot. The membrane was then incubated for 30 minutes 
with blocking buffer (5% low~fat milk in TBS (20 mM Tris~base, 150 mM NaCI, 
pH 7.6) with 0.2% Tween 20 to reduce unspecific binding of the antibodies to 
the membrane. For detection of proteins of interest the membrane was further 
incubated in TBS with 0.2% Tween 20 buffer containing the appropriate primary 
antibody (at a dilution of 1:1 000) for one hour at RT or at 4 °C for about 12 hours. 
After extensive washing in TBS/0.2% Tween 20, the membrane was incubated 
again in TBS with 0.5% Tween 20 containing a 1 :2000 dilution of a peroxidase~ 
coupled anti~rabbit secondary antibody. Once the membrane had been washed 
3 times 5 min each in TBS/0.2% Tween 20, detection of specific proteins was 
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achieved by enhanced chemifluoresence using Amersham ECL Western b/otting 
detection reagents (RPN 21 06) following the manufacturer's instructions. 
(e) antibodies used 
Anti p27-KIP (rabbit polyclonal antibody, sc 528, Santa Cruz, 
Heidelberg) 
Anti ERK1 (rabbit polyclonal antibody, sc 094, Santa Cruz, Heidelberg) 
Anti-rabbit immunoglobulins (polyclonal lgGs, peroxidase-coupled, 
from goat, DAKO, G!ostrup, Denmark) 
DNA-staining procedure for hepatocytes 
Logarithmically growing cells were washed once with PBS (-Ca2+/Mg2+), 
trypsinized and collected in DMEM medium containing 10% FBS. The cells were 
collected by centrifugation at 250xg. 
After washing once in PBS, the cells were resuspended in 2ml PBS and an 
equal volume of fixation solution (8% formaldehyde, 2% methanol dissolved in 
PBS) was added. Cells were incubated for 10 min at RT and permeabilized by 
addition of 400 J..LI 0.5% Tween 20 for another 10 min. 10 ml of ice cold 
PBS/5% FBS was added and cells were collected at 800xg. For DNA-staining 
cells were resuspended in PBS/5% FBS containing the DNA bisbenzimide dye 
H33258 (1 J..Lg/ ml, Hoechst). 
lmmunofluorescence assay for the detection of 5-Bromo-2'-
deoxy-uridine {BrdU) incorporated into cellular DNA {kit by 
Boehringer Mannheim) 
32h after transfection cells were treated with 1 nM of TCDD or 0.1% DMSO 
for additional 18h of which du ring the last 5h 1 0 J..LM BrdU was present in the 
culture medium. Cells were harvested using trypsin and green fluorescing cells 
were sorted to a purity greater than 80% by FACS (Becton Dickinson, FACS Star 
Plus). Sorted cells were spun onto glass slides for immunocytochemical staining. 
Slides were washed three times in washing buffer and fixed in 70% ethanol (in 
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50 mM glycine buffer, pH 2.0) for at least 20 min at -20°C. After three times 
washing cells were covered with anti-BrdU-working solution and incubated for 
30 min at 37°C. Again cells were washed three times and incubated with anti-
mouse-lg-fluorescein working solution and incubated at 37°C for 30 min. Finally 
cells were washed three times, covered with a mounting medium and examined 
in a fluorescence microscope. 
Cell cycle analysis by flow cytometry 
Cells were analysed by using a flow cytometry assisted cell sorter (FACS 
Star Plus, Secton Dickinson) having an argon Iaser for measuring the DNA dye 
H33258 (Hoechst) at 350-360 nm (extinction) and 425±22 nm (emission), GFP at 
488 nm (extinction) and 530±15 nm (emission) and red autofluorescence of the 
cells at 488 nm (extinction) and 575±13 nm (emission). Data analysis was done 
using the supplied software (Cell Quest). 
Measurements of Firefly luciferase activity 
The medium was removed and cells were washed twice in PBS without 
Ca2+ and Mg2+. The PBS was removed from cultures and 200 111 of Iysis buffer 
(0.1 M Tris acetate , pH 7 .5, 2mM EDTA, 1% Triton-X-1 00) was added. The 
cultures were kept on ice for 10 min and occasionally rocked to distribute the 
buffer evenly over the plates. 
The cell lysates were collected with a policeman into precooled eppendorf tubes 
and the cleared supernatant was collected after 5 min of centrifugation at 
12000xg. Luciferase activity was measured by a Iuminator (Berthold, Wildbad). 
The lysate was transferred into a reading tube with autoinjection of 350 111 of 
assay buffer (1mM DTT, 1mM ATP in glycylglycine buffer (25mM GlyGiy, 15mM 
MgS04 and 4mM EGTA) and 100 111 of Iuciferin assay solution (1 mM Iuciferin 
stock solution (0.28 mg/ml) in glycylglycine buffer diluted 1 :5). 
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Measurement of Renilla luciferase activity tagether with Firefly 
luciferase activity out of the same cell lysate 
(J.C. Matthews et al., 1977) 
Transfeeted cells were washed with PBS without Ca2+ and Mg2+ and lysed 
in 200 J!l passive Iysis buffer (Promega, Mann heim). 100 J!l of lysate were 
analyzed for firefly luciferase activity (see above). To determine renilla luciferase 
activity 10 J!l of lysate were mixed with 390 J!l of reaction buffer (0.1 M KPi-buffer 
(0,2 M KH2P04 and 0,2 M K2HP04, pH 7,6), 0.5 M NaCI, 1 mM EDTA) together 
with 100 J!l of 5x substrate solution (125 nM coelenterazine (Biosynth AG, 
Gstaad, Schweiz) in reaction buffer). After vortexing luminescence was 
measured by a Iuminator (Berthold, Vl/ildbad). 
Oligonucleotides 
All oligos were obtained from either MWG Biotech GmbH or from Birsner & 
Grob-Biotech GmbH and were all of a HPLC purified grade. 
For Sequencing 
(i). 5'- GTTTTCCCAGTCACGAC-3' 
(ii). 5'- CAGGAAACAGCTATGAC-3' 
(iii). 5'- TAATACGACTCACTATAGGG-3' 
(iv). 5'- ATTAACCCTCACTAAAG-3' 
For PCR 
(i). 5'- ACCACAGTCCATGCCATCAC-3' 
(ii). 5'-TCCACCACCCTGTTGCTGTA-3' 
(iii). 5' -GCCCAAGTCTGTGAAACTACTTGATTTCC-3' 
(iv). 5' -GACCCAGCGGTGGAGTAGTGCTGTC-3' 
(v) 5'-TGGCTCCTGGCTGCAGCAGGAGTGG-3' 
(vi) 5' -GCAGAGGGAAAGAGGTCAGAAGGCTGGC-3' 
PUC/M13 For-Texas red 
PUC/M13 Rev-Texas red 
T7-Texas red 
T3-Texas red 
GP5 
GP3 
106.1 
106.2 
GST-YA 5 
GST-YA 3 
(vii) 5' -ATGCATCCCTTCTACACTCGG-3' BTG1.1 
(viii) 5'-CTATATCTTAACCTGATACAGTC-3' BTG1.2 
(ix) 5' -AGCCCGAGCCTGGAGCGGATGGACGCC-3' Kip1.5 
(x) 5' -GGCCAGGCTTCTTGGGCGTCTGCTCCACAG-3' Kip1.3 
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Northern probes 
(i) GAPDH: 1.3 kB Pst I fragment from the plasmid pGAPDH-13 (Fort et al., 
1985) 
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(ii) CYP1A1: Pst I-digestion of pSV4501A1 (Dogra et al., 1990) generated an 
approximately 400bp fragment which was gel purified and used as a probe 
(iii) GSTya: GSTya cDNA probe was generated by RT-PCR from 5L cell RNA 
using primers GST~YA 5 and GST-YA 3 
(iv) p27: rat Kip1 cDNA probe was generated by RT-PCR from 5L cell RNA 
using primers corresponding to nt 28-54 and nt 548-577 of the murine 
cDNA 
Plasmids 
pCMV5: (Weiß et al., 1996) 
pCMV5-hGFP: Xho 1/Hind 111 open reading frame from GFP (Heim et al.,1995) 
was subcloned into Sal 1/Hind 111 digested pCMV5. 
pCMV5-AhR1-805: pmu-AhR (passed by M. Göttlicher) was Sal I digested and 
partially filled in by Klenow polymerase, digested with Nhe I torelease AhR1-805 
cDNA. This was inserted into pCMV5, which was Bglll digested, partially filled in 
by Klenow polymerase and again digested by Xba I. 
pCMV5-Ahr1-605: pmu-AhR was digested with Pst I, 3'-overhangs were 
removed by Klenow enzyme and digested again which BamH I to release AhR 
cDNA 418-605. 
This fragment is Iigated into Sma I and BamH I digested CMV5-AhR1-805 (which 
releases cDNA portion of AhR 418-805) to get AhR 1-605. 
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pCMV5-AhR1-408: pmu-AhR was digested with Sal I, filled in by Klenow 
polymerase and digested with Bgl II to generate AhR1-408 fragment. This was 
Iigated into pHook 2 (invitrogen, Netherlands), which was digested with Hind 111, 
filled in by Klenow polymerase and then digested by Bgl II. The cDNA fragment 
of AHR1-408 containing the stop codon was released from pHook 2-AhR-1-408 
by Hind 111/BamH I digestion and Iigated into Hind 111/BamH I digested pCMV5. 
pCMV5-AhRm39: passed by M. Göttlicher 
pCMV5-ARNT: Cla 1/Xba I released fragment from plasmid pCMV4-ARNT 
(Weiß et al., 1996) was subcloned into Cla 1/ Xba I digested pCMV5. 
pCMV5-ilbHLH-ARNT: pBS-ilbHLH-ARNT (Weiß et al., 1996) was 
BamH 1/Sall digested and subcloned into Bgl 11/Sal I digested pCMV5. 
pCMV5-antiKip1: the antisense expression vector was generated by cloning 
the PCR-product used as a northern probe into pCMV5. 
89 
5. Literature 
Abdollahi, A., Godwin, A.K., Miller, P.D., Getts, LA., Schultz, D.C., Taguchi, T., 
Testa, J.R. and Hamilton, T.C. (1997) ldentification of a gene containing zinc-
finger motifs based on lost expression in malignantly transformed rat ovarian 
surface epithelial cells. Cancer Res, 57, 2029-2034. 
Astroff, 8., Rowlands, C., Dickerson, R. and Safe, S. (1990) 2,3,7,8-
T etrachlorodibenzo-p-dioxin inhibition of 17 beta-estradiol- induced increases in 
rat uterine epidermal growth factor receptor binding activity and gene expression. 
Mol Gell Endocrinol, 72, 247-252. 
Ausubel, F., Brent, R., Kingston, R., Moore, 0., Seidman, J., Smith, J. and Struhl, 
K. (1989) Current Protocols in Molecular Biology. (New York: John Wiley and 
Sons, /nc.). 
Bacsi, S.G. and Hankinson, 0. (1996) Functional characterization of DNA-
binding domains of the subunits of the heterodimeric aryl hydrocarbon receptor 
complex imputing novel and canonical basic helix-loop-helix protein-DNA 
interactions. J Bio/ Chem, 271, 8843-8850. 
Bartek, J., Bartkova, J. and Lukas, J. (1996) The retinoblastoma protein pathway 
and the restriction point. Gurr Opin Gell Bio/, 8, 805-814. 
Berghard, A., Gradin, K. and Toftgard, R. (1992) The stability of dioxin-receptor 
ligands influences cytochrome . P4501A 1 expression in human keratinocytes. 
Carcinogenesis, 13, 651-655. 
Bertazzi, A., Pesatori, A.C., Consonni, D., Tironi, A., Landi, M.T. and Zocchetti, C. 
(1993) Cancer incidence in a population accidentally exposed to 2,3,7,8-
tetrachlorodibenzo-para-dioxin. Epidemiology, 4, 398-406. 
Bertazzi, P.A., Zocchetti, C., Guercilena, S., Consonni, D., Tironi, A., Landi, M.T. 
and Pesatori, A.C. (1997) Dioxin exposure and cancer risk: a 15-year mortality 
study after the 11 Seveso accident ... Epidemiology, 8, 646-652. 
90 
Bolen, J., Veillette, A., Schwartz, A., DeSeau, V. and Rosen, N. (1987) Activation 
of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad 
Sei USA, 84, 2251-2255. 
Burbach, K.M., Poland, A. and Bradfield, C.A. (1992) Cloning of the Ah-receptor 
cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad 
Sei USA, 89, 8185-8189. 
Carlstedt-Duke, J.M., Harnemo, U.B., Hogberg, B. and Gustafsson, J.A. (1981) 
Interaction of the hepatic receptor protein for 2,3,7,8- tetrachlorodibenzo-rho-
dioxin with DNA. Biochim Biophys Acta, 672, 131-141 . 
Cartwright, C.A., Mamajiwalla, S., Skolnick, S.A., Eckhart, W. and Burgess, D.R. 
(1993) Intestinal crypt cells contain higher Ieveis of cytoskeletal-associated 
pp60c-src protein tyrosine kinase activity than do differentiated enterocytes. 
Oncogene,8, 1033-1039. 
Chalfie, M., Tu, Y., Euskirchen, G., Ward, W.W. and Prasher, D.C. (1994) Green 
fluorescent protein as a marker for gene expression. Science, 263, 802-805. 
Christian, B.J., lnhorn, S.L. and Peterson, R.E. (1986) Relationship of the wasting 
syndrome to lethality in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. 
Toxico/ Appl Pharmacol, 82, 239-255. 
Church, G. and Gilbert, W. (1984) Genomic sequencing. Proc Natl Acad Sei U S 
A, 81, 1991-1995. 
Cikryt, P., Göttlicher, M. and Neumann, H. (1990) Competitive binding affinity of 
carcinogenic aromatic amines to the rat hepatic aromatic hydrocarbon (Ah) 
receptor in vitro and potency to induce monooxygenase activity in vivo. 
Carcinogenesis, 11, 1359-1366. 
9.1 
Cikryt, P., Göttlicher, M., Veser, U. and Schwarz, L. (1992) The Ievel of aryl 
hydrocarbon (Ah) receptor and of 48 polycyclic aromatic hydrocarbon (PAH) 
binding protein in diploid and polyploid hepatocytes of 2-acetylaminofluorene-
treated rats. Garcinogenesis, 13, 807-81 0. 
Citri, Y., Colot, H., Jacquier, A., Yu, Q., Hall, J., Baltimore, 0. and Rosbash, M. 
(1987) A family of unusually spliced biologically active transcripts encoded by a 
Drosophila clock gene. Nature, 326, 42-47. 
Coats, S., Flanagan, W.M., Nourse, J. and Roberts, J.M. (1996) Requirement of 
p27Kip1 for restriction point control of the fibroblast cell cycle. Science, 272, 
877-880. 
Couture, L., Abbott, B. and Birnbaum, L. (1990) A critical review of the 
developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: 
recent advances toward understanding the mechanism. Teratology, 42, 619-627. 
Crews, S., Thomas, J. and Goodman, C. (1988) The Drosophila single-minded 
Gene Encodes a Nuclear Protein with Sequence Similarity tothe per Gene 
Product. Gell, 52, 143-151. 
Cuthill, S., Wilhelmsson, A. and Poellinger, L. (1991) RoJe of the Iigand in 
intracellular receptor function: receptor affinity determines activation in vitro of the 
latent dioxin receptor to a DNA-binding form. Mol Gell Bio/, 11, 401-411. 
Davis, R.L., Cheng, P.F., Lassar, A.B. and Weintraub, H. (1990) The MyoD DNA 
binding domain contains a recognition code for muscle- specific gene activation. 
Gell, 60, 733-746. 
Denis, M., Cuthill, S., Wikstrom, A.C., Poellinger, L. and Gustafsson, J.A. {1988) 
Association of the dioxin receptor with the Mr 90,000 heat shock protein: a 
structural kinship with the glucocorticoid receptor. Bioehern Biophys Res 
Gommun, 155, 801-807. 
Denison, M., Fisher, J. and Whitlock, J.J. (1989) Protein-DNA Interaction at 
Recognition Sites for the Dioxin-Ah Receptor Complex. J Bio/ Ghem, 264, 
16478-16482. 
92 
Diamond, M., Miner, J., Yoshinaga, S. and Yamamoto, K. (1990) Transcription 
factor interactions: selectors of positive or negative regulation from a single DNA 
element. Science, 249, 1266-1272. 
Diatchenko, L., Lau, Y.F., Campbell, A.P., Chenchik, A., Moqadam, F., Huang, 8., 
Lukyanov, S., Lukyanov, K., Gurskaya, N., Sverdlov, E.D. and Siebert, P.D. 
(1996) Suppression subtractive hybridization: a method for generating 
differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl 
Acad Sei USA, 93, 6025-6030. 
Dogra, S., Doehmer, J., Glatt, H., Mölders, H., Siegert, P., Friedberg, T., Seidel, A. 
and Oesch, F. (1990) Stable Expression of Rat Cytochrome P-450/A 1 cDNA in 
V79 Chinese Hamster Cells and Their Use in Mutagenitiy Testing. Mol. 
Pharmacol., 37, 608-613. 
Dong, L., Ma, Q. and Whitlock, J.P., Jr. (1996) DNA binding by the heterodimeric 
Ah receptor. Relationship to dioxin- induced CYP1A 1 transcription in vivo. J Bio/ 
Ghem, 271, 7942-7948. 
Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., 
Elledge, S.J. and Reed; S.l. (1994) p53-dependent inhibition of cyclin-dependent 
kinase activities in human fibroblasts during radiation-induced G1 arrest. Gell, 
76, 1013-1023. 
Eadon, G., Kaminsky, L., Silkworth, J., Aldous, K., Hilker, D., O'Keefe, P., Smith, 
R., Gierthy, J., Hawley, J., Kim, N. and et al. (1986) Calculation of 2,3,7,8-TCDD 
equivalent concentrations of complex environmental contaminant mixtures. 
Environ Hea/th Perspect, 70, 221-227. 
EI-Deiry, W., Tokino, T., Velculescu, V., Levy, D., Parsons, R., Trent, J., Lin, D., 
Mercer, W., Kinzler, K. and Vogelstein, B. (1993) WAF1, a potential mediater of 
p53 tumor suppression. Gell, 75, 817-825. 
Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, 0., 
Funae, Y. and Fujii-Kuriyama, Y. (1992) cDNA cloning and structure of mouse 
putative Ah receptor. Bioehern Biophys Res Gommun, 184, 246-253. 
93 
Enan, E. and Matsumura, F. (1995) Evidence for a second pathway in the action 
mechanism of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-
receptor mediated activation of protein kinase under cell-free conditions. 
Bioehern Pharmaco/, 49, 249-261. 
Fernandez-Salguero, P., Pineau, T., Hilbert, D.M., McPhail, T., Lee, S.S., Kimura, 
S., Nebert, D.W., Rudikoff, S., Ward, J.M. and Gonzalez, F.J. (1995) Immune 
system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah 
receptor . Science, 268, 722-726. 
Fernandez-Salguero, P.M., Hilbert, D.M., Rudikoff, S., Ward, J.M. and Gonzalez, 
F.J. (1996) Aryl-hydrocarbon receptor-deticient mice are resistant to 2,3,7,8-
tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol, 140, 173-
179. 
Fero, M.L., Rivkin, M., Tasch, M., Porter, P., Carow, C.E., Firpo, E., Polyak, K., 
Tsai, L.H., Broudy, V., Perlmutter, R.M., Kaushansky, K. and Roberts, J.M. (1996} 
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, 
and female sterility in p27(Kip1)-deficient mice. Gell, 85, 733-744. 
Fine, J.S., Silverstone, A.E. and Gasiewicz, T.A. (1990) lmpairment of 
prothymocyte activity by 2,3,7,8-tetrachlorodibenzo-p- dioxin. J lmmuno/, 144, 
1169-i 176. 
Flesch-Janys, 0., Berger, J., Gurn, P., Manz, A., Nagel, S., Waltsgott, H. and 
Dwyer, J.H. (1995) Exposure to polychlorinated dioxins and furans (PCDD/F) and 
mortality in a cohort of workers from a herbicide-producing plant in Hamburg, 
Federal Republic of Germany. Am J Epidemio/, 142, 1165-1175. 
Fort, P., Marty, L., Piechaczyk, M., EI Saboutry, S., Dani, C., Jeanteur, P. and 
Blanchard, J. (1985) Various rat adult tissues express only one major m-RNA 
species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. 
Nucleic Acids Res., 13, 1431-1442. 
Fox, T., Best, L., Goldsworthy, S., Mills, J. and Goldsworthy, T. (1993) Gene 
expression and cell proliferation in rat liver after 2,3,7,8-tetrachlorodibenzo-p-
dioxin exposure. Cancer Res, 53, 2265-2271. 
94 
Frazier, D.E., Jr., Silverstone, A.E., Soults, J.A. and Gasiewicz, T.A. (1994) The 
thymus does not mediate 2,3, 7 ,8-tetrachlorodibenzo-p-dioxin- elicited alterations 
in bone marrow lymphocyte stem cells. Toxico/ Appl Pharmacol, 124, 242-247. 
Frohman, M.A., Dush, M.K. and Martin, G.R. (1988) Rapid production of full-length 
cDNAs from rare transcripts: amplification using a single gene-specific 
oligonucleotide primer. Proc Natl Acad Sei U S A, 85, 8998-9002. 
Fujisawa-Sehara, A., Yamane, M. and Fujii-Kuriyama, Y. (1988) A DNA-binding 
factor specific for xenobiotic responsive elements of P-450c gene exists as a 
cryptic form in cytoplasm: lts possible translocation to nucleus. Proc Natl Acad 
Sei USA, 85, 5859-5863. 
Fukunaga, B.N. and Hankinson, 0. (1996) ldentification of a novel domain in the 
aryl hydrocarbon receptor required for DNA binding. J Bio/ Chem, 271 , 37 43-
3749. 
Fukunaga, B.N., Probst, M.R., Reisz-Porszasz, S. and Hankinson, 0. (1995) 
ldentification of functional domains of the aryl hydrocarbon receptor. J Bio/ Chem, 
270, 29270-29278. 
Gao, L., Dang, L. and Whitlock, J.P., Jr. (1998) A novel response to dioxin. 
lnduction of ecto-ATPase gene expression. J Bio/ Chem, 273, 15358-15365. 
Ge, N. and Elferink, C. (1998) A direct interaction between the aryl hydrocarbon 
receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle. J 
Bio/ Chem, 273, 22708-22713. 
Gentile, V., Saydak, M., Chiocca, A., Akande, 0., Birckbichler, P., Lee, K., Stein, J. 
and Davies, P. (1991) Isolation and Characterization of cDNA Clones to Mouse 
Macraphage and Human Endothelial Cell Tissue Transglutaminases. J Bio/ 
Chem, 266, 478-483. 
95 
Giang, O.K. and Cravatt, B.F. (1998) A second mammalian N-
myristoyltransferase. J Bio/ Chem, 273, 6595-6598. 
Göttlicher, M., Cikryt, P. and Wiebel, F.J. (1990) Inhibition of growth by 2,3,7,8-
tetrachlorodibenzo-p-dioxin in 5L rat hepatoma cells is associated with the 
presence of Ah receptor. Careinogenesis, 11, 2205-2210. 
Göttlicher, M., Heck, S. and Herrlich, P. (1998) Transcriptional cross-talk, the 
second mode of steroid hormone receptor action. J Mol Med, 76, 480-489. 
Göttlicher, M. and Wiebel, F.J. (1991) 2,3,7,8-Tetrachlorodibenzo-p-dioxin 
causes unbalanced growth in 5L rat hepatoma ce!ls. Toxicol Appl Pharmaeol, 
111' 496-503. 
Gottlinger, H., Sodroski, J. and Haseltine, W. (1989) Role of capsid precursor 
processing and myristoylation in morphogenesis and infectivity of human 
immunodeficiency virustype 1. Proe Natl Aead Sei USA, 86, 5781-5785. 
Gurskaya, N.G., Oiatchenko, L., Chenchik, A., Siebert, P.O., Khaspekov, G.L., 
Lukyanov, K.A., Vagner, L.L., Ermolaeva, 0.0., Lukyanov, S.A. and Sverdlov, 
E.D. (1996) Equalizing cONA subtraction based on selective Suppression of 
polymerase chain reaction: cloning of Jurkat cell transcripts induced by 
phytohemaglutinin and phorbol 12-myristate 13-acetate. Anal Bioehem, 240, 90-
97. 
Hankinson, 0. (1995) The aryl hydrocarbon receptor complex. Annu Rev 
Pharmaeol Toxieol, 35, 307-340. 
Hannon, G.J. and Beach, 0. (1994) p151NK4B is a potential effector of TGF-beta-
induced cell cycle arrest. Nature, 371, 257-261. 
Hapgood, J., Cuthill, S., Oenis, M., Poellinger, L. and Gustafsson, J.A. (1989) 
Specific protein-ONA interactions at a xenobiotic-responsive element: 
copurification of dioxin receptor and ONA-binding activity. Proe Natl Aead Sei U 
S A, 86, 60-64. 
96 
Heck, S., Kullmann, M., Gast, A., Ponta, H., Rahmsdorf, H.J., Herrlich, P. and 
Cato, A.C. (1994) A distinct modulating domain in glucocorticoid receptor 
monemers in the repression of activity of the transcription factor AP-1 . Embo J, 
13, 4087-4095. 
Heichman, K. and Roberts, J. (1994) Rules to Replicate By. Gel/, 79, 557-562. 
Heim, R., Cubitt, A.B. and Tsien, R.Y. (1995) lmproved green fluorescence. 
Nature, 373, 663-664. 
Hengst, L., Dulic, V., Slingerland, J., Lees, E. and Reed, S. (1994) A cell cycle-
regulated inhibitor of cyc!in-dependent kinases. Proc Natl Acad Sei U S A, 91 , 
5291-5295. 
Hengst, L. and Reed, S.l. (1996) Translational control of p27Kip1 accumulation 
during the cell cycle. Science, 271, 1861-1864. 
Hoffer, A., Chang, C.Y. and Puga, A. (1996) Dioxin induces transcription of tos 
and jun genes by Ah receptor-dependent and -independent pathways. Toxicol 
Appl Pharmacol, 141 , 238-24 7. 
Hoffman, E.C., Reyes, H., Chu, F.F., Sander, F., Conley, L.H., Brooks, B.A. and 
Hankinson, 0. (1991) Cloning of a factor required for activity of the Ah (dioxin) 
receptor. Science, 252, 954-958. 
Huang, Z., Edery, I. and Rosbash, M. (1993) PAS is a dimerization domain 
common to Drosophila Period and several transcription factors. Nature, 364, 
259-262. 
Hubank, M. and Schatz, D. (1994) ldentifying differences in mRNA expression by 
representational difference analysis of cDNA. Nuc/eic Acids Res, 22, 5640-5648. 
Hudson, L.G., Toscano, W.A., Jr. and Greenlee, W.F. (1985) Regulation of 
epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-
tetrachlorodibenzo-p-dioxin. Toxicol App/ Pharmacol, 77, 251-259. 
97 
Huff, J., Lucier, G. and Tritscher, A. (1994) Carcinogenicity of TCDD: 
experimental, mechanistic, and epidemiologic evidence. Annu Rev Pharmaco/ 
Toxicol, 34, 343-372. 
Hushka, D.R. and Greenlee, W.F. (1995) 2,3,7,8-Tetrachlorodibenzo-p-dioxin 
inhibits DNA synthesis in rat primary hepatocytes. Mutat Res, 333, 89-99. 
ltoh, S. and Kamataki, T. (1993) Human Ah receptor cDNA: analysis for highly 
conserved sequences. Nuc/eic Acids Res, 21, 3578. 
Jain, S., Dolwick, K.M., Schmidt, J.V. and Bradfield, C.A. (1994) Potent 
transactivation domains of the Ah receptor and the Ah receptor nuclear 
translocator map to their carboxyl termini. J Bio/ Ghem, 269, 31518-31524. 
Johnson, D., Bhatnagar, R., Knoll, L. and Gordon, J. (1994) Genetic and 
biochemical studies of protein N-myristoylation. Annu Rev Biochem, 63, 869-
914. 
Jonat, C., Rahmsdorf, H., Park, K., Cato, A., Gebel, S., Ponta, H. and Herrlich, P. 
(1990) Antitumor Promotion and Antiinflammation: Down-Modulation of AP-1 
(Fos/Jun) Activity by Glucocorticoid Hormone. Gell, 62, 1189-1204. 
Kadesch, T. (1993) Consequences of heteromeric interactions among helix-loop-
helix proteins. Gell Growth Differ, 4, 49-55. 
Kamps, M.P., Buss, J.E. and Sefton, B.M. (1986) Rous sarcoma virus 
transforming protein lacking myristic acid phosphorylates known polypeptide 
substrates without inducing transformation. Gell, 45, 1 05-112. 
Karenlampi, S., Legraverend, C., Gudas, J., Carramanzana, N. and Hankinson, 
0. (1988) A Third Genetic Locus Affecting the Ah (Dioxin) Receptor. J Bio/ Ghem, 
263, 10111-10117. 
Kato, J.Y., Matsuoka, M., Polyak, K., Massague, J. and Sherr, C.J. (1994) Cyclic 
AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-
dependent kinase 4 activation. Gell, 79, 487-496. 
98 
Kiyokawa, H., Kineman, R.D., Manova-Todorova, K.O., Soares, V.C., Hoffman, 
E.S., Ono, M., Khanam, D., Hayday, A.C., Frohman, L.A. and Kaff, A. (1996) 
Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor tunction 
of p27(Kip1 ). Gell, 85, 721-732. 
Kleman, M.l., Poellinger, L. and Gustafsson, J.A. (1994) Regulation of human 
dioxin receptor function by indolocarbazoles, receptor ligands of dietary origin. J 
Bio/ Ghem, 269, 5137-5144. 
Knutson, J. and Poland, A. (1980) 2,3,7,8-Tetrachlorodibenzo-p-dioxin: failure to 
demonstrate toxicity in twenty-three cultured cell types. Toxicol Appl Pharmacol, 
54, 377-383. 
Knutson, J. and Poland, A. (1982) Response of Murine Epidermis to 2,3,7,8-
Tetrachlorodibenzo-p-dioxin: Interaction of the Ah and hr Loci. Gell, 30, 225-234. 
Kociba, R.J., Keyes, D.G., Beyer, J.E., Carreon, R.M., Wade, C.E., Dittenber, D.A., 
Kalnins, R.P., Frauson, L.E., Park, C.N., Barnard, S.O., Hummel, R.A. and 
Humiston, C.G. (1978) Results of a two-year chronic toxicity and oncogenicity 
study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmaco/, 46, 
279-303. 
Kogevinas, M., Becher, H., Benn, T., Bertazzi, P.A., Boffetta, P., Bueno-de-
Mesquita, H.B., Coggon, D., Colin, D., Flesch-Janys, D., Fingerhut, M., Green, L., 
Kauppinen, T., Littorin, M., Lynge, E., Mathews, J.D., Neuberger, M., Pearce, N. 
and Saracci, R. (1997) Cancer mortality in workers exposed to phenoxy 
herbicides, chlorophenols, and dioxins. An expanded and updated international 
cohort study. Am J Epidemiol, 145, 1061-1075. 
Kwon, T.K., Nagel, J.E., Buchholz, M.A. and Nordin, A.A. (1996) Characterization 
of the murine cyclin-dependent kinase inhibitor gene p27Kip1. Gene, 180, 113-
120. 
Laemmli, U. (1970) Cleavage of structural proteins during the assembly of the 
head of pacteriophage T4. Nature, 227, 680-685. 
99 
Lai, Z.W., Hundeiker, C., Gleichmann, E. and Esser, C. (1997) Cytokine gene 
expression during ontogeny in murine thymus on activation of the aryl 
hydrocarbon receptor by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Pharmaco/, 
52, 30-37. 
Lees, E. (1995) Cyclin dependent kinase regulation. Gurr Opin Gell Bio/, 7, 773-
780. 
Legraverend, C., Hannah, R., Eisen, H., Owens, I., Nebert, D. and Hankinson, 0. 
(1982} Regulatory Gene Product of the Ah Locus. Characterization of receptor 
mutants among mouse hepatoma clones. J Bio/ Ghem, 257, 6402-6407. 
Li, H., Dong, L. and Whitlock, J.J. (1994) Transcriptional activation function of the 
mouse Ah receptor nuclear translocator. J Bio/ Ghem, 269, 28098-28105. 
Liang, P. and Pardee, A.B. (1992} Differential display of eukaryotic messenger 
RNA by means of the polymerase chain reaction. Science, 257, 967-971 . 
Lin, F.H., Clark, G., Birnbaum, L.S., Lucier, G.W. and Goldstein, J.A. (1991) 
lnfluence of the Ah locus on the effects of 2,3,7,8-tetrachlorodibenzo- p-dioxin on 
the hepatic epidermal growth factor receptor. Mol Pharmacol, 39, 307-313. 
Lindebro, M.C., Poellinger, L. and Whitelaw, M.L. (1995) Protein-protein 
interaction via PAS domains: role of the PAS domain in positive and negative 
regulation of the bHLH/PAS dioxin receptor-Arnt transcription factor complex. 
Embo J, 14, 3528-3539. 
Lisitsyn, N., Lisitsyn, N. and Wigler, M. (1993) Cloning the differences between 
two complex genomes. Science, 259, 946-951. 
Lowell, C. and Soriano, P. (1996) Knockouts of Src-family kinases: stiff bones, 
wimpy T cells, and bad memories. Genes Dev, 10, 1845-1857. 
Lucier, G.W., Portier, C.J. and Gallo, M.A. (1993) Receptor mechanisms and 
dose-response models for the effects of dioxins. Environ Hea/th Perspect, 1 01 , 
36-44. 
100 
Madhukar, B., Brewster, D. and Matsumura, F. (1984) Effects of in vivo-
administrered 2,3,7,8-tetrachlorodibenzo-p-dioxin on receptor binding of 
epidermal growth factor in the hepatic plasma membrane of rat, guinea pig, 
mouse, and hamster. Proc Natl Acad Sei USA, 81. 
Magnuson, B.A., Raju, R.V., Moyana, T.N. and Sharma, R.K. (1995) lncreased N-
myristoyltransferase activity observed in rat and human colonic tumors. J Natl 
Cancer lnst, 87, 1630-1635. 
Maniatis, T., Fritsch, E. and Sambrook, J. (1989) Molecular Cloning. A Iabaratory 
manual. (2nd ed.). Cold Spring Harbor Laboratory, N. Y. 
Manz, A., Berger, J., Dwyer, J.H., Flesch-Janys, 0., Nagel, S. and Waltsgott, H. 
(1991) Cancer mortality among workers in chemical plant contaminated with 
dioxin. Lancet, 338, 959-964. 
Mason, G.G., Witte, A.M., Whitelaw, M.L., Antonsson, C., McGuire, J., 
Wilhelmsson, A., Poellinger, L. and Gustafsson, J.A. (1994) Purification of the 
DNA binding form of dioxin receptor. Role of the Arnt cofactor in regulation of 
dioxin receptor function. J Bio/ Chem, 269, 4438-4449. 
Massague', J. and Polyak, K. (1995) Mammalian antiproliferative signals and 
their targets. Gurr Opin Genet Dev, 5, 91-96. 
Matsushime, H., Quelle, D.E., Shurtleff, S.A., Shibuya, M., Sherr, C.J. and Kato, 
J.Y. (1994) D-type cyclin-dependent kinase activity in mammalian cells. Mol Gell 
Bio/, 14, 2066-2076. 
Matthews, J.C., Hori, K. and Cormier, M.J. (1977) Purification and properties of 
Renilla reniformis luciferase. Biochemistry, 16, 85-91. 
Migliaccio, A., Di Domenico, M., Castoria, G., de Falco, A., Bontempo, P., Nola, E. 
and Auricchio, F. (1996) Tyrosine kinase/p21 ras/MAP-kinase pathway activation 
by estradiol-receptor complex in MCF-7 cells. EMBO J., 15, 1292-1300. 
Millard, S.S., Yan, J.S., Nguyen, H., Pagano, M., Kiyokawa, H. and Koff, A. (1997) 
Enhanced ribosemal association of p27(Kip1) mRNA is a mechanism 
contributing to accumulation during growth arrest. J Bio/ Chem, 272, 7093-7098. 
101 
Miller, AG., Israel, D. and Whitlock, J.P., Jr. (1983) Biochemical and genetic 
analysis of variant mause hepatoma cells defective in the induction of 
benzo(a)pyrene-metabolizing enzyme activity. J Bio/ Ghem, 258, 3523-3527. 
Minami, S., Ohtani-Fujita, N., lgata, E., Tamaki, T. and Sakai, T. (1997) Molecular 
cloning and characterization of the human p27Kip1 gene promoter. FEBS Lett, 
411' 1-6. 
Morgan, D.O. (1995) Principles of CDK regulation. Nature, 374, 131-134. 
Moses, M. and Prioleau, P. (1985) Cutaneous histologic findings in chemical 
workers with and without chloracne with past exposure to 2,3,7,8-
tetrachlorodibenzo-p-dioxin. J Am Acad Dermatol., 12, 497-506. 
Murre, C., McCaw, P.S. and Baltimore, D. (1989) A new DNA binding and 
dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, 
and myc proteins. Gell, 56, 777-783. 
Nakayama, K., lshida, N., Shirane, M., lnomata, A., lnoue, T., Shishido, N., Horii, I. 
and Loh, D.Y. (1996) Mice lacking p27(Kip1) display increased body size, 
multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Gell, 85, 707-
720. 
Nambu, J., Franks, R., Hu, S. and Crews, S. (1990) The sing/e-minded Gene of 
Drosophila ls Required for the Expression of Genes lmportant for the 
Development of CNS Midline Cells. Gell, 63, 63-75. 
Nambu, J., Lewis, J., Wharton, K.J. and Crews, S. (1991) The Drosophila single-
minded gene encodes a helix-loop-helix protein that acts as a master regulator of 
CNS midline development. Gell, 67, 1157-1167. 
Nebert, D.W., Puga, A. and Vasiliou, V. (1993) Role of the Ah receptor and the 
dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction. Ann 
NY Acad Sei, 685, 624-640. 
102 
Noda, A, Ning, Y., Venable, S.F., Pereira-Smith, O.M. and Smith, J.R. (1994) 
Cloning of senescent cell-derived inhibitors of DNA synthesis using an 
expression screen. Exp Gell Res, 211, 90-98. 
Okey, AB., Riddick, D.S. and Harper, P.A (1994) Molecular biology of the 
aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol Sei, 15, 226-232. 
Ott, M.G. and Zober, A (1996) Cause specific mortality and cancer incidence 
among employees exposed to 2,3,7,8-TCDD after a 1953 reactor accident. 
Occup Environ Med, 53, 606-612. 
Pagano, M., Tam, S.W., Theodoras, AM., Beer-Romero, P., Dei Sal, G., Chau, V., 
Yew, P.R., Draetta, G.F. and Rolfe, M. (1995) Role of the ubiquitin-proteasome 
pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. 
Science, 269, 682-685. 
Pardee, AB. (1989) G1 events and regulation of cell proliferation. Science, 246, 
603-608. 
Park, J., Meisler, A and Cartwright, C. (1993) c-Yes tyrosine kinase activity in 
human colon carcinoma. Oncogene, 8, 2627-2635. 
Peng, D., Fan, Z., Lu, Y., DeBiasio, T., Scher, H. and Mendelsohn, J. (1996) Anti-
epidermal growth factor receptor monoclonal antibody 225 up-regulates p27KIP1 
and induces G1 arrest in prostatic cancer cellline DU145. Cancer Res, 56, 3666-
3669. 
Perdew, G. (1988) Association of the Ah receptor with the 90-kDa heat shock 
protein. J Bio/ Chem, 263, 13802-13805. 
Perdew, G. and Poland, A. (1988) Purification of the Ah receptor from C57BU6J 
mouse liver. J Bio/ Chem, 263, 9848-9852. 
Pesatori, AC., Consonni, D., Tironi, A, Zocchetti, C., Fini, A and Bertazzi, P.A 
(1993) Cancer in a young population in a dioxin-contaminated area. lnt J 
Epidemiol, 22, 1010-1013. 
103 
Peterson, R.E., Theobald, H.M. and Kimme!, G.L. (1993) Developmental and 
reproductive toxicity of dioxins and related compounds: cross-species 
comparisons. Grit Rev Toxieol, 23, 283-335. 
Peterziel, H. (1998) Signaltransduktion durch den Androgenrezeptor: 
genornisehe und nicht-genornisehe Wirkungen von Androgenen und 
Antiandrogenen. Dissertation at the institute of genefies (Forsehungszentrum 
Karlsruhe). 
Poellinger, L., Göttlicher, M. and Gustafsson, J.A. (1992) The dioxin and 
peroxisome proliferator-activated receptors: nuclear receptors in search of 
endogenaus ligands. Trends Pharmacol Sei, 13, 241-245. 
Pokrovsky, A., Cherykh, A., Yastrebova, 0. and Tsyrlov, I. (1991) 2,3,7,8-
Tetrachlorodibenzo-P-dioxin as a possible activator of HIV infection. Bioehern 
Biophys Res Commun, 179, 46-51. 
Po land, A., Glover, E. and Bradfield, C. (1991) Characterization of polyclonal 
antibodies to the Ah receptor prepared by immunization with a synthetic peptide 
hapten. Mol Pharmaeol, 39, 20-26. 
Poland, A. and Knutson, J.C. (1982) 2,3,7,8-tetrachlorodibenzo-p-dioxin and 
related halogenated aromatic hydrocarbons: examination of the mechanism of 
toxicity. Annu Rev Pharmaeol Toxieol, 22, 517-554. 
Pollenz, R., Sattler, C. and Poland, A. (1994) The aryl hydrocarbon receptor and 
aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular 
localizations in Hepa 1 c1 c7 cells by immunofluorescence microscopy. Mol 
Pharmacol, 45, 428-438. 
Polyak, K., Kato, J., Solomon, M., Sherr, C., Massague, J., Roberts, J. and Koff, A. 
(1994a) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and 
contact inhibition to cell cycle arrest. Genes Dev, 8, 9-22. 
Polyak, K., Lee, M.H., Erdjument-Bromage, H., Koff, A., Roberts, J.M., Tempst, P. 
and Massague, J. (1994b) Cloning of p27Kip1, a cyclin-dependent kinase 
inhibitor and a potential mediater of extracellular antimitogenic signals. Gell, 78, 
59-66. 
104 
Pongratz, 1., Mason, G. and Poellinger, L. {1992) Dual roles of the 90-kDa heat 
shock protein hsp90 in modulating functional activities of the dioxin receptor. 
Evidence that the dioxin receptor functionally belongs to a subclass of nuclear 
receptors which require hsp90 both for Iigand binding activity and repression of 
intrinsic DNA binding activity. J Bio/ Ghem, 267, 13728-13734. 
Portier, C., Tritscher, A., Kohn, M., Sewall, C., Clark, G., Edler, L., Hoel, 0. and 
Lucier, G. (1993) Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk 
assessment. Fundam Appl Toxicol, 20, 48-56. 
Puga, A, Nebert, D. and Carrier, F. (1992) Dioxin induces expression of c-fos 
and c-jun proto-oncogenes and a large increase in transcription factor AP-1 . 
DNA Gell Bio/, 11 , 269-281 . 
Puhvel, S.M., Ertl, D.C. and Lynberg, C.A. {1984) lncreased epidermal 
transglutaminase activity following 2,3,7,8- tetrachlorodibenzo-p-dioxin: in vivo 
and in vitro studies with mouse skin. Toxico/ Appl Pharmacol, 73, 42-47. 
Raju, R.V., Moyana, T.N. and Sharma, R.K. {1997) N-Myristoyltransferase 
overexpression in human colorectal adenocarcinomas. Exp Gell Res, 235, 145-
154. 
Rao, M., Subbarao, V., Prasad, J. and Scarpelli, 0. (1988) Carcinogenicity of 
2,3, 7 ,8-tetrachlorodibenzo-p-dioxin in the Syrian golden hamster. 
Garcinogenesis, 9, 1677-1679. 
Reyes, H., Reisz-Porszasz, S. and Hankinson, 0. (1992) ldentification of the Ah 
receptor nuclear translocator protein {Arnt) as a component of the DNA binding 
form of the Ah receptor. Science, 256, 1193-1195. 
Reynisdottir, 1., Polyak, K., lavarone, A. and Massague, J. (1995) Kip/Cip and lnk4 
Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. 
Genes Dev, 9, 1831-1845. 
Rodriguez-Pichardo, A., Camacho, F., Rappe, C., Hansson, M., Smith, A.G. and 
Greig, J.B. {1991) Chloracne caused by ingestion of olive oil contaminated with 
PCDDs and PCDFs. Hum Exp Toxicol, 10, 311-322. 
105 
Rouault, J.-P., Rimokh, R., Tessa, C., Paranhos, G., Ffrench, M., Duret, L., 
Garoccio, M., Germain, 0., Samarut, J. and Magaud, J.-P. (1992) BTG1, a 
member of a new family of antiproliferative genes. EMBO J, 11, 1663-1670. 
Schmidt, J.V. and Bradfield, C.A. (1996) Ah receptor signaling pathways. Annu 
Rev Gel/ Dev Bio/, 12, 55-89. 
Schmith, V.D., Piraino, B., Smith, R.B. and Kroboth, P.D. (1992) Alprazolam in 
end-stage renal disease. II. Pharmacodynamics. Clin Pharmacol Ther, 51, 533-
540. 
Schüle, R. and Evans, R. (1991) Cross-coupling of signal transduction pathways: 
zinc finger meets leueine zipper. Trends Genet, 7, 377-381. 
Selmin, 0., Lucier, G., Clark, G., Tritscher, A., Vanden Heuvel, J., Gastel, J., 
Walker, N., Sutter, T. and Bell, D. (1996) Isolation and characterization of a novel 
gene induced by 2,3, 7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis, 
17, 2609-2615. 
Shemshedini, L., Knautthe, R., Sassone-Corsi, P., Pornon, A. and Gronemeyer, 
H. (1991) Cell-specific inhibitory and stimulatory effects of Fos and Jun on 
transcription activation by nuclear receptors. EMBO J, 10, 3839-3849. 
Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-
dependent kinases. Genes Dev, 9, 1149-1163. 
Shoji, S., Kida, Y., Takenaka, 0., Yoshinaga, T., Funakoshi, T. and Kubota, Y. 
(1990) Myristoylated src-oncogene products are potently detected by the 
monoclonal antibody to the NH2-terminal myristoyi-Giy-Ser-Ser-Lys src- peptide. 
Bioehern Biophys Res Commun, 170, 657-664. 
Siebert, P.D., Chenchik, A., Kellogg, D.E., Lukyanov, K.A. and Lukyanov, S.A. 
(1995) An improved PCR method for walking in uncloned genomic DNA. Nucleic 
Acids Res, 23, 1087-1088. 
106 
Silkworth, J.B., Antrim, L.A. and Sack, G. (1986) Ah receptor mediated 
suppression of the antibody response in mice is primarily dependent on the Ah 
phenotype of lymphoid tissue. Toxico/ Appl Pharmacol, 86, 380-390. 
Silverstone, A.E., Frazier, D.E., Jr., Fiore, N.C., Soults, J.A. and Gasiewicz, T.A. 
(1994a) Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin 
elicit thymic atrophy through different cellular targets. Toxicol Appl Pharmacol, 
126, 248-259. 
Silverstone, A.E., Frazier, D.E., Jr. and Gasiewicz, T.A. (1994b) Alternate immune 
system targets for TCDD: lymphocyte stem cells and extrathymic T-cell 
development. Ex,o Clin lmmunogenet, 11, 94-101. 
Smith, A. and Bates, M. (1992) Confidence Iimit analyses should replace power 
calculations in the interpretation of epidemiologic studies. Epidemiology, 3, 449-
452. 
Smith, A., Patterson, Jr, D., Warner, M., MacKenzie, R. and Needham, L. (1992) 
Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin Ieveis of New Zealand pesticide 
applicators and their implication for cancer hypotheses. J Natl Cancer Jnst, 84, 
104-108. 
Smith, A.H. (1987) Infant exposure assessment for breast milk dioxins and furans 
derived from waste incineration emissions. Risk Anal, 7, 347-353. 
Staples, J., Murante, F., Fiore, N., Gasiewicz, T. and Silverstone, A. (1998) 
Thymic Alterations lnduced by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Are Strictly 
Dependent on Acryl Hydrocarbon Receptor Activation in Hemopoietic Cells. J 
lmmunol, 160, 3844-3854. 
Sutter, T.R., Guzman, K., Dold, K.M. and Greenlee, W.F. (1991) Targets for dioxin: 
genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science, 254, 
415-418. 
Swanson, H. and Yang, J. (1996) Mapping the protein/DNA contact sites of the 
Ah receptor and Ah receptor nuclear translocator. J Bio/ Chem, 271, 31657-
31665. 
107 
Swanson, H.l. and Bradfield, C.A. (1993) The AH-receptor: genetics, structure 
and function. Pharmacogenetics, 3, 213-230. 
Swanson, H.l., Chan, W.K. and Bradfield, C.A. (1995) DNA binding specificities 
and pairing rules of the Ah receptor, ARNT, and SIM proteins. J Bio/ Chem, 270, 
26292-26302. 
Teurich, S. and Angel, P. (1995) The glucocordicoid receptor synergizes with Jun 
homodimers to activate AP-1-regulated promotors lacking GR binding sites. 
Chem. Senses., 20, 251-255. 
Toth, K., Somfai-Reiie, S., Sugar, J. and Bence, J. (1979) Carcinogenicity testing 
of herbicide 2,4,5-trichlorophenoxyethanol containing dioxin and of pure dioxin 
in Swiss mice. Nature, 278, 548-549. 
Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk 
protein kinase activity, is related to p21. Ce//, 78, 67-74. 
Tsyrlov, I. and Pokrovsky, A. (1993) Stimulatory effect of the CYP1A 1 inducer 
2,3,7,8-tetrachlorodibenzo-p-dioxin on the reproduction of HIV-1 in human 
lymphoid cell culture. Xenobiotica, 23, 457-467. 
Turteltaub, K.W., Felton, J.S., Gledhill, B.L., Vogel, J.S., Southon, J.R., Caffee, 
M.W., Finkel, R.C., Nelson, D.E., Proctor, 1.0. and Davis, J.C. (1990) Aceeierater 
mass spectrometry in biomedical dosimetry: relationship between low-level 
exposure and covalent binding of heterocyclic amine carcinogens to DNA. Proc 
Natl Acad Sei USA, 87, 5288-5292. 
Vanden Heuvel, J., Clark, G., Kahn, M., Tritscher, A., Greenlee, W., Lucier, G. and 
Bell, D. (1994) Dioxin-responsive Genes: Examination of Dose-Response 
Relationships Using Quantitative Reverse Transcriptase-Polymerase Chain 
Reaction. Cancer Res, 54, 62-68. 
Velculescu, V., Zhang, L., Vogelstein, 8. and KW, K. (1995) Serial analysis of 
gene expression. Science, 270, 484-487. 
108 
von Stein, O.D., Thies, W.G. and Hofmann, M. (1997) A high throughput 
screening for rarely transcribed differentially expressed genes. Nucleic Acids 
Res, 25, 2598-2602. 
Wang, G.L. and Semenza, G.L. (1995) Purification and characterization of 
hypoxia-inducible factor 1. J Bio/ Ghem, 270, 1230-1237. 
Weinberg, R.A. (1995) The retinoblastoma protein and cell cycle control. Gell, 81, 
323-330. 
Weiß, C., Kolluri, S.K., Kiefer, F. and Gottlicher, M. (1996) Complementation of Ah 
receptor deficiency in hepatoma cells: negative feedback regulation and cell 
cycle control by the Ah receptor. Exp Gell Res, 226, 154-163. 
Whitelaw, M., Göttlicher, M., Gustafsson, J. and Poellinger, L. (1993) Definition of 
a novel Iigand binding domain of a nuclear bHLH receptor: co-localization of 
Iigand and hsp90 binding activities within the regulable inactivation domain of 
the dioxin receptor. EMBO J, 12, 4169-4179. 
Whitelaw, M., McGuire, J., Picard, 0., Gustafsson, J. and Poellinger, L. (1995) 
Heat shock protein hsp90 regulates dioxin receptor function in vivo. Proc Natl 
Acad Sei USA., 92, 4437-4441. 
Whitelaw, M.L., Gustafsson, J.A. and Poellinger, L. (1994) ldentification of 
transactivation and repression functions of the dioxin receptor and its basic helix-
loop-helix/PAS partner factor Arnt: inducible versus constitutive modes of 
regulation. Mol Gell Bio/, 14, 8343-8355. 
Whitlock, J.P., Jr. (1990) Genetic and molecular aspects of 2,3,7,8-
tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmaco/ Toxicol, 30, 251-277. 
Wilhelmsson, A., Whitelaw, M.L., Gustafsson, J.A. and Poellinger, L. (1994) 
Agonistic and antagonistic effects of alpha-naphthoflavone on dioxin receptor 
function. Role of the basic region helix-loop-helix dioxin receptor partner factor 
Arnt. J Bio/ Chem, 269, 19028-19033. 
109 
Yang, J., Thraves, P., Dritschilo, A. and Rhim, J. (1992) Neoplastic transformation 
of immortalized human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. 
Cancer Res, 52, 3478-3482. 
Zavitz, K. and Zipursky, S. (1997) Controlling cell proliferation in differentiating 
tissues: genetic analysis of negative regulators of G1-->S-phase progression. 
Gurr Opin Gell Bio/, 9, 773-781. 
Zober, A., Ott, M.G. and Messerer, P. (1994) Morbidity follow up study of BASF 
employees exposed to 2,3,7, 8- tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 
chemical reactor incident. Occup Environ Med, 51, 479-486. 
